
                                SEQUENCE LISTING

<110> Vir Biotechnology, Inc.
      Humabs BioMed SA

<120> ANTIBODIES AGAINST SARS-COV-2

<130> 930585.409WO

<140> PCT
<141> 2021-05-07

<150> US 63/170,368
<151> 2021-04-02

<150> US 63/153,784
<151> 2021-02-25

<150> US 63/113,450
<151> 2020-11-13

<150> US 63/090,667
<151> 2020-10-12

<150> US 63/057,767
<151> 2020-07-28

<150> US 63/046,465
<151> 2020-06-30

<150> US 63/039,939
<151> 2020-06-16

<150> US 63/036,683
<151> 2020-06-09

<150> US 63/033,045
<151> 2020-06-01

<150> US 63/031,286
<151> 2020-05-28

<150> US 63/029,338
<151> 2020-05-22

<150> US 63/027,814
<151> 2020-05-20

<150> US 63/024,372
<151> 2020-05-13

<150> US 63/022,392
<151> 2020-05-08

<160> 773

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 29902
<212> DNA
<213> betacoronavirus SARS coronavirus 2

<400> 1
attaaaggtt tataccttcc caggtaacaa accaaccaac tttcgatctc ttgtagatct      60
gttctctaaa cgaactttaa aatctgtgtg gctgtcactc ggctgcatgc ttagtgcact     120
cacgcagtat aattaataac taattactgt cgttgacagg acacgagtaa ctcgtctatc     180
ttctgcaggc tgcttacggt ttcgtccgtg ttgcagccga tcatcagcac atctaggttt     240
cgtccgggtg tgaccgaaag gtaagatgga gagccttgtc cctggtttca acgagaaaac     300
acacgtccaa ctcagtttgc ctgttttaca ggttcgcgac gtgctcgtac gtggctttgg     360
agactccgtg gaggaggtct tatcagaggc cgtcaacatc ttaaagatgg cacttgtggc     420
ttagtagaag ttgaaaaagg cgttttgcct caacttgaac agccctatgt gttcatcaaa     480
cgttcggatg ctcgaactgc acctcatggt catgttatgg ttgagctggt agcagaactc     540
gaaggcattc agtacggtcg tagtggtgag acacttggtg tccttgtccc tcatgtgggc     600
gaaataccag tggcttaccg caaggttctt cttcgtaaga acggtaataa aggagctggt     660
ggccatagtt acggcgccga tctaaagtca tttgacttag gcgacgagct tggcactgat     720
ccttatgaag attttcaaga aaactggaac actaaacata gcagtggtgt tacccgtgaa     780
ctcatgcgtg agcttaacgg aggggcatac actcgctatg tcgataacaa cttctgtggc     840
cctgatggct accctcttga gtgcattaaa gaccttctag cacgtgctgg taaagcttca     900
tgcactttgt ccgaacaact ggactttatt gacactaaga ggggtgtata ctgctgccgt     960
gaacatgagc atgaaattgc ttggtacacg gaacgttctg aaaagagcta tgaattgcag    1020
acaccttttg aaattaaatt ggcaaagaaa tttgacacct tcaatgggga atgtccaaat    1080
tttgtatttc ccttaaattc cataatcaag actattcaac caagggttga aaagaaaaag    1140
cttgatggct ttatgggtag aattcgatct gtctatccag ttgcgtcacc aaatgaatgc    1200
aaccaaatgt gcctttcaac tctcatgaag tgtgatcatt gtggtgaaac ttcatggcag    1260
acgggcgatt ttgttaaagc cacttgcgaa ttttgtggca ctgagaattt gactaaagaa    1320
ggtgccacta cttgtggtta cttaccccaa aatgctgttg ttaaaattta ttgtccagca    1380
tgtcacaatt cagaagtagg acctgagcat agtcttgccg aataccataa tgaatctggc    1440
ttgaaaacca ttcttcgtaa gggtggtcgc actattgcct ttggaggctg tgtgttctct    1500
tatgttggtt gccataacaa gtgtgcctat tgggttccac gtgctagcgc taacataggt    1560
tgtaaccata caggtgttgt tggagaaggt tccgaaggtc ttaatgacaa ccttcttgaa    1620
atactccaaa aagagaaagt caacatcaat attgttggtg actttaaact taatgaagag    1680
atcgccatta ttttggcatc tttttctgct tccacaagtg cttttgtgga aactgtgaaa    1740
ggtttggatt ataaagcatt caaacaaatt gttgaatcct gtggtaattt taaagttaca    1800
aaaggaaaag ctaaaaaagg tgcctggaat attggtgaac agaaatcaat actgagtcct    1860
ctttatgcat ttgcatcaga ggctgctcgt gttgtacgat caattttctc ccgcactctt    1920
gaaactgctc aaaattctgt gcgtgtttta cagaaggccg ctataacaat actagatgga    1980
atttcacagt attcactgag actcattgat gctatgatgt tcacatctga tttggctact    2040
aacaatctag ttgtaatggc ctacattaca ggtggtgttg ttcagttgac ttcgcagtgg    2100
ctaactaaca tctttggcac tgtttatgaa aaactcaaac ccgtccttga ttggcttgaa    2160
gagaagttta aggaaggtgt agagtttctt agagacggtt gggaaattgt taaatttatc    2220
tcaacctgtg cttgtgaaat tgtcggtgga caaattgtca cctgtgcaaa ggaaattaag    2280
gagagtgttc agacattctt taagcttgta aataaatttt tggctttgtg tgctgactct    2340
atcattattg gtggagctaa acttaaagcc ttgaatttag gtgaaacatt tgtcacgcac    2400
tcaaagggat tgtacagaaa gtgtgttaaa tccagagaag aaactggcct actcatgcct    2460
ctaaaagccc caaaagaaat tatcttctta gagggagaaa cacttcccac agaagtgtta    2520
acagaggaag ttgtcttgaa aactggtgat ttacaaccat tagaacaacc tactagtgaa    2580
gctgttgaag ctccattggt tggtacacca gtttgtatta acgggcttat gttgctcgaa    2640
atcaaagaca cagaaaagta ctgtgccctt gcacctaata tgatggtaac aaacaatacc    2700
ttcacactca aaggcggtgc accaacaaag gttacttttg gtgatgacac tgtgatagaa    2760
gtgcaaggtt acaagagtgt gaatatcact tttgaacttg atgaaaggat tgataaagta    2820
cttaatgaga agtgctctgc ctatacagtt gaactcggta cagaagtaaa tgagttcgcc    2880
tgtgttgtgg cagatgctgt cataaaaact ttgcaaccag tatctgaatt acttacacca    2940
ctgggcattg atttagatga gtggagtatg gctacatact acttatttga tgagtctggt    3000
gagtttaaat tggcttcaca tatgtattgt tctttctacc ctccagatga ggatgaagaa    3060
gaaggtgatt gtgaagaaga agagtttgag ccatcaactc aatatgagta tggtactgaa    3120
gatgattacc aaggtaaacc tttggaattt ggtgccactt ctgctgctct tcaacctgaa    3180
gaagagcaag aagaagattg gttagatgat gatagtcaac aaactgttgg tcaacaagac    3240
ggcagtgagg acaatcagac aactactatt caaacaattg ttgaggttca acctcaatta    3300
gagatggaac ttacaccagt tgttcagact attgaagtga atagttttag tggttattta    3360
aaacttactg acaatgtata cattaaaaat gcagacattg tggaagaagc taaaaaggta    3420
aaaccaacag tggttgttaa tgcagccaat gtttacctta aacatggagg aggtgttgca    3480
ggagccttaa ataaggctac taacaatgcc atgcaagttg aatctgatga ttacatagct    3540
actaatggac cacttaaagt gggtggtagt tgtgttttaa gcggacacaa tcttgctaaa    3600
cactgtcttc atgttgtcgg cccaaatgtt aacaaaggtg aagacattca acttcttaag    3660
agtgcttatg aaaattttaa tcagcacgaa gttctacttg caccattatt atcagctggt    3720
atttttggtg ctgaccctat acattcttta agagtttgtg tagatactgt tcgcacaaat    3780
gtctacttag ctgtctttga taaaaatctc tatgacaaac ttgtttcaag ctttttggaa    3840
atgaagagtg aaaagcaagt tgaacaaaag atcgctgaga ttcctaaaga ggaagttaag    3900
ccatttataa ctgaaagtaa accttcagtt gaacagagaa aacaagatga taagaaaatc    3960
aaagcttgtg ttgaagaagt tacaacaact ctggaagaaa ctaagttcct cacagaaaac    4020
ttgttacttt atattgacat taatggcaat cttcatccag attctgccac tcttgttagt    4080
gacattgaca tcactttctt aaagaaagat gctccatata tagtgggtga tgttgttcaa    4140
gagggtgttt taactgctgt ggttatacct actaaaaagg ctggtggcac tactgaaatg    4200
ctagcgaaag ctttgagaaa agtgccaaca gacaattata taaccactta cccgggtcag    4260
ggtttaaatg gttacactgt agaggaggca aagacagtgc ttaaaaagtg taaaagtgcc    4320
ttttacattc taccatctat tatctctaat gagaagcaag aaattcttgg aactgtttct    4380
tggaatttgc gagaaatgct tgcacatgca gaagaaacac gcaaattaat gcctgtctgt    4440
gtggaaacta aagccatagt ttcaactata cagcgtaaat ataagggtat taaaatacaa    4500
gagggtgtgg ttgattatgg tgctagattt tacttttaca ccagtaaaac aactgtagcg    4560
tcacttatca acacacttaa cgatctaaat gaaactcttg ttacaatgcc acttggctat    4620
gtaacacatg gcttaaattt ggaagaagct gctcggtata tgagatctct caaagtgcca    4680
gctacagttt ctgtttcttc acctgatgct gttacagcgt ataatggtta tcttacttct    4740
tcttctaaaa cacctgaaga acattttatt gaaaccatct cacttgctgg ttcctataaa    4800
gattggtcct attctggaca atctacacaa ctaggtatag aatttcttaa gagaggtgat    4860
aaaagtgtat attacactag taatcctacc acattccacc tagatggtga agttatcacc    4920
tttgacaatc ttaagacact tctttctttg agagaagtga ggactattaa ggtgtttaca    4980
acagtagaca acattaacct ccacacgcaa gttgtggaca tgtcaatgac atatggacaa    5040
cagtttggtc caacttattt ggatggagct gatgttacta aaataaaacc tcataattca    5100
catgaaggta aaacatttta tgttttacct aatgatgaca ctctacgtgt tgaggctttt    5160
gagtactacc acacaactga tcctagtttt ctgggtaggt acatgtcagc attaaatcac    5220
actaaaaagt ggaaataccc acaagttaat ggtttaactt ctattaaatg ggcagataac    5280
aactgttatc ttgccactgc attgttaaca ctccaacaaa tagagttgaa gtttaatcca    5340
cctgctctac aagatgctta ttacagagca agggctggtg aagctgctaa cttttgtgca    5400
cttatcttag cctactgtaa taagacagta ggtgagttag gtgatgttag agaaacaatg    5460
agttacttgt ttcaacatgc caatttagat tcttgcaaaa gagtcttgaa cgtggtgtgt    5520
aaaacttgtg gacaacagca gacaaccctt aagggtgtag aagctgttat gtacatgggc    5580
acactttctt atgaacaatt taagaaaggt gttcagatac cttgtacgtg tggtaaacaa    5640
gctacaaaat atctagtaca acaggagtca ccttttgtta tgatgtcagc accacctgct    5700
cagtatgaac ttaagcatgg tacatttact tgtgctagtg agtacactgg taattaccag    5760
tgtggtcact ataaacatat aacttctaaa gaaactttgt attgcataga cggtgcttta    5820
cttacaaagt cctcagaata caaaggtcct attacggatg ttttctacaa agaaaacagt    5880
tacacaacaa ccataaaacc agttacttat aaattggatg gtgttgtttg tacagaaatt    5940
gaccctaagt tggacaatta ttataagaaa gacaattctt atttcacaga gcaaccaatt    6000
gatcttgtac caaaccaacc atatccaaac gcaagcttcg ataattttaa gtttgtatgt    6060
gataatatca aatttgctga tgatttaaac cagttaactg gttataagaa acctgcttca    6120
agagagctta aagttacatt tttccctgac ttaaatggtg atgtggtggc tattgattat    6180
aaacactaca caccctcttt taagaaagga gctaaattgt tacataaacc tattgtttgg    6240
catgttaaca atgcaactaa taaagccacg tataaaccaa atacctggtg tatacgttgt    6300
ctttggagca caaaaccagt tgaaacatca aattcgtttg atgtactgaa gtcagaggac    6360
gcgcagggaa tggataatct tgcctgcgaa gatctaaaac cagtctctga agaagtagtg    6420
gaaaatccta ccatacagaa agacgttctt gagtgtaatg tgaaaactac cgaagttgta    6480
ggagacatta tacttaaacc agcaaataat agtttaaaaa ttacagaaga ggttggccac    6540
acagatctaa tggctgctta tgtagacaat tctagtctta ctattaagaa acctaatgaa    6600
ttatctagag tattaggttt gaaaaccctt gctactcatg gtttagctgc tgttaatagt    6660
gtcccttggg atactatagc taattatgct aagccttttc ttaacaaagt tgttagtaca    6720
actactaaca tagttacacg gtgtttaaac cgtgtttgta ctaattatat gccttatttc    6780
tttactttat tgctacaatt gtgtactttt actagaagta caaattctag aattaaagca    6840
tctatgccga ctactatagc aaagaatact gttaagagtg tcggtaaatt ttgtctagag    6900
gcttcattta attatttgaa gtcacctaat ttttctaaac tgataaatat tataatttgg    6960
tttttactat taagtgtttg cctaggttct ttaatctact caaccgctgc tttaggtgtt    7020
ttaatgtcta atttaggcat gccttcttac tgtactggtt acagagaagg ctatttgaac    7080
tctactaatg tcactattgc aacctactgt actggttcta taccttgtag tgtttgtctt    7140
agtggtttag attctttaga cacctatcct tctttagaaa ctatacaaat taccatttca    7200
tcttttaaat gggatttaac tgcttttggc ttagttgcag agtggttttt ggcatatatt    7260
cttttcacta ggtttttcta tgtacttgga ttggctgcaa tcatgcaatt gtttttcagc    7320
tattttgcag tacattttat tagtaattct tggcttatgt ggttaataat taatcttgta    7380
caaatggccc cgatttcagc tatggttaga atgtacatct tctttgcatc attttattat    7440
gtatggaaaa gttatgtgca tgttgtagac ggttgtaatt catcaacttg tatgatgtgt    7500
tacaaacgta atagagcaac aagagtcgaa tgtacaacta ttgttaatgg tgttagaagg    7560
tccttttatg tctatgctaa tggaggtaaa ggcttttgca aactacacaa ttggaattgt    7620
gttaattgtg atacattctg tgctggtagt acatttatta gtgatgaagt tgcgagagac    7680
ttgtcactac agtttaaaag accaataaat cctactgacc agtcttctta catcgttgat    7740
agtgttacag tgaagaatgg ttccatccat ctttactttg ataaagctgg tcaaaagact    7800
tatgaaagac attctctctc tcattttgtt aacttagaca acctgagagc taataacact    7860
aaaggttcat tgcctattaa tgttatagtt tttgatggta aatcaaaatg tgaagaatca    7920
tctgcaaaat cagcgtctgt ttactacagt cagcttatgt gtcaacctat actgttacta    7980
gatcaggcat tagtgtctga tgttggtgat agtgcggaag ttgcagttaa aatgtttgat    8040
gcttacgtta atacgttttc atcaactttt aacgtaccaa tggaaaaact caaaacacta    8100
gttgcaactg cagaagctga acttgcaaag aatgtgtcct tagacaatgt cttatctact    8160
tttatttcag cagctcggca agggtttgtt gattcagatg tagaaactaa agatgttgtt    8220
gaatgtctta aattgtcaca tcaatctgac atagaagtta ctggcgatag ttgtaataac    8280
tatatgctca cctataacaa agttgaaaac atgacacccc gtgaccttgg tgcttgtatt    8340
gactgtagtg cgcgtcatat taatgcgcag gtagcaaaaa gtcacaacat tgctttgata    8400
tggaacgtta aagatttcat gtcattgtct gaacaactac gaaaacaaat acgtagtgct    8460
gctaaaaaga ataacttacc ttttaagttg acatgtgcaa ctactagaca agttgttaat    8520
gttgtaacaa caaagatagc acttaagggt ggtaaaattg ttaataattg gttgaagcag    8580
ttaattaaag ttacacttgt gttccttttt gttgctgcta ttttctattt aataacacct    8640
gttcatgtca tgtctaaaca tactgacttt tcaagtgaaa tcataggata caaggctatt    8700
gatggtggtg tcactcgtga catagcatct acagatactt gttttgctaa caaacatgct    8760
gattttgaca catggtttag ccagcgtggt ggtagttata ctaatgacaa agcttgccca    8820
ttgattgctg cagtcataac aagagaagtg ggttttgtcg tgcctggttt gcctggcacg    8880
atattacgca caactaatgg tgactttttg catttcttac ctagagtttt tagtgcagtt    8940
ggtaacatct gttacacacc atcaaaactt atagagtaca ctgactttgc aacatcagct    9000
tgtgttttgg ctgctgaatg tacaattttt aaagatgctt ctggtaagcc agtaccatat    9060
tgttatgata ccaatgtact agaaggttct gttgcttatg aaagtttacg ccctgacaca    9120
cgttatgtgc tcatggatgg ctctattatt caatttccta acacctacct tgaaggttct    9180
gttagagtgg taacaacttt tgattctgag tactgtaggc acggcacttg tgaaagatca    9240
gaagctggtg tttgtgtatc tactagtggt agatgggtac ttaacaatga ttattacaga    9300
tctttaccag gagttttctg tggtgtagat gctgtaaatt tacttactaa tatgtttaca    9360
ccactaattc aacctattgg tgctttggac atatcagcat ctatagtagc tggtggtatt    9420
gtagctatcg tagtaacatg ccttgcctac tattttatga ggtttagaag agcttttggt    9480
gaatacagtc atgtagttgc ctttaatact ttactattcc ttatgtcatt cactgtactc    9540
tgtttaacac cagtttactc attcttacct ggtgtttatt ctgttattta cttgtacttg    9600
acattttatc ttactaatga tgtttctttt ttagcacata ttcagtggat ggttatgttc    9660
acacctttag tacctttctg gataacaatt gcttatatca tttgtatttc cacaaagcat    9720
ttctattggt tctttagtaa ttacctaaag agacgtgtag tctttaatgg tgtttccttt    9780
agtacttttg aagaagctgc gctgtgcacc tttttgttaa ataaagaaat gtatctaaag    9840
ttgcgtagtg atgtgctatt acctcttacg caatataata gatacttagc tctttataat    9900
aagtacaagt attttagtgg agcaatggat acaactagct acagagaagc tgcttgttgt    9960
catctcgcaa aggctctcaa tgacttcagt aactcaggtt ctgatgttct ttaccaacca   10020
ccacaaacct ctatcacctc agctgttttg cagagtggtt ttagaaaaat ggcattccca   10080
tctggtaaag ttgagggttg tatggtacaa gtaacttgtg gtacaactac acttaacggt   10140
ctttggcttg atgacgtagt ttactgtcca agacatgtga tctgcacctc tgaagacatg   10200
cttaacccta attatgaaga tttactcatt cgtaagtcta atcataattt cttggtacag   10260
gctggtaatg ttcaactcag ggttattgga cattctatgc aaaattgtgt acttaagctt   10320
aaggttgata cagccaatcc taagacacct aagtataagt ttgttcgcat tcaaccagga   10380
cagacttttt cagtgttagc ttgttacaat ggttcaccat ctggtgttta ccaatgtgct   10440
atgaggccca atttcactat taagggttca ttccttaatg gttcatgtgg tagtgttggt   10500
tttaacatag attatgactg tgtctctttt tgttacatgc accatatgga attaccaact   10560
ggagttcatg ctggcacaga cttagaaggt aacttttatg gaccttttgt tgacaggcaa   10620
acagcacaag cagctggtac ggacacaact attacagtta atgttttagc ttggttgtac   10680
gctgctgtta taaatggaga caggtggttt ctcaatcgat ttaccacaac tcttaatgac   10740
tttaaccttg tggctatgaa gtacaattat gaacctctaa cacaagacca tgttgacata   10800
ctaggacctc tttctgctca aactggaatt gccgttttag atatgtgtgc ttcattaaaa   10860
gaattactgc aaaatggtat gaatggacgt accatattgg gtagtgcttt attagaagat   10920
gaatttacac cttttgatgt tgttagacaa tgctcaggtg ttactttcca aagtgcagtg   10980
aaaagaacaa tcaagggtac acaccactgg ttgttactca caattttgac ttcactttta   11040
gttttagtcc agagtactca atggtctttg ttcttttttt tgtatgaaaa tgccttttta   11100
ccttttgcta tgggtattat tgctatgtct gcttttgcaa tgatgtttgt caaacataag   11160
catgcatttc tctgtttgtt tttgttacct tctcttgcca ctgtagctta ttttaatatg   11220
gtctatatgc ctgctagttg ggtgatgcgt attatgacat ggttggatat ggttgatact   11280
agtttgtctg gttttaagct aaaagactgt gttatgtatg catcagctgt agtgttacta   11340
atccttatga cagcaagaac tgtgtatgat gatggtgcta ggagagtgtg gacacttatg   11400
aatgtcttga cactcgttta taaagtttat tatggtaatg ctttagatca agccatttcc   11460
atgtgggctc ttataatctc tgttacttct aactactcag gtgtagttac aactgtcatg   11520
tttttggcca gaggtattgt ttttatgtgt gttgagtatt gccctatttt cttcataact   11580
ggtaatacac ttcagtgtat aatgctagtt tattgtttct taggctattt ttgtacttgt   11640
tactttggcc tcttttgttt actcaaccgc tactttagac tgactcttgg tgtttatgat   11700
tacttagttt ctacacagga gtttagatat atgaattcac agggactact cccacccaag   11760
aatagcatag atgccttcaa actcaacatt aaattgttgg gtgttggtgg caaaccttgt   11820
atcaaagtag ccactgtaca gtctaaaatg tcagatgtaa agtgcacatc agtagtctta   11880
ctctcagttt tgcaacaact cagagtagaa tcatcatcta aattgtgggc tcaatgtgtc   11940
cagttacaca atgacattct cttagctaaa gatactactg aagcctttga aaaaatggtt   12000
tcactacttt ctgttttgct ttccatgcag ggtgctgtag acataaacaa gctttgtgaa   12060
gaaatgctgg acaacagggc aaccttacaa gctatagcct cagagtttag ttcccttcca   12120
tcatatgcag cttttgctac tgctcaagaa gcttatgagc aggctgttgc taatggtgat   12180
tctgaagttg ttcttaaaaa gttgaagaag tctttgaatg tggctaaatc tgaatttgac   12240
cgtgatgcag ccatgcaacg taagttggaa aagatggctg atcaagctat gacccaaatg   12300
tataaacagg ctagatctga ggacaagagg gcaaaagtta ctagtgctat gcagacaatg   12360
cttttcacta tgcttagaaa gttggataat gatgcactca acaacattat caacaatgca   12420
agagatggtt gtgttccctt gaacataata cctcttacaa cagcagccaa actaatggtt   12480
gtcataccag actataacac atataaaaat acgtgtgatg gtacaacatt tacttatgca   12540
tcagcattgt gggaaatcca acaggttgta gatgcagata gtaaaattgt tcaacttagt   12600
gaaattagta tggacaattc acctaattta gcatggcctc ttattgtaac agctttaagg   12660
gccaattctg ctgtcaaatt acagaataat gagcttagtc ctgttgcact acgacagatg   12720
tcttgtgctg ccggtactac acaaactgct tgcactgatg acaatgcgtt agcttactac   12780
aacacaacaa agggaggtag gtttgtactt gcactgttat ccgatttaca ggatttgaaa   12840
tgggctagat tccctaagag tgatggaact ggtactatct atacagaact ggaaccacct   12900
tgtaggtttg ttacagacac acctaaaggt cctaaagtga agtatttata ctttattaaa   12960
ggattaaaca acctaaatag aggtatggta cttggtagtt tagctgccac agtacgtcta   13020
caagctggta atgcaacaga agtgcctgcc aattcaactg tattatcttt ctgtgctttt   13080
gctgtagatg ctgctaaagc ttacaaagat tatctagcta gtgggggaca accaatcact   13140
aattgtgtta agatgttgtg tacacacact ggtactggtc aggcaataac agttacaccg   13200
gaagccaata tggatcaaga atcctttggt ggtgcatcgt gttgtctgta ctgccgttgc   13260
cacatagatc atccaaatcc taaaggattt tgtgacttaa aaggtaagta tgtacaaata   13320
cctacaactt gtgctaatga ccctgtgggt tttacactta aaaacacagt ctgtaccgtc   13380
tgcggtatgt ggaaaggtta tggctgtagt tgtgatcaac tccgcgaacc catgcttcag   13440
tcagctgatg cacaatcgtt tttaaacggg tttgcggtgt aagtgcagcc cgtcttacac   13500
cgtgcggcac aggcactagt actgatgtcg tatacagggc ttttgacatc tacaatgata   13560
aagtagctgg ttttgctaaa ttcctaaaaa ctaattgttg tcgcttccaa gaaaaggacg   13620
aagatgacaa tttaattgat tcttactttg tagttaagag acacactttc tctaactacc   13680
aacatgaaga aacaatttat aatttactta aggattgtcc agctgttgct aaacatgact   13740
tctttaagtt tagaatagac ggtgacatgg taccacatat atcacgtcaa cgtcttacta   13800
aatacacaat ggcagacctc gtctatgctt taaggcattt tgatgaaggt aattgtgaca   13860
cattaaaaga aatacttgtc acatacaatt gttgtgatga tgattatttc aataaaaagg   13920
actggtatga ttttgtagaa aacccagata tattacgcgt atacgccaac ttaggtgaac   13980
gtgtacgcca agctttgtta aaaacagtac aattctgtga tgccatgcga aatgctggta   14040
ttgttggtgt actgacatta gataatcaag atctcaatgg taactggtat gatttcggtg   14100
atttcataca aaccacgcca ggtagtggag ttcctgttgt agattcttat tattcattgt   14160
taatgcctat attaaccttg accagggctt taactgcaga gtcacatgtt gacactgact   14220
taacaaagcc ttacattaag tgggatttgt taaaatatga cttcacggaa gagaggttaa   14280
aactctttga ccgttatttt aaatattggg atcagacata ccacccaaat tgtgttaact   14340
gtttggatga cagatgcatt ctgcattgtg caaactttaa tgttttattc tctacagtgt   14400
tcccacctac aagttttgga ccactagtga gaaaaatatt tgttgatggt gttccatttg   14460
tagtttcaac tggataccac ttcagagagc taggtgttgt acataatcag gatgtaaact   14520
tacatagctc tagacttagt tttaaggaat tacttgtgta tgctgctgac cctgctatgc   14580
acgctgcttc tggtaatcta ttactagata aacgcactac gtgcttttca gtagctgcac   14640
ttactaacaa tgttgctttt caaactgtca aacccggtaa ttttaacaaa gacttctatg   14700
actttgctgt gtctaagggt ttctttaagg aaggaagttc tgttgaatta aaacacttct   14760
tctttgctca ggatggtaat gctgctatca gcgattatga ctactatcgt tataatctac   14820
caacaatgtg tgatatcaga caactactat ttgtagttga agttgttgat aagtactttg   14880
attgttacga tggtggctgt attaatgcta accaagtcat cgtcaacaac ctagacaaat   14940
cagctggttt tccatttaat aaatggggta aggctagact ttattatgat tcaatgagtt   15000
atgaggatca agatgcactt ttcgcatata caaaacgtaa tgtcatccct actataactc   15060
aaatgaatct taagtatgcc attagtgcaa agaatagagc tcgcaccgta gctggtgtct   15120
ctatctgtag tactatgacc aatagacagt ttcatcaaaa attattgaaa tcaatagccg   15180
ccactagagg agctactgta gtaattggaa caagcaaatt ctatggtggt tggcacaaca   15240
tgttaaaaac tgtttatagt gatgtagaaa accctcacct tatgggttgg gattatccta   15300
aatgtgatag agccatgcct aacatgctta gaattatggc ctcacttgtt cttgctcgca   15360
aacatacaac gtgttgtagc ttgtcacacc gtttctatag attagctaat gagtgtgctc   15420
aagtattgag tgaaatggtc atgtgtggcg gttcactata tgttaaacca ggtggaacct   15480
catcaggaga tgccacaact gcttatgcta atagtgtttt taacatttgt caagctgtca   15540
cggccaatgt taatgcactt ttatctactg atggtaacaa aattgccgat aagtatgtcc   15600
gcaatttaca acacagactt tatgagtgtc tctatagaaa tagagatgtt gacacagact   15660
ttgtgaatga gttttacgca tatttgcgta aacatttctc aatgatgata ctctctgacg   15720
atgctgttgt gtgtttcaat agcacttatg catctcaagg tctagtggct agcataaaga   15780
actttaagtc agttctttat tatcaaaaca atgtttttat gtctgaagca aaatgttgga   15840
ctgagactga ccttactaaa ggacctcatg aattttgctc tcaacataca atgctagtta   15900
aacagggtga tgattatgtg taccttcctt acccagatcc atcaagaatc ctaggggccg   15960
gctgttttgt agatgatatc gtaaaaacag atggtacact tatgattgaa cggttcgtgt   16020
ctttagctat agatgcttac ccacttacta aacatcctaa tcaggagtat gctgatgtct   16080
ttcatttgta cttacaatac ataagaaagc tacatgatga gttaacagga cacatgttag   16140
acatgtattc tgttatgctt actaatgata acacttcaag gtattgggaa cctgagtttt   16200
atgaggctat gtacacaccg catacagtct tacaggctgt tggggcttgt gttctttgca   16260
attcacagac ttcattaaga tgtggtgctt gcatacgtag accattctta tgttgtaaat   16320
gctgttacga ccatgtcata tcaacatcac ataaattagt cttgtctgtt aatccgtatg   16380
tttgcaatgc tccaggttgt gatgtcacag atgtgactca actttactta ggaggtatga   16440
gctattattg taaatcacat aaaccaccca ttagttttcc attgtgtgct aatggacaag   16500
tttttggttt atataaaaat acatgtgttg gtagcgataa tgttactgac tttaatgcaa   16560
ttgcaacatg tgactggaca aatgctggtg attacatttt agctaacacc tgtactgaaa   16620
gactcaagct ttttgcagca gaaacgctca aagctactga ggagacattt aaactgtctt   16680
atggtattgc tactgtacgt gaagtgctgt ctgacagaga attacatctt tcatgggaag   16740
ttggtaaacc tagaccacca cttaaccgaa attatgtctt tactggttat cgtgtaacta   16800
aaaacagtaa agtacaaata ggagagtaca cctttgaaaa aggtgactat ggtgatgctg   16860
ttgtttaccg aggtacaaca acttacaaat taaatgttgg tgattatttt gtgctgacat   16920
cacatacagt aatgccatta agtgcaccta cactagtgcc acaagagcac tatgttagaa   16980
ttactggctt atacccaaca ctcaatatct cagatgagtt ttctagcaat gttgcaaatt   17040
atcaaaaggt tggtatgcaa aagtattcta cactccaggg accacctggt actggtaaga   17100
gtcattttgc tattggccta gctctctact acccttctgc tcgcatagtg tatacagctt   17160
gctctcatgc cgctgttgat gcactatgtg agaaggcatt aaaatatttg cctatagata   17220
aatgtagtag aattatacct gcacgtgctc gtgtagagtg ttttgataaa ttcaaagtga   17280
attcaacatt agaacagtat gtcttttgta ctgtaaatgc attgcctgag acgacagcag   17340
atatagttgt ctttgatgaa atttcaatgg ccacaaatta tgatttgagt gttgtcaatg   17400
ccagattacg tgctaagcac tatgtgtaca ttggcgaccc tgctcaatta cctgcaccac   17460
gcacattgct aactaagggc acactagaac cagaatattt caattcagtg tgtagactta   17520
tgaaaactat aggtccagac atgttcctcg gaacttgtcg gcgttgtcct gctgaaattg   17580
ttgacactgt gagtgctttg gtttatgata ataagcttaa agcacataaa gacaaatcag   17640
ctcaatgctt taaaatgttt tataagggtg ttatcacgca tgatgtttca tctgcaatta   17700
acaggccaca aataggcgtg gtaagagaat tccttacacg taaccctgct tggagaaaag   17760
ctgtctttat ttcaccttat aattcacaga atgctgtagc ctcaaagatt ttgggactac   17820
caactcaaac tgttgattca tcacagggct cagaatatga ctatgtcata ttcactcaaa   17880
ccactgaaac agctcactct tgtaatgtaa acagatttaa tgttgctatt accagagcaa   17940
aagtaggcat actttgcata atgtctgata gagaccttta tgacaagttg caatttacaa   18000
gtcttgaaat tccacgtagg aatgtggcaa ctttacaagc tgaaaatgta acaggactct   18060
ttaaagattg tagtaaggta atcactgggt tacatcctac acaggcacct acacacctca   18120
gtgttgacac taaattcaaa actgaaggtt tatgtgttga catacctggc atacctaagg   18180
acatgaccta tagaagactc atctctatga tgggttttaa aatgaattat caagttaatg   18240
gttaccctaa catgtttatc acccgcgaag aagctataag acatgtacgt gcatggattg   18300
gcttcgatgt cgaggggtgt catgctacta gagaagctgt tggtaccaat ttacctttac   18360
agctaggttt ttctacaggt gttaacctag ttgctgtacc tacaggttat gttgatacac   18420
ctaataatac agatttttcc agagttagtg ctaaaccacc gcctggagat caatttaaac   18480
acctcatacc acttatgtac aaaggacttc cttggaatgt agtgcgtata aagattgtac   18540
aaatgttaag tgacacactt aaaaatctct ctgacagagt cgtatttgtc ttatgggcac   18600
atggctttga gttgacatct atgaagtatt ttgtgaaaat aggacctgag cgcacctgtt   18660
gtctatgtga tagacgtgcc acatgctttt ccactgcttc agacacttat gcctgttggc   18720
atcattctat tggatttgat tacgtctata atccgtttat gattgatgtt caacaatggg   18780
gttttacagg taacctacaa agcaaccatg atctgtattg tcaagtccat ggtaatgcac   18840
atgtagctag ttgtgatgca atcatgacta ggtgtctagc tgtccacgag tgctttgtta   18900
agcgtgttga ctggactatt gaatatccta taattggtga tgaactgaag attaatgcgg   18960
cttgtagaaa ggttcaacac atggttgtta aagctgcatt attagcagac aaattcccag   19020
ttcttcacga cattggtaac cctaaagcta ttaagtgtgt acctcaagct gatgtagaat   19080
ggaagttcta tgatgcacag ccttgtagtg acaaagctta taaaatagaa gaattattct   19140
attcttatgc cacacattct gacaaattca cagatggtgt atgcctattt tggaattgca   19200
atgtcgatag atatcctgct aattccattg tttgtagatt tgacactaga gtgctatcta   19260
accttaactt gcctggttgt gatggtggca gtttgtatgt aaataaacat gcattccaca   19320
caccagcttt tgataaaagt gcttttgtta atttaaaaca attaccattt ttctattact   19380
ctgacagtcc atgtgagtct catggaaaac aagtagtgtc agatatagat tatgtaccac   19440
taaagtctgc tacgtgtata acacgttgca atttaggtgg tgctgtctgt agacatcatg   19500
ctaatgagta cagattgtat ctcgatgctt ataacatgat gatctcagct ggctttagct   19560
tgtgggttta caaacaattt gatacttata acctctggaa cacttttaca agacttcaga   19620
gtttagaaaa tgtggctttt aatgttgtaa ataagggaca ctttgatgga caacagggtg   19680
aagtaccagt ttctatcatt aataacactg tttacacaaa agttgatggt gttgatgtag   19740
aattgtttga aaataaaaca acattacctg ttaatgtagc atttgagctt tgggctaagc   19800
gcaacattaa accagtacca gaggtgaaaa tactcaataa tttgggtgtg gacattgctg   19860
ctaatactgt gatctgggac tacaaaagag atgctccagc acatatatct actattggtg   19920
tttgttctat gactgacata gccaagaaac caactgaaac gatttgtgca ccactcactg   19980
tcttttttga tggtagagtt gatggtcaag tagacttatt tagaaatgcc cgtaatggtg   20040
ttcttattac agaaggtagt gttaaaggtt tacaaccatc tgtaggtccc aaacaagcta   20100
gtcttaatgg agtcacatta attggagaag ccgtaaaaac acagttcaat tattataaga   20160
aagttgatgg tgttgtccaa caattacctg aaacttactt tactcagagt agaaatttac   20220
aagaatttaa acccaggagt caaatggaaa ttgatttctt agaattagct atggatgaat   20280
tcattgaacg gtataaatta gaaggctatg ccttcgaaca tatcgtttat ggagatttta   20340
gtcatagtca gttaggtggt ttacatctac tgattggact agctaaacgt tttaaggaat   20400
caccttttga attagaagat tttattccta tggacagtac agttaaaaac tatttcataa   20460
cagatgcgca aacaggttca tctaagtgtg tgtgttctgt tattgattta ttacttgatg   20520
attttgttga aataataaaa tcccaagatt tatctgtagt ttctaaggtt gtcaaagtga   20580
ctattgacta tacagaaatt tcatttatgc tttggtgtaa agatggccat gtagaaacat   20640
tttacccaaa attacaatct agtcaagcgt ggcaaccggg tgttgctatg cctaatcttt   20700
acaaaatgca aagaatgcta ttagaaaagt gtgaccttca aaattatggt gatagtgcaa   20760
cattacctaa aggcataatg atgaatgtcg caaaatatac tcaactgtgt caatatttaa   20820
acacattaac attagctgta ccctataata tgagagttat acattttggt gctggttctg   20880
ataaaggagt tgcaccaggt acagctgttt taagacagtg gttgcctacg ggtacgctgc   20940
ttgtcgattc agatcttaat gactttgtct ctgatgcaga ttcaactttg attggtgatt   21000
gtgcaactgt acatacagct aataaatggg atctcattat tagtgatatg tacgacccta   21060
agactaaaaa tgttacaaaa gaaaatgact ctaaagaggg ttttttcact tacatttgtg   21120
ggtttataca acaaaagcta gctcttggag gttccgtggc tataaagata acagaacatt   21180
cttggaatgc tgatctttat aagctcatgg gacacttcgc atggtggaca gcctttgtta   21240
ctaatgtgaa tgcgtcatca tctgaagcat ttttaattgg atgtaattat cttggcaaac   21300
cacgcgaaca aatagatggt tatgtcatgc atgcaaatta catattttgg aggaatacaa   21360
atccaattca gttgtcttcc tattctttat ttgacatgag taaatttccc cttaaattaa   21420
ggggtactgc tgttatgtct ttaaaagaag gtcaaatcaa tgatatgatt ttatctcttc   21480
ttagtaaagg tagacttata attagagaaa acaacagagt tgttatttct agtgatgttc   21540
ttgttaacaa ctaaacgaac aatgtttgtt tttcttgttt tattgccact agtctctagt   21600
cagtgtgtta atcttacaac cagaactcaa ttaccccctg catacactaa ttctttcaca   21660
cgtggtgttt attaccctga caaagttttc agatcctcag ttttacattc aactcaggac   21720
ttgttcttac ctttcttttc caatgttact tggttccatg ctatacatgt ctctgggacc   21780
aatggtacta agaggtttga taaccctgtc ctaccattta atgatggtgt ttattttgct   21840
tccactgaga agtctaacat aataagaggc tggatttttg gtactacttt agattcgaag   21900
acccagtccc tacttattgt taataacgct actaatgttg ttattaaagt ctgtgaattt   21960
caattttgta atgatccatt tttgggtgtt tattaccaca aaaacaacaa aagttggatg   22020
gaaagtgagt tcagagttta ttctagtgcg aataattgca cttttgaata tgtctctcag   22080
ccttttctta tggaccttga aggaaaacag ggtaatttca aaaatcttag ggaatttgtg   22140
tttaagaata ttgatggtta ttttaaaata tattctaagc acacgcctat taatttagtg   22200
cgtgatctcc ctcagggttt ttcggcttta gaaccattgg tagatttgcc aataggtatt   22260
aacatcacta ggtttcaaac tttacttgct ttacatagaa gttatttgac tcctggtgat   22320
tcttcttcag gttggacagc tggtgctgca gcttattatg tgggttatct tcaacctagg   22380
acttttctat taaaatataa tgaaaatgga accattacag atgctgtaga ctgtgcactt   22440
gaccctctct cagaaacaaa gtgtacgttg aaatccttca ctgtagaaaa aggaatctat   22500
caaacttcta actttagagt ccaaccaaca gaatctattg ttagatttcc taatattaca   22560
aacttgtgcc cttttggtga agtttttaac gccaccagat ttgcatctgt ttatgcttgg   22620
aacaggaaga gaatcagcaa ctgtgttgct gattattctg tcctatataa ttccgcatca   22680
ttttccactt ttaagtgtta tggagtgtct cctactaaat taaatgatct ctgctttact   22740
aatgtctatg cagattcatt tgtaattaga ggtgatgaag tcagacaaat cgctccaggg   22800
caaactggaa agattgctga ttataattat aaattaccag atgattttac aggctgcgtt   22860
atagcttgga attctaacaa tcttgattct aaggttggtg gtaattataa ttacctgtat   22920
agattgttta ggaagtctaa tctcaaacct tttgagagag atatttcaac tgaaatctat   22980
caggccggta gcacaccttg taatggtgtt gaaggtttta attgttactt tcctttacaa   23040
tcatatggtt tccaacccac taatggtgtt ggttaccaac catacagagt agtagtactt   23100
tcttttgaac ttctacatgc accagcaact gtttgtggac ctaaaaagtc tactaatttg   23160
gttaaaaaca aatgtgtcaa tttcaacttc aatggtttaa caggcacagg tgttcttact   23220
gagtctaaca aaaagtttct gcctttccaa caatttggca gagacattgc tgacactact   23280
gatgctgtcc gtgatccaca gacacttgag attcttgaca ttacaccatg ttcttttggt   23340
ggtgtcagtg ttataacacc aggaacaaat acttctaacc aggttgctgt tctttatcag   23400
gatgttaact gcacagaagt ccctgttgct attcatgcag atcaacttac tcctacttgg   23460
cgtgtttatt ctacaggttc taatgttttt caaacacgtg caggctgttt aataggggct   23520
gaacatgtca acaactcata tgagtgtgac atacccattg gtgcaggtat atgcgctagt   23580
tatcagactc agactaattc tcctcggcgg gcacgtagtg tagctagtca atccatcatt   23640
gcctacacta tgtcacttgg tgcagaaaat tcagttgctt actctaataa ctctattgcc   23700
atacccacaa attttactat tagtgttacc acagaaattc taccagtgtc tatgaccaag   23760
acatcagtag attgtacaat gtacatttgt ggtgattcaa ctgaatgcag caatcttttg   23820
ttgcaatatg gcagtttttg tacacaatta aaccgtgctt taactggaat agctgttgaa   23880
caagacaaaa acacccaaga agtttttgca caagtcaaac aaatttacaa aacaccacca   23940
attaaagatt ttggtggttt taatttttca caaatattac cagatccatc aaaaccaagc   24000
aagaggtcat ttattgaaga tctacttttc aacaaagtga cacttgcaga tgctggcttc   24060
atcaaacaat atggtgattg ccttggtgat attgctgcta gagacctcat ttgtgcacaa   24120
aagtttaacg gccttactgt tttgccacct ttgctcacag atgaaatgat tgctcaatac   24180
acttctgcac tgttagcggg tacaatcact tctggttgga cctttggtgc aggtgctgca   24240
ttacaaatac catttgctat gcaaatggct tataggttta atggtattgg agttacacag   24300
aatgttctct atgagaacca aaaattgatt gccaaccaat ttaatagtgc tattggcaaa   24360
attcaagact cactttcttc cacagcaagt gcacttggaa aacttcaaga tgtggtcaac   24420
caaaatgcac aagctttaaa cacgcttgtt aaacaactta gctccaattt tggtgcaatt   24480
tcaagtgttt taaatgatat cctttcacgt cttgacaaag ttgaggctga agtgcaaatt   24540
gataggttga tcacaggcag acttcaaagt ttgcagacat atgtgactca acaattaatt   24600
agagctgcag aaatcagagc ttctgctaat cttgctgcta ctaaaatgtc agagtgtgta   24660
cttggacaat caaaaagagt tgatttttgt ggaaagggct atcatcttat gtccttccct   24720
cagtcagcac ctcatggtgt agtcttcttg catgtgactt atgtccctgc acaagaaaag   24780
aacttcacaa ctgctcctgc catttgtcat gatggaaaag cacactttcc tcgtgaaggt   24840
gtctttgttt caaatggcac acactggttt gtaacacaaa ggaattttta tgaaccacaa   24900
atcattacta cagacaacac atttgtgtct ggtaactgtg atgttgtaat aggaattgtc   24960
aacaacacag tttatgatcc tttgcaacct gaattagact cattcaagga ggagttagat   25020
aaatatttta agaatcatac atcaccagat gttgatttag gtgacatctc tggcattaat   25080
gcttcagttg taaacattca aaaagaaatt gaccgcctca atgaggttgc caagaattta   25140
aatgaatctc tcatcgatct ccaagaactt ggaaagtatg agcagtatat aaaatggcca   25200
tggtacattt ggctaggttt tatagctggc ttgattgcca tagtaatggt gacaattatg   25260
ctttgctgta tgaccagttg ctgtagttgt ctcaagggct gttgttcttg tggatcctgc   25320
tgcaaatttg atgaagacga ctctgagcca gtgctcaaag gagtcaaatt acattacaca   25380
taaacgaact tatggatttg tttatgagaa tcttcacaat tggaactgta actttgaagc   25440
aaggtgaaat caaggatgct actccttcag attttgttcg cgctactgca acgataccga   25500
tacaagcctc actccctttc ggatggctta ttgttggcgt tgcacttctt gctgtttttc   25560
agagcgcttc caaaatcata accctcaaaa agagatggca actagcactc tccaagggtg   25620
ttcactttgt ttgcaacttg ctgttgttgt ttgtaacagt ttactcacac cttttgctcg   25680
ttgctgctgg ccttgaagcc ccttttctct atctttatgc tttagtctac ttcttgcaga   25740
gtataaactt tgtaagaata ataatgaggc tttggctttg ctggaaatgc cgttccaaaa   25800
acccattact ttatgatgcc aactattttc tttgctggca tactaattgt tacgactatt   25860
gtatacctta caatagtgta acttcttcaa ttgtcattac ttcaggtgat ggcacaacaa   25920
gtcctatttc tgaacatgac taccagattg gtggttatac tgaaaaatgg gaatctggag   25980
taaaagactg tgttgtatta cacagttact tcacttcaga ctattaccag ctgtactcaa   26040
ctcaattgag tacagacact ggtgttgaac atgttacctt cttcatctac aataaaattg   26100
ttgatgagcc tgaagaacat gtccaaattc acacaatcga cggttcatcc ggagttgtta   26160
atccagtaat ggaaccaatt tatgatgaac cgacgacgac tactagcgtg cctttgtaag   26220
cacaagctga tgagtacgaa cttatgtact cattcgtttc ggaagagaca ggtacgttaa   26280
tagttaatag cgtacttctt tttcttgctt tcgtggtatt cttgctagtt acactagcca   26340
tccttactgc gcttcgattg tgtgcgtact gctgcaatat tgttaacgtg agtcttgtaa   26400
aaccttcttt ttacgtttac tctcgtgtta aaaatctgaa ttcttctaga gttcctgatc   26460
ttctggtcta aacgaactaa atattatatt agtttttctg tttggaactt taattttagc   26520
catggcagat tccaacggta ctattaccgt tgaagagctt aaaaagctcc ttgaacaatg   26580
gaacctagta ataggtttcc tattccttac atggatttgt cttctacaat ttgcctatgc   26640
caacaggaat aggtttttgt atataattaa gttaattttc ctctggctgt tatggccagt   26700
aactttagct tgttttgtgc ttgctgctgt ttacagaata aattggatca ccggtggaat   26760
tgctatcgca atggcttgtc ttgtaggctt gatgtggctc agctacttca ttgcttcttt   26820
cagactgttt gcgcgtacgc gttccatgtg gtcattcaat ccagaaacta acattcttct   26880
caacgtgcca ctccatggca ctattctgac cagaccgctt ctagaaagtg aactcgtaat   26940
cggagctgtg atccttcgtg gacatcttcg tattgctgga caccatctag gacgctgtga   27000
catcaaggac ctgcctaaag aaatcactgt tgctacatca cgaacgcttt cttattacaa   27060
attgggagct tcgcagcgtg tagcaggtga ctcaggtttt gctgcataca gtcgctacag   27120
gattggcaac tataaattaa acacagacca ttccagtagc agtgacaata ttgctttgct   27180
tgtacagtaa gtgacaacag atgtttcatc tcgttgactt tcaggttact atagcagaga   27240
tattactaat tattatgagg acttttaaag tttccatttg gaatcttgat tacatcataa   27300
acctcataat taaaaattta tctaagtcac taactgagaa taaatattct caattagatg   27360
aagagcaacc aatggagatt gattaaacga acatgaaaat tattcttttc ttggcactga   27420
taacactcgc tacttgtgag ctttatcact accaagagtg tgttagaggt acaacagtac   27480
ttttaaaaga accttgctct tctggaacat acgagggcaa ttcaccattt catcctctag   27540
ctgataacaa atttgcactg acttgcttta gcactcaatt tgcttttgct tgtcctgacg   27600
gcgtaaaaca cgtctatcag ttacgtgcca gatcagtttc acctaaactg ttcatcagac   27660
aagaggaagt tcaagaactt tactctccaa tttttcttat tgttgcggca atagtgttta   27720
taacactttg cttcacactc aaaagaaaga cagaatgatt gaactttcat taattgactt   27780
ctatttgtgc tttttagcct ttctgctatt ccttgtttta attatgctta ttatcttttg   27840
gttctcactt gaactgcaag atcataatga aacttgtcac gcctaaacga acatgaaatt   27900
tcttgttttc ttaggaatca tcacaactgt agctgcattt caccaagaat gtagtttaca   27960
gtcatgtact caacatcaac catatgtagt tgatgacccg tgtcctattc acttctattc   28020
taaatggtat attagagtag gagctagaaa atcagcacct ttaattgaat tgtgcgtgga   28080
tgaggctggt tctaaatcac ccattcagta catcgatatc ggtaattata cagtttcctg   28140
tttacctttt acaattaatt gccaggaacc taaattgggt agtcttgtag tgcgttgttc   28200
gttctatgaa gactttttag agtatcatga cgttcgtgtt gttttagatt tcatctaaac   28260
gaacaaacta aaatgtctga taatggaccc caaaatcagc gaaatgcacc ccgcattacg   28320
tttggtggac cctcagattc aactggcagt aaccagaatg gagaacgcag tggggcgcga   28380
tcaaaacaac gtcggcccca aggtttaccc aataatactg cgtcttggtt caccgctctc   28440
actcaacatg gcaaggaaga ccttaaattc cctcgaggac aaggcgttcc aattaacacc   28500
aatagcagtc cagatgacca aattggctac taccgaagag ctaccagacg aattcgtggt   28560
ggtgacggta aaatgaaaga tctcagtcca agatggtatt tctactacct aggaactggg   28620
ccagaagctg gacttcccta tggtgctaac aaagacggca tcatatgggt tgcaactgag   28680
ggagccttga atacaccaaa agatcacatt ggcacccgca atcctgctaa caatgctgca   28740
atcgtgctac aacttcctca aggaacaaca ttgccaaaag gcttctacgc agaagggagc   28800
agaggcggca gtcaagcctc ttctcgttcc tcatcacgta gtcgcaacag ttcaagaaat   28860
tcaactccag gcagcagtag gggaacttct cctgctagaa tggctggcaa tggcggtgat   28920
gctgctcttg ctttgctgct gcttgacaga ttgaaccagc ttgagagcaa aatgtctggt   28980
aaaggccaac aacaacaagg ccaaactgtc actaagaaat ctgctgctga ggcttctaag   29040
aagcctcggc aaaaacgtac tgccactaaa gcatacaatg taacacaagc tttcggcaga   29100
cgtggtccag aacaaaccca aggaaatttt ggggaccagg aactaatcag acaaggaact   29160
gattacaaac attggccgca aattgcacaa tttgccccca gcgcttcagc gttcttcgga   29220
atgtcgcgca ttggcatgga agtcacacct tcgggaacgt ggttgaccta cacaggtgcc   29280
atcaaattgg atgacaaaga tccaaatttc aaagatcaag tcattttgct gaataagcat   29340
attgacgcat acaaaacatt cccaccaaca gagcctaaaa aggacaaaaa gaagaaggct   29400
gatgaaactc aagccttacc gcagagacag aagaaacagc aaactgtgac tcttcttcct   29460
gctgcagatt tggatgattt ctccaaacaa ttgcaacaat ccatgagcag tgctgactca   29520
actcaggcct aaactcatgc agaccacaca aggcagatgg gctatataaa cgttttcgct   29580
tttccgttta cgatatatag tctactcttg tgcagaatga attctcgtaa ctacatagca   29640
caagtagatg tagttaactt taatctcaca tagcaatctt taatcagtgt gtaacattag   29700
ggaggacttg aaagagccac cacattttca ccgaggccac gcggagtacg atcgagtgta   29760
cagtgaacaa tgctagggag agctgcctat atggaagagc cctaatgtgt aaaattaatt   29820
ttagtagtgc tatccccatg tgattttaat agcttcttag gagaatgaca aaaaaaaaaa   29880
aaaaaaaaaa aaaaaaaaaa aa                                            29902



<210> 2
<211> 7096
<212> PRT
<213> betacoronavirus SARS coronavirus 2

<400>  2

Met Glu Ser Leu Val Pro Gly Phe Asn Glu Lys Thr His Val Gln Leu 
1               5                   10                  15      


Ser Leu Pro Val Leu Gln Val Arg Asp Val Leu Val Arg Gly Phe Gly 
            20                  25                  30          


Asp Ser Val Glu Glu Val Leu Ser Glu Ala Arg Gln His Leu Lys Asp 
        35                  40                  45              


Gly Thr Cys Gly Leu Val Glu Val Glu Lys Gly Val Leu Pro Gln Leu 
    50                  55                  60                  


Glu Gln Pro Tyr Val Phe Ile Lys Arg Ser Asp Ala Arg Thr Ala Pro 
65                  70                  75                  80  


His Gly His Val Met Val Glu Leu Val Ala Glu Leu Glu Gly Ile Gln 
                85                  90                  95      


Tyr Gly Arg Ser Gly Glu Thr Leu Gly Val Leu Val Pro His Val Gly 
            100                 105                 110         


Glu Ile Pro Val Ala Tyr Arg Lys Val Leu Leu Arg Lys Asn Gly Asn 
        115                 120                 125             


Lys Gly Ala Gly Gly His Ser Tyr Gly Ala Asp Leu Lys Ser Phe Asp 
    130                 135                 140                 


Leu Gly Asp Glu Leu Gly Thr Asp Pro Tyr Glu Asp Phe Gln Glu Asn 
145                 150                 155                 160 


Trp Asn Thr Lys His Ser Ser Gly Val Thr Arg Glu Leu Met Arg Glu 
                165                 170                 175     


Leu Asn Gly Gly Ala Tyr Thr Arg Tyr Val Asp Asn Asn Phe Cys Gly 
            180                 185                 190         


Pro Asp Gly Tyr Pro Leu Glu Cys Ile Lys Asp Leu Leu Ala Arg Ala 
        195                 200                 205             


Gly Lys Ala Ser Cys Thr Leu Ser Glu Gln Leu Asp Phe Ile Asp Thr 
    210                 215                 220                 


Lys Arg Gly Val Tyr Cys Cys Arg Glu His Glu His Glu Ile Ala Trp 
225                 230                 235                 240 


Tyr Thr Glu Arg Ser Glu Lys Ser Tyr Glu Leu Gln Thr Pro Phe Glu 
                245                 250                 255     


Ile Lys Leu Ala Lys Lys Phe Asp Thr Phe Asn Gly Glu Cys Pro Asn 
            260                 265                 270         


Phe Val Phe Pro Leu Asn Ser Ile Ile Lys Thr Ile Gln Pro Arg Val 
        275                 280                 285             


Glu Lys Lys Lys Leu Asp Gly Phe Met Gly Arg Ile Arg Ser Val Tyr 
    290                 295                 300                 


Pro Val Ala Ser Pro Asn Glu Cys Asn Gln Met Cys Leu Ser Thr Leu 
305                 310                 315                 320 


Met Lys Cys Asp His Cys Gly Glu Thr Ser Trp Gln Thr Gly Asp Phe 
                325                 330                 335     


Val Lys Ala Thr Cys Glu Phe Cys Gly Thr Glu Asn Leu Thr Lys Glu 
            340                 345                 350         


Gly Ala Thr Thr Cys Gly Tyr Leu Pro Gln Asn Ala Val Val Lys Ile 
        355                 360                 365             


Tyr Cys Pro Ala Cys His Asn Ser Glu Val Gly Pro Glu His Ser Leu 
    370                 375                 380                 


Ala Glu Tyr His Asn Glu Ser Gly Leu Lys Thr Ile Leu Arg Lys Gly 
385                 390                 395                 400 


Gly Arg Thr Ile Ala Phe Gly Gly Cys Val Phe Ser Tyr Val Gly Cys 
                405                 410                 415     


His Asn Lys Cys Ala Tyr Trp Val Pro Arg Ala Ser Ala Asn Ile Gly 
            420                 425                 430         


Cys Asn His Thr Gly Val Val Gly Glu Gly Ser Glu Gly Leu Asn Asp 
        435                 440                 445             


Asn Leu Leu Glu Ile Leu Gln Lys Glu Lys Val Asn Ile Asn Ile Val 
    450                 455                 460                 


Gly Asp Phe Lys Leu Asn Glu Glu Ile Ala Ile Ile Leu Ala Ser Phe 
465                 470                 475                 480 


Ser Ala Ser Thr Ser Ala Phe Val Glu Thr Val Lys Gly Leu Asp Tyr 
                485                 490                 495     


Lys Ala Phe Lys Gln Ile Val Glu Ser Cys Gly Asn Phe Lys Val Thr 
            500                 505                 510         


Lys Gly Lys Ala Lys Lys Gly Ala Trp Asn Ile Gly Glu Gln Lys Ser 
        515                 520                 525             


Ile Leu Ser Pro Leu Tyr Ala Phe Ala Ser Glu Ala Ala Arg Val Val 
    530                 535                 540                 


Arg Ser Ile Phe Ser Arg Thr Leu Glu Thr Ala Gln Asn Ser Val Arg 
545                 550                 555                 560 


Val Leu Gln Lys Ala Ala Ile Thr Ile Leu Asp Gly Ile Ser Gln Tyr 
                565                 570                 575     


Ser Leu Arg Leu Ile Asp Ala Met Met Phe Thr Ser Asp Leu Ala Thr 
            580                 585                 590         


Asn Asn Leu Val Val Met Ala Tyr Ile Thr Gly Gly Val Val Gln Leu 
        595                 600                 605             


Thr Ser Gln Trp Leu Thr Asn Ile Phe Gly Thr Val Tyr Glu Lys Leu 
    610                 615                 620                 


Lys Pro Val Leu Asp Trp Leu Glu Glu Lys Phe Lys Glu Gly Val Glu 
625                 630                 635                 640 


Phe Leu Arg Asp Gly Trp Glu Ile Val Lys Phe Ile Ser Thr Cys Ala 
                645                 650                 655     


Cys Glu Ile Val Gly Gly Gln Ile Val Thr Cys Ala Lys Glu Ile Lys 
            660                 665                 670         


Glu Ser Val Gln Thr Phe Phe Lys Leu Val Asn Lys Phe Leu Ala Leu 
        675                 680                 685             


Cys Ala Asp Ser Ile Ile Ile Gly Gly Ala Lys Leu Lys Ala Leu Asn 
    690                 695                 700                 


Leu Gly Glu Thr Phe Val Thr His Ser Lys Gly Leu Tyr Arg Lys Cys 
705                 710                 715                 720 


Val Lys Ser Arg Glu Glu Thr Gly Leu Leu Met Pro Leu Lys Ala Pro 
                725                 730                 735     


Lys Glu Ile Ile Phe Leu Glu Gly Glu Thr Leu Pro Thr Glu Val Leu 
            740                 745                 750         


Thr Glu Glu Val Val Leu Lys Thr Gly Asp Leu Gln Pro Leu Glu Gln 
        755                 760                 765             


Pro Thr Ser Glu Ala Val Glu Ala Pro Leu Val Gly Thr Pro Val Cys 
    770                 775                 780                 


Ile Asn Gly Leu Met Leu Leu Glu Ile Lys Asp Thr Glu Lys Tyr Cys 
785                 790                 795                 800 


Ala Leu Ala Pro Asn Met Met Val Thr Asn Asn Thr Phe Thr Leu Lys 
                805                 810                 815     


Gly Gly Ala Pro Thr Lys Val Thr Phe Gly Asp Asp Thr Val Ile Glu 
            820                 825                 830         


Val Gln Gly Tyr Lys Ser Val Asn Ile Thr Phe Glu Leu Asp Glu Arg 
        835                 840                 845             


Ile Asp Lys Val Leu Asn Glu Lys Cys Ser Ala Tyr Thr Val Glu Leu 
    850                 855                 860                 


Gly Thr Glu Val Asn Glu Phe Ala Cys Val Val Ala Asp Ala Val Ile 
865                 870                 875                 880 


Lys Thr Leu Gln Pro Val Ser Glu Leu Leu Thr Pro Leu Gly Ile Asp 
                885                 890                 895     


Leu Asp Glu Trp Ser Met Ala Thr Tyr Tyr Leu Phe Asp Glu Ser Gly 
            900                 905                 910         


Glu Phe Lys Leu Ala Ser His Met Tyr Cys Ser Phe Tyr Pro Pro Asp 
        915                 920                 925             


Glu Asp Glu Glu Glu Gly Asp Cys Glu Glu Glu Glu Phe Glu Pro Ser 
    930                 935                 940                 


Thr Gln Tyr Glu Tyr Gly Thr Glu Asp Asp Tyr Gln Gly Lys Pro Leu 
945                 950                 955                 960 


Glu Phe Gly Ala Thr Ser Ala Ala Leu Gln Pro Glu Glu Glu Gln Glu 
                965                 970                 975     


Glu Asp Trp Leu Asp Asp Asp Ser Gln Gln Thr Val Gly Gln Gln Asp 
            980                 985                 990         


Gly Ser Glu Asp Asn Gln Thr Thr  Thr Ile Gln Thr Ile  Val Glu Val 
        995                 1000                 1005             


Gln Pro  Gln Leu Glu Met Glu  Leu Thr Pro Val Val  Gln Thr Ile 
    1010                 1015                 1020             


Glu Val  Asn Ser Phe Ser Gly  Tyr Leu Lys Leu Thr  Asp Asn Val 
    1025                 1030                 1035             


Tyr Ile  Lys Asn Ala Asp Ile  Val Glu Glu Ala Lys  Lys Val Lys 
    1040                 1045                 1050             


Pro Thr  Val Val Val Asn Ala  Ala Asn Val Tyr Leu  Lys His Gly 
    1055                 1060                 1065             


Gly Gly  Val Ala Gly Ala Leu  Asn Lys Ala Thr Asn  Asn Ala Met 
    1070                 1075                 1080             


Gln Val  Glu Ser Asp Asp Tyr  Ile Ala Thr Asn Gly  Pro Leu Lys 
    1085                 1090                 1095             


Val Gly  Gly Ser Cys Val Leu  Ser Gly His Asn Leu  Ala Lys His 
    1100                 1105                 1110             


Cys Leu  His Val Val Gly Pro  Asn Val Asn Lys Gly  Glu Asp Ile 
    1115                 1120                 1125             


Gln Leu  Leu Lys Ser Ala Tyr  Glu Asn Phe Asn Gln  His Glu Val 
    1130                 1135                 1140             


Leu Leu  Ala Pro Leu Leu Ser  Ala Gly Ile Phe Gly  Ala Asp Pro 
    1145                 1150                 1155             


Ile His  Ser Leu Arg Val Cys  Val Asp Thr Val Arg  Thr Asn Val 
    1160                 1165                 1170             


Tyr Leu  Ala Val Phe Asp Lys  Asn Leu Tyr Asp Lys  Leu Val Ser 
    1175                 1180                 1185             


Ser Phe  Leu Glu Met Lys Ser  Glu Lys Gln Val Glu  Gln Lys Ile 
    1190                 1195                 1200             


Ala Glu  Ile Pro Lys Glu Glu  Val Lys Pro Phe Ile  Thr Glu Ser 
    1205                 1210                 1215             


Lys Pro  Ser Val Glu Gln Arg  Lys Gln Asp Asp Lys  Lys Ile Lys 
    1220                 1225                 1230             


Ala Cys  Val Glu Glu Val Thr  Thr Thr Leu Glu Glu  Thr Lys Phe 
    1235                 1240                 1245             


Leu Thr  Glu Asn Leu Leu Leu  Tyr Ile Asp Ile Asn  Gly Asn Leu 
    1250                 1255                 1260             


His Pro  Asp Ser Ala Thr Leu  Val Ser Asp Ile Asp  Ile Thr Phe 
    1265                 1270                 1275             


Leu Lys  Lys Asp Ala Pro Tyr  Ile Val Gly Asp Val  Val Gln Glu 
    1280                 1285                 1290             


Gly Val  Leu Thr Ala Val Val  Ile Pro Thr Lys Lys  Ala Gly Gly 
    1295                 1300                 1305             


Thr Thr  Glu Met Leu Ala Lys  Ala Leu Arg Lys Val  Pro Thr Asp 
    1310                 1315                 1320             


Asn Tyr  Ile Thr Thr Tyr Pro  Gly Gln Gly Leu Asn  Gly Tyr Thr 
    1325                 1330                 1335             


Val Glu  Glu Ala Lys Thr Val  Leu Lys Lys Cys Lys  Ser Ala Phe 
    1340                 1345                 1350             


Tyr Ile  Leu Pro Ser Ile Ile  Ser Asn Glu Lys Gln  Glu Ile Leu 
    1355                 1360                 1365             


Gly Thr  Val Ser Trp Asn Leu  Arg Glu Met Leu Ala  His Ala Glu 
    1370                 1375                 1380             


Glu Thr  Arg Lys Leu Met Pro  Val Cys Val Glu Thr  Lys Ala Ile 
    1385                 1390                 1395             


Val Ser  Thr Ile Gln Arg Lys  Tyr Lys Gly Ile Lys  Ile Gln Glu 
    1400                 1405                 1410             


Gly Val  Val Asp Tyr Gly Ala  Arg Phe Tyr Phe Tyr  Thr Ser Lys 
    1415                 1420                 1425             


Thr Thr  Val Ala Ser Leu Ile  Asn Thr Leu Asn Asp  Leu Asn Glu 
    1430                 1435                 1440             


Thr Leu  Val Thr Met Pro Leu  Gly Tyr Val Thr His  Gly Leu Asn 
    1445                 1450                 1455             


Leu Glu  Glu Ala Ala Arg Tyr  Met Arg Ser Leu Lys  Val Pro Ala 
    1460                 1465                 1470             


Thr Val  Ser Val Ser Ser Pro  Asp Ala Val Thr Ala  Tyr Asn Gly 
    1475                 1480                 1485             


Tyr Leu  Thr Ser Ser Ser Lys  Thr Pro Glu Glu His  Phe Ile Glu 
    1490                 1495                 1500             


Thr Ile  Ser Leu Ala Gly Ser  Tyr Lys Asp Trp Ser  Tyr Ser Gly 
    1505                 1510                 1515             


Gln Ser  Thr Gln Leu Gly Ile  Glu Phe Leu Lys Arg  Gly Asp Lys 
    1520                 1525                 1530             


Ser Val  Tyr Tyr Thr Ser Asn  Pro Thr Thr Phe His  Leu Asp Gly 
    1535                 1540                 1545             


Glu Val  Ile Thr Phe Asp Asn  Leu Lys Thr Leu Leu  Ser Leu Arg 
    1550                 1555                 1560             


Glu Val  Arg Thr Ile Lys Val  Phe Thr Thr Val Asp  Asn Ile Asn 
    1565                 1570                 1575             


Leu His  Thr Gln Val Val Asp  Met Ser Met Thr Tyr  Gly Gln Gln 
    1580                 1585                 1590             


Phe Gly  Pro Thr Tyr Leu Asp  Gly Ala Asp Val Thr  Lys Ile Lys 
    1595                 1600                 1605             


Pro His  Asn Ser His Glu Gly  Lys Thr Phe Tyr Val  Leu Pro Asn 
    1610                 1615                 1620             


Asp Asp  Thr Leu Arg Val Glu  Ala Phe Glu Tyr Tyr  His Thr Thr 
    1625                 1630                 1635             


Asp Pro  Ser Phe Leu Gly Arg  Tyr Met Ser Ala Leu  Asn His Thr 
    1640                 1645                 1650             


Lys Lys  Trp Lys Tyr Pro Gln  Val Asn Gly Leu Thr  Ser Ile Lys 
    1655                 1660                 1665             


Trp Ala  Asp Asn Asn Cys Tyr  Leu Ala Thr Ala Leu  Leu Thr Leu 
    1670                 1675                 1680             


Gln Gln  Ile Glu Leu Lys Phe  Asn Pro Pro Ala Leu  Gln Asp Ala 
    1685                 1690                 1695             


Tyr Tyr  Arg Ala Arg Ala Gly  Glu Ala Ala Asn Phe  Cys Ala Leu 
    1700                 1705                 1710             


Ile Leu  Ala Tyr Cys Asn Lys  Thr Val Gly Glu Leu  Gly Asp Val 
    1715                 1720                 1725             


Arg Glu  Thr Met Ser Tyr Leu  Phe Gln His Ala Asn  Leu Asp Ser 
    1730                 1735                 1740             


Cys Lys  Arg Val Leu Asn Val  Val Cys Lys Thr Cys  Gly Gln Gln 
    1745                 1750                 1755             


Gln Thr  Thr Leu Lys Gly Val  Glu Ala Val Met Tyr  Met Gly Thr 
    1760                 1765                 1770             


Leu Ser  Tyr Glu Gln Phe Lys  Lys Gly Val Gln Ile  Pro Cys Thr 
    1775                 1780                 1785             


Cys Gly  Lys Gln Ala Thr Lys  Tyr Leu Val Gln Gln  Glu Ser Pro 
    1790                 1795                 1800             


Phe Val  Met Met Ser Ala Pro  Pro Ala Gln Tyr Glu  Leu Lys His 
    1805                 1810                 1815             


Gly Thr  Phe Thr Cys Ala Ser  Glu Tyr Thr Gly Asn  Tyr Gln Cys 
    1820                 1825                 1830             


Gly His  Tyr Lys His Ile Thr  Ser Lys Glu Thr Leu  Tyr Cys Ile 
    1835                 1840                 1845             


Asp Gly  Ala Leu Leu Thr Lys  Ser Ser Glu Tyr Lys  Gly Pro Ile 
    1850                 1855                 1860             


Thr Asp  Val Phe Tyr Lys Glu  Asn Ser Tyr Thr Thr  Thr Ile Lys 
    1865                 1870                 1875             


Pro Val  Thr Tyr Lys Leu Asp  Gly Val Val Cys Thr  Glu Ile Asp 
    1880                 1885                 1890             


Pro Lys  Leu Asp Asn Tyr Tyr  Lys Lys Asp Asn Ser  Tyr Phe Thr 
    1895                 1900                 1905             


Glu Gln  Pro Ile Asp Leu Val  Pro Asn Gln Pro Tyr  Pro Asn Ala 
    1910                 1915                 1920             


Ser Phe  Asp Asn Phe Lys Phe  Val Cys Asp Asn Ile  Lys Phe Ala 
    1925                 1930                 1935             


Asp Asp  Leu Asn Gln Leu Thr  Gly Tyr Lys Lys Pro  Ala Ser Arg 
    1940                 1945                 1950             


Glu Leu  Lys Val Thr Phe Phe  Pro Asp Leu Asn Gly  Asp Val Val 
    1955                 1960                 1965             


Ala Ile  Asp Tyr Lys His Tyr  Thr Pro Ser Phe Lys  Lys Gly Ala 
    1970                 1975                 1980             


Lys Leu  Leu His Lys Pro Ile  Val Trp His Val Asn  Asn Ala Thr 
    1985                 1990                 1995             


Asn Lys  Ala Thr Tyr Lys Pro  Asn Thr Trp Cys Ile  Arg Cys Leu 
    2000                 2005                 2010             


Trp Ser  Thr Lys Pro Val Glu  Thr Ser Asn Ser Phe  Asp Val Leu 
    2015                 2020                 2025             


Lys Ser  Glu Asp Ala Gln Gly  Met Asp Asn Leu Ala  Cys Glu Asp 
    2030                 2035                 2040             


Leu Lys  Pro Val Ser Glu Glu  Val Val Glu Asn Pro  Thr Ile Gln 
    2045                 2050                 2055             


Lys Asp  Val Leu Glu Cys Asn  Val Lys Thr Thr Glu  Val Val Gly 
    2060                 2065                 2070             


Asp Ile  Ile Leu Lys Pro Ala  Asn Asn Ser Leu Lys  Ile Thr Glu 
    2075                 2080                 2085             


Glu Val  Gly His Thr Asp Leu  Met Ala Ala Tyr Val  Asp Asn Ser 
    2090                 2095                 2100             


Ser Leu  Thr Ile Lys Lys Pro  Asn Glu Leu Ser Arg  Val Leu Gly 
    2105                 2110                 2115             


Leu Lys  Thr Leu Ala Thr His  Gly Leu Ala Ala Val  Asn Ser Val 
    2120                 2125                 2130             


Pro Trp  Asp Thr Ile Ala Asn  Tyr Ala Lys Pro Phe  Leu Asn Lys 
    2135                 2140                 2145             


Val Val  Ser Thr Thr Thr Asn  Ile Val Thr Arg Cys  Leu Asn Arg 
    2150                 2155                 2160             


Val Cys  Thr Asn Tyr Met Pro  Tyr Phe Phe Thr Leu  Leu Leu Gln 
    2165                 2170                 2175             


Leu Cys  Thr Phe Thr Arg Ser  Thr Asn Ser Arg Ile  Lys Ala Ser 
    2180                 2185                 2190             


Met Pro  Thr Thr Ile Ala Lys  Asn Thr Val Lys Ser  Val Gly Lys 
    2195                 2200                 2205             


Phe Cys  Leu Glu Ala Ser Phe  Asn Tyr Leu Lys Ser  Pro Asn Phe 
    2210                 2215                 2220             


Ser Lys  Leu Ile Asn Ile Ile  Ile Trp Phe Leu Leu  Leu Ser Val 
    2225                 2230                 2235             


Cys Leu  Gly Ser Leu Ile Tyr  Ser Thr Ala Ala Leu  Gly Val Leu 
    2240                 2245                 2250             


Met Ser  Asn Leu Gly Met Pro  Ser Tyr Cys Thr Gly  Tyr Arg Glu 
    2255                 2260                 2265             


Gly Tyr  Leu Asn Ser Thr Asn  Val Thr Ile Ala Thr  Tyr Cys Thr 
    2270                 2275                 2280             


Gly Ser  Ile Pro Cys Ser Val  Cys Leu Ser Gly Leu  Asp Ser Leu 
    2285                 2290                 2295             


Asp Thr  Tyr Pro Ser Leu Glu  Thr Ile Gln Ile Thr  Ile Ser Ser 
    2300                 2305                 2310             


Phe Lys  Trp Asp Leu Thr Ala  Phe Gly Leu Val Ala  Glu Trp Phe 
    2315                 2320                 2325             


Leu Ala  Tyr Ile Leu Phe Thr  Arg Phe Phe Tyr Val  Leu Gly Leu 
    2330                 2335                 2340             


Ala Ala  Ile Met Gln Leu Phe  Phe Ser Tyr Phe Ala  Val His Phe 
    2345                 2350                 2355             


Ile Ser  Asn Ser Trp Leu Met  Trp Leu Ile Ile Asn  Leu Val Gln 
    2360                 2365                 2370             


Met Ala  Pro Ile Ser Ala Met  Val Arg Met Tyr Ile  Phe Phe Ala 
    2375                 2380                 2385             


Ser Phe  Tyr Tyr Val Trp Lys  Ser Tyr Val His Val  Val Asp Gly 
    2390                 2395                 2400             


Cys Asn  Ser Ser Thr Cys Met  Met Cys Tyr Lys Arg  Asn Arg Ala 
    2405                 2410                 2415             


Thr Arg  Val Glu Cys Thr Thr  Ile Val Asn Gly Val  Arg Arg Ser 
    2420                 2425                 2430             


Phe Tyr  Val Tyr Ala Asn Gly  Gly Lys Gly Phe Cys  Lys Leu His 
    2435                 2440                 2445             


Asn Trp  Asn Cys Val Asn Cys  Asp Thr Phe Cys Ala  Gly Ser Thr 
    2450                 2455                 2460             


Phe Ile  Ser Asp Glu Val Ala  Arg Asp Leu Ser Leu  Gln Phe Lys 
    2465                 2470                 2475             


Arg Pro  Ile Asn Pro Thr Asp  Gln Ser Ser Tyr Ile  Val Asp Ser 
    2480                 2485                 2490             


Val Thr  Val Lys Asn Gly Ser  Ile His Leu Tyr Phe  Asp Lys Ala 
    2495                 2500                 2505             


Gly Gln  Lys Thr Tyr Glu Arg  His Ser Leu Ser His  Phe Val Asn 
    2510                 2515                 2520             


Leu Asp  Asn Leu Arg Ala Asn  Asn Thr Lys Gly Ser  Leu Pro Ile 
    2525                 2530                 2535             


Asn Val  Ile Val Phe Asp Gly  Lys Ser Lys Cys Glu  Glu Ser Ser 
    2540                 2545                 2550             


Ala Lys  Ser Ala Ser Val Tyr  Tyr Ser Gln Leu Met  Cys Gln Pro 
    2555                 2560                 2565             


Ile Leu  Leu Leu Asp Gln Ala  Leu Val Ser Asp Val  Gly Asp Ser 
    2570                 2575                 2580             


Ala Glu  Val Ala Val Lys Met  Phe Asp Ala Tyr Val  Asn Thr Phe 
    2585                 2590                 2595             


Ser Ser  Thr Phe Asn Val Pro  Met Glu Lys Leu Lys  Thr Leu Val 
    2600                 2605                 2610             


Ala Thr  Ala Glu Ala Glu Leu  Ala Lys Asn Val Ser  Leu Asp Asn 
    2615                 2620                 2625             


Val Leu  Ser Thr Phe Ile Ser  Ala Ala Arg Gln Gly  Phe Val Asp 
    2630                 2635                 2640             


Ser Asp  Val Glu Thr Lys Asp  Val Val Glu Cys Leu  Lys Leu Ser 
    2645                 2650                 2655             


His Gln  Ser Asp Ile Glu Val  Thr Gly Asp Ser Cys  Asn Asn Tyr 
    2660                 2665                 2670             


Met Leu  Thr Tyr Asn Lys Val  Glu Asn Met Thr Pro  Arg Asp Leu 
    2675                 2680                 2685             


Gly Ala  Cys Ile Asp Cys Ser  Ala Arg His Ile Asn  Ala Gln Val 
    2690                 2695                 2700             


Ala Lys  Ser His Asn Ile Ala  Leu Ile Trp Asn Val  Lys Asp Phe 
    2705                 2710                 2715             


Met Ser  Leu Ser Glu Gln Leu  Arg Lys Gln Ile Arg  Ser Ala Ala 
    2720                 2725                 2730             


Lys Lys  Asn Asn Leu Pro Phe  Lys Leu Thr Cys Ala  Thr Thr Arg 
    2735                 2740                 2745             


Gln Val  Val Asn Val Val Thr  Thr Lys Ile Ala Leu  Lys Gly Gly 
    2750                 2755                 2760             


Lys Ile  Val Asn Asn Trp Leu  Lys Gln Leu Ile Lys  Val Thr Leu 
    2765                 2770                 2775             


Val Phe  Leu Phe Val Ala Ala  Ile Phe Tyr Leu Ile  Thr Pro Val 
    2780                 2785                 2790             


His Val  Met Ser Lys His Thr  Asp Phe Ser Ser Glu  Ile Ile Gly 
    2795                 2800                 2805             


Tyr Lys  Ala Ile Asp Gly Gly  Val Thr Arg Asp Ile  Ala Ser Thr 
    2810                 2815                 2820             


Asp Thr  Cys Phe Ala Asn Lys  His Ala Asp Phe Asp  Thr Trp Phe 
    2825                 2830                 2835             


Ser Gln  Arg Gly Gly Ser Tyr  Thr Asn Asp Lys Ala  Cys Pro Leu 
    2840                 2845                 2850             


Ile Ala  Ala Val Ile Thr Arg  Glu Val Gly Phe Val  Val Pro Gly 
    2855                 2860                 2865             


Leu Pro  Gly Thr Ile Leu Arg  Thr Thr Asn Gly Asp  Phe Leu His 
    2870                 2875                 2880             


Phe Leu  Pro Arg Val Phe Ser  Ala Val Gly Asn Ile  Cys Tyr Thr 
    2885                 2890                 2895             


Pro Ser  Lys Leu Ile Glu Tyr  Thr Asp Phe Ala Thr  Ser Ala Cys 
    2900                 2905                 2910             


Val Leu  Ala Ala Glu Cys Thr  Ile Phe Lys Asp Ala  Ser Gly Lys 
    2915                 2920                 2925             


Pro Val  Pro Tyr Cys Tyr Asp  Thr Asn Val Leu Glu  Gly Ser Val 
    2930                 2935                 2940             


Ala Tyr  Glu Ser Leu Arg Pro  Asp Thr Arg Tyr Val  Leu Met Asp 
    2945                 2950                 2955             


Gly Ser  Ile Ile Gln Phe Pro  Asn Thr Tyr Leu Glu  Gly Ser Val 
    2960                 2965                 2970             


Arg Val  Val Thr Thr Phe Asp  Ser Glu Tyr Cys Arg  His Gly Thr 
    2975                 2980                 2985             


Cys Glu  Arg Ser Glu Ala Gly  Val Cys Val Ser Thr  Ser Gly Arg 
    2990                 2995                 3000             


Trp Val  Leu Asn Asn Asp Tyr  Tyr Arg Ser Leu Pro  Gly Val Phe 
    3005                 3010                 3015             


Cys Gly  Val Asp Ala Val Asn  Leu Leu Thr Asn Met  Phe Thr Pro 
    3020                 3025                 3030             


Leu Ile  Gln Pro Ile Gly Ala  Leu Asp Ile Ser Ala  Ser Ile Val 
    3035                 3040                 3045             


Ala Gly  Gly Ile Val Ala Ile  Val Val Thr Cys Leu  Ala Tyr Tyr 
    3050                 3055                 3060             


Phe Met  Arg Phe Arg Arg Ala  Phe Gly Glu Tyr Ser  His Val Val 
    3065                 3070                 3075             


Ala Phe  Asn Thr Leu Leu Phe  Leu Met Ser Phe Thr  Val Leu Cys 
    3080                 3085                 3090             


Leu Thr  Pro Val Tyr Ser Phe  Leu Pro Gly Val Tyr  Ser Val Ile 
    3095                 3100                 3105             


Tyr Leu  Tyr Leu Thr Phe Tyr  Leu Thr Asn Asp Val  Ser Phe Leu 
    3110                 3115                 3120             


Ala His  Ile Gln Trp Met Val  Met Phe Thr Pro Leu  Val Pro Phe 
    3125                 3130                 3135             


Trp Ile  Thr Ile Ala Tyr Ile  Ile Cys Ile Ser Thr  Lys His Phe 
    3140                 3145                 3150             


Tyr Trp  Phe Phe Ser Asn Tyr  Leu Lys Arg Arg Val  Val Phe Asn 
    3155                 3160                 3165             


Gly Val  Ser Phe Ser Thr Phe  Glu Glu Ala Ala Leu  Cys Thr Phe 
    3170                 3175                 3180             


Leu Leu  Asn Lys Glu Met Tyr  Leu Lys Leu Arg Ser  Asp Val Leu 
    3185                 3190                 3195             


Leu Pro  Leu Thr Gln Tyr Asn  Arg Tyr Leu Ala Leu  Tyr Asn Lys 
    3200                 3205                 3210             


Tyr Lys  Tyr Phe Ser Gly Ala  Met Asp Thr Thr Ser  Tyr Arg Glu 
    3215                 3220                 3225             


Ala Ala  Cys Cys His Leu Ala  Lys Ala Leu Asn Asp  Phe Ser Asn 
    3230                 3235                 3240             


Ser Gly  Ser Asp Val Leu Tyr  Gln Pro Pro Gln Thr  Ser Ile Thr 
    3245                 3250                 3255             


Ser Ala  Val Leu Gln Ser Gly  Phe Arg Lys Met Ala  Phe Pro Ser 
    3260                 3265                 3270             


Gly Lys  Val Glu Gly Cys Met  Val Gln Val Thr Cys  Gly Thr Thr 
    3275                 3280                 3285             


Thr Leu  Asn Gly Leu Trp Leu  Asp Asp Val Val Tyr  Cys Pro Arg 
    3290                 3295                 3300             


His Val  Ile Cys Thr Ser Glu  Asp Met Leu Asn Pro  Asn Tyr Glu 
    3305                 3310                 3315             


Asp Leu  Leu Ile Arg Lys Ser  Asn His Asn Phe Leu  Val Gln Ala 
    3320                 3325                 3330             


Gly Asn  Val Gln Leu Arg Val  Ile Gly His Ser Met  Gln Asn Cys 
    3335                 3340                 3345             


Val Leu  Lys Leu Lys Val Asp  Thr Ala Asn Pro Lys  Thr Pro Lys 
    3350                 3355                 3360             


Tyr Lys  Phe Val Arg Ile Gln  Pro Gly Gln Thr Phe  Ser Val Leu 
    3365                 3370                 3375             


Ala Cys  Tyr Asn Gly Ser Pro  Ser Gly Val Tyr Gln  Cys Ala Met 
    3380                 3385                 3390             


Arg Pro  Asn Phe Thr Ile Lys  Gly Ser Phe Leu Asn  Gly Ser Cys 
    3395                 3400                 3405             


Gly Ser  Val Gly Phe Asn Ile  Asp Tyr Asp Cys Val  Ser Phe Cys 
    3410                 3415                 3420             


Tyr Met  His His Met Glu Leu  Pro Thr Gly Val His  Ala Gly Thr 
    3425                 3430                 3435             


Asp Leu  Glu Gly Asn Phe Tyr  Gly Pro Phe Val Asp  Arg Gln Thr 
    3440                 3445                 3450             


Ala Gln  Ala Ala Gly Thr Asp  Thr Thr Ile Thr Val  Asn Val Leu 
    3455                 3460                 3465             


Ala Trp  Leu Tyr Ala Ala Val  Ile Asn Gly Asp Arg  Trp Phe Leu 
    3470                 3475                 3480             


Asn Arg  Phe Thr Thr Thr Leu  Asn Asp Phe Asn Leu  Val Ala Met 
    3485                 3490                 3495             


Lys Tyr  Asn Tyr Glu Pro Leu  Thr Gln Asp His Val  Asp Ile Leu 
    3500                 3505                 3510             


Gly Pro  Leu Ser Ala Gln Thr  Gly Ile Ala Val Leu  Asp Met Cys 
    3515                 3520                 3525             


Ala Ser  Leu Lys Glu Leu Leu  Gln Asn Gly Met Asn  Gly Arg Thr 
    3530                 3535                 3540             


Ile Leu  Gly Ser Ala Leu Leu  Glu Asp Glu Phe Thr  Pro Phe Asp 
    3545                 3550                 3555             


Val Val  Arg Gln Cys Ser Gly  Val Thr Phe Gln Ser  Ala Val Lys 
    3560                 3565                 3570             


Arg Thr  Ile Lys Gly Thr His  His Trp Leu Leu Leu  Thr Ile Leu 
    3575                 3580                 3585             


Thr Ser  Leu Leu Val Leu Val  Gln Ser Thr Gln Trp  Ser Leu Phe 
    3590                 3595                 3600             


Phe Phe  Leu Tyr Glu Asn Ala  Phe Leu Pro Phe Ala  Met Gly Ile 
    3605                 3610                 3615             


Ile Ala  Met Ser Ala Phe Ala  Met Met Phe Val Lys  His Lys His 
    3620                 3625                 3630             


Ala Phe  Leu Cys Leu Phe Leu  Leu Pro Ser Leu Ala  Thr Val Ala 
    3635                 3640                 3645             


Tyr Phe  Asn Met Val Tyr Met  Pro Ala Ser Trp Val  Met Arg Ile 
    3650                 3655                 3660             


Met Thr  Trp Leu Asp Met Val  Asp Thr Ser Leu Ser  Gly Phe Lys 
    3665                 3670                 3675             


Leu Lys  Asp Cys Val Met Tyr  Ala Ser Ala Val Val  Leu Leu Ile 
    3680                 3685                 3690             


Leu Met  Thr Ala Arg Thr Val  Tyr Asp Asp Gly Ala  Arg Arg Val 
    3695                 3700                 3705             


Trp Thr  Leu Met Asn Val Leu  Thr Leu Val Tyr Lys  Val Tyr Tyr 
    3710                 3715                 3720             


Gly Asn  Ala Leu Asp Gln Ala  Ile Ser Met Trp Ala  Leu Ile Ile 
    3725                 3730                 3735             


Ser Val  Thr Ser Asn Tyr Ser  Gly Val Val Thr Thr  Val Met Phe 
    3740                 3745                 3750             


Leu Ala  Arg Gly Ile Val Phe  Met Cys Val Glu Tyr  Cys Pro Ile 
    3755                 3760                 3765             


Phe Phe  Ile Thr Gly Asn Thr  Leu Gln Cys Ile Met  Leu Val Tyr 
    3770                 3775                 3780             


Cys Phe  Leu Gly Tyr Phe Cys  Thr Cys Tyr Phe Gly  Leu Phe Cys 
    3785                 3790                 3795             


Leu Leu  Asn Arg Tyr Phe Arg  Leu Thr Leu Gly Val  Tyr Asp Tyr 
    3800                 3805                 3810             


Leu Val  Ser Thr Gln Glu Phe  Arg Tyr Met Asn Ser  Gln Gly Leu 
    3815                 3820                 3825             


Leu Pro  Pro Lys Asn Ser Ile  Asp Ala Phe Lys Leu  Asn Ile Lys 
    3830                 3835                 3840             


Leu Leu  Gly Val Gly Gly Lys  Pro Cys Ile Lys Val  Ala Thr Val 
    3845                 3850                 3855             


Gln Ser  Lys Met Ser Asp Val  Lys Cys Thr Ser Val  Val Leu Leu 
    3860                 3865                 3870             


Ser Val  Leu Gln Gln Leu Arg  Val Glu Ser Ser Ser  Lys Leu Trp 
    3875                 3880                 3885             


Ala Gln  Cys Val Gln Leu His  Asn Asp Ile Leu Leu  Ala Lys Asp 
    3890                 3895                 3900             


Thr Thr  Glu Ala Phe Glu Lys  Met Val Ser Leu Leu  Ser Val Leu 
    3905                 3910                 3915             


Leu Ser  Met Gln Gly Ala Val  Asp Ile Asn Lys Leu  Cys Glu Glu 
    3920                 3925                 3930             


Met Leu  Asp Asn Arg Ala Thr  Leu Gln Ala Ile Ala  Ser Glu Phe 
    3935                 3940                 3945             


Ser Ser  Leu Pro Ser Tyr Ala  Ala Phe Ala Thr Ala  Gln Glu Ala 
    3950                 3955                 3960             


Tyr Glu  Gln Ala Val Ala Asn  Gly Asp Ser Glu Val  Val Leu Lys 
    3965                 3970                 3975             


Lys Leu  Lys Lys Ser Leu Asn  Val Ala Lys Ser Glu  Phe Asp Arg 
    3980                 3985                 3990             


Asp Ala  Ala Met Gln Arg Lys  Leu Glu Lys Met Ala  Asp Gln Ala 
    3995                 4000                 4005             


Met Thr  Gln Met Tyr Lys Gln  Ala Arg Ser Glu Asp  Lys Arg Ala 
    4010                 4015                 4020             


Lys Val  Thr Ser Ala Met Gln  Thr Met Leu Phe Thr  Met Leu Arg 
    4025                 4030                 4035             


Lys Leu  Asp Asn Asp Ala Leu  Asn Asn Ile Ile Asn  Asn Ala Arg 
    4040                 4045                 4050             


Asp Gly  Cys Val Pro Leu Asn  Ile Ile Pro Leu Thr  Thr Ala Ala 
    4055                 4060                 4065             


Lys Leu  Met Val Val Ile Pro  Asp Tyr Asn Thr Tyr  Lys Asn Thr 
    4070                 4075                 4080             


Cys Asp  Gly Thr Thr Phe Thr  Tyr Ala Ser Ala Leu  Trp Glu Ile 
    4085                 4090                 4095             


Gln Gln  Val Val Asp Ala Asp  Ser Lys Ile Val Gln  Leu Ser Glu 
    4100                 4105                 4110             


Ile Ser  Met Asp Asn Ser Pro  Asn Leu Ala Trp Pro  Leu Ile Val 
    4115                 4120                 4125             


Thr Ala  Leu Arg Ala Asn Ser  Ala Val Lys Leu Gln  Asn Asn Glu 
    4130                 4135                 4140             


Leu Ser  Pro Val Ala Leu Arg  Gln Met Ser Cys Ala  Ala Gly Thr 
    4145                 4150                 4155             


Thr Gln  Thr Ala Cys Thr Asp  Asp Asn Ala Leu Ala  Tyr Tyr Asn 
    4160                 4165                 4170             


Thr Thr  Lys Gly Gly Arg Phe  Val Leu Ala Leu Leu  Ser Asp Leu 
    4175                 4180                 4185             


Gln Asp  Leu Lys Trp Ala Arg  Phe Pro Lys Ser Asp  Gly Thr Gly 
    4190                 4195                 4200             


Thr Ile  Tyr Thr Glu Leu Glu  Pro Pro Cys Arg Phe  Val Thr Asp 
    4205                 4210                 4215             


Thr Pro  Lys Gly Pro Lys Val  Lys Tyr Leu Tyr Phe  Ile Lys Gly 
    4220                 4225                 4230             


Leu Asn  Asn Leu Asn Arg Gly  Met Val Leu Gly Ser  Leu Ala Ala 
    4235                 4240                 4245             


Thr Val  Arg Leu Gln Ala Gly  Asn Ala Thr Glu Val  Pro Ala Asn 
    4250                 4255                 4260             


Ser Thr  Val Leu Ser Phe Cys  Ala Phe Ala Val Asp  Ala Ala Lys 
    4265                 4270                 4275             


Ala Tyr  Lys Asp Tyr Leu Ala  Ser Gly Gly Gln Pro  Ile Thr Asn 
    4280                 4285                 4290             


Cys Val  Lys Met Leu Cys Thr  His Thr Gly Thr Gly  Gln Ala Ile 
    4295                 4300                 4305             


Thr Val  Thr Pro Glu Ala Asn  Met Asp Gln Glu Ser  Phe Gly Gly 
    4310                 4315                 4320             


Ala Ser  Cys Cys Leu Tyr Cys  Arg Cys His Ile Asp  His Pro Asn 
    4325                 4330                 4335             


Pro Lys  Gly Phe Cys Asp Leu  Lys Gly Lys Tyr Val  Gln Ile Pro 
    4340                 4345                 4350             


Thr Thr  Cys Ala Asn Asp Pro  Val Gly Phe Thr Leu  Lys Asn Thr 
    4355                 4360                 4365             


Val Cys  Thr Val Cys Gly Met  Trp Lys Gly Tyr Gly  Cys Ser Cys 
    4370                 4375                 4380             


Asp Gln  Leu Arg Glu Pro Met  Leu Gln Ser Ala Asp  Ala Gln Ser 
    4385                 4390                 4395             


Phe Leu  Asn Arg Val Cys Gly  Val Ser Ala Ala Arg  Leu Thr Pro 
    4400                 4405                 4410             


Cys Gly  Thr Gly Thr Ser Thr  Asp Val Val Tyr Arg  Ala Phe Asp 
    4415                 4420                 4425             


Ile Tyr  Asn Asp Lys Val Ala  Gly Phe Ala Lys Phe  Leu Lys Thr 
    4430                 4435                 4440             


Asn Cys  Cys Arg Phe Gln Glu  Lys Asp Glu Asp Asp  Asn Leu Ile 
    4445                 4450                 4455             


Asp Ser  Tyr Phe Val Val Lys  Arg His Thr Phe Ser  Asn Tyr Gln 
    4460                 4465                 4470             


His Glu  Glu Thr Ile Tyr Asn  Leu Leu Lys Asp Cys  Pro Ala Val 
    4475                 4480                 4485             


Ala Lys  His Asp Phe Phe Lys  Phe Arg Ile Asp Gly  Asp Met Val 
    4490                 4495                 4500             


Pro His  Ile Ser Arg Gln Arg  Leu Thr Lys Tyr Thr  Met Ala Asp 
    4505                 4510                 4515             


Leu Val  Tyr Ala Leu Arg His  Phe Asp Glu Gly Asn  Cys Asp Thr 
    4520                 4525                 4530             


Leu Lys  Glu Ile Leu Val Thr  Tyr Asn Cys Cys Asp  Asp Asp Tyr 
    4535                 4540                 4545             


Phe Asn  Lys Lys Asp Trp Tyr  Asp Phe Val Glu Asn  Pro Asp Ile 
    4550                 4555                 4560             


Leu Arg  Val Tyr Ala Asn Leu  Gly Glu Arg Val Arg  Gln Ala Leu 
    4565                 4570                 4575             


Leu Lys  Thr Val Gln Phe Cys  Asp Ala Met Arg Asn  Ala Gly Ile 
    4580                 4585                 4590             


Val Gly  Val Leu Thr Leu Asp  Asn Gln Asp Leu Asn  Gly Asn Trp 
    4595                 4600                 4605             


Tyr Asp  Phe Gly Asp Phe Ile  Gln Thr Thr Pro Gly  Ser Gly Val 
    4610                 4615                 4620             


Pro Val  Val Asp Ser Tyr Tyr  Ser Leu Leu Met Pro  Ile Leu Thr 
    4625                 4630                 4635             


Leu Thr  Arg Ala Leu Thr Ala  Glu Ser His Val Asp  Thr Asp Leu 
    4640                 4645                 4650             


Thr Lys  Pro Tyr Ile Lys Trp  Asp Leu Leu Lys Tyr  Asp Phe Thr 
    4655                 4660                 4665             


Glu Glu  Arg Leu Lys Leu Phe  Asp Arg Tyr Phe Lys  Tyr Trp Asp 
    4670                 4675                 4680             


Gln Thr  Tyr His Pro Asn Cys  Val Asn Cys Leu Asp  Asp Arg Cys 
    4685                 4690                 4695             


Ile Leu  His Cys Ala Asn Phe  Asn Val Leu Phe Ser  Thr Val Phe 
    4700                 4705                 4710             


Pro Pro  Thr Ser Phe Gly Pro  Leu Val Arg Lys Ile  Phe Val Asp 
    4715                 4720                 4725             


Gly Val  Pro Phe Val Val Ser  Thr Gly Tyr His Phe  Arg Glu Leu 
    4730                 4735                 4740             


Gly Val  Val His Asn Gln Asp  Val Asn Leu His Ser  Ser Arg Leu 
    4745                 4750                 4755             


Ser Phe  Lys Glu Leu Leu Val  Tyr Ala Ala Asp Pro  Ala Met His 
    4760                 4765                 4770             


Ala Ala  Ser Gly Asn Leu Leu  Leu Asp Lys Arg Thr  Thr Cys Phe 
    4775                 4780                 4785             


Ser Val  Ala Ala Leu Thr Asn  Asn Val Ala Phe Gln  Thr Val Lys 
    4790                 4795                 4800             


Pro Gly  Asn Phe Asn Lys Asp  Phe Tyr Asp Phe Ala  Val Ser Lys 
    4805                 4810                 4815             


Gly Phe  Phe Lys Glu Gly Ser  Ser Val Glu Leu Lys  His Phe Phe 
    4820                 4825                 4830             


Phe Ala  Gln Asp Gly Asn Ala  Ala Ile Ser Asp Tyr  Asp Tyr Tyr 
    4835                 4840                 4845             


Arg Tyr  Asn Leu Pro Thr Met  Cys Asp Ile Arg Gln  Leu Leu Phe 
    4850                 4855                 4860             


Val Val  Glu Val Val Asp Lys  Tyr Phe Asp Cys Tyr  Asp Gly Gly 
    4865                 4870                 4875             


Cys Ile  Asn Ala Asn Gln Val  Ile Val Asn Asn Leu  Asp Lys Ser 
    4880                 4885                 4890             


Ala Gly  Phe Pro Phe Asn Lys  Trp Gly Lys Ala Arg  Leu Tyr Tyr 
    4895                 4900                 4905             


Asp Ser  Met Ser Tyr Glu Asp  Gln Asp Ala Leu Phe  Ala Tyr Thr 
    4910                 4915                 4920             


Lys Arg  Asn Val Ile Pro Thr  Ile Thr Gln Met Asn  Leu Lys Tyr 
    4925                 4930                 4935             


Ala Ile  Ser Ala Lys Asn Arg  Ala Arg Thr Val Ala  Gly Val Ser 
    4940                 4945                 4950             


Ile Cys  Ser Thr Met Thr Asn  Arg Gln Phe His Gln  Lys Leu Leu 
    4955                 4960                 4965             


Lys Ser  Ile Ala Ala Thr Arg  Gly Ala Thr Val Val  Ile Gly Thr 
    4970                 4975                 4980             


Ser Lys  Phe Tyr Gly Gly Trp  His Asn Met Leu Lys  Thr Val Tyr 
    4985                 4990                 4995             


Ser Asp  Val Glu Asn Pro His  Leu Met Gly Trp Asp  Tyr Pro Lys 
    5000                 5005                 5010             


Cys Asp  Arg Ala Met Pro Asn  Met Leu Arg Ile Met  Ala Ser Leu 
    5015                 5020                 5025             


Val Leu  Ala Arg Lys His Thr  Thr Cys Cys Ser Leu  Ser His Arg 
    5030                 5035                 5040             


Phe Tyr  Arg Leu Ala Asn Glu  Cys Ala Gln Val Leu  Ser Glu Met 
    5045                 5050                 5055             


Val Met  Cys Gly Gly Ser Leu  Tyr Val Lys Pro Gly  Gly Thr Ser 
    5060                 5065                 5070             


Ser Gly  Asp Ala Thr Thr Ala  Tyr Ala Asn Ser Val  Phe Asn Ile 
    5075                 5080                 5085             


Cys Gln  Ala Val Thr Ala Asn  Val Asn Ala Leu Leu  Ser Thr Asp 
    5090                 5095                 5100             


Gly Asn  Lys Ile Ala Asp Lys  Tyr Val Arg Asn Leu  Gln His Arg 
    5105                 5110                 5115             


Leu Tyr  Glu Cys Leu Tyr Arg  Asn Arg Asp Val Asp  Thr Asp Phe 
    5120                 5125                 5130             


Val Asn  Glu Phe Tyr Ala Tyr  Leu Arg Lys His Phe  Ser Met Met 
    5135                 5140                 5145             


Ile Leu  Ser Asp Asp Ala Val  Val Cys Phe Asn Ser  Thr Tyr Ala 
    5150                 5155                 5160             


Ser Gln  Gly Leu Val Ala Ser  Ile Lys Asn Phe Lys  Ser Val Leu 
    5165                 5170                 5175             


Tyr Tyr  Gln Asn Asn Val Phe  Met Ser Glu Ala Lys  Cys Trp Thr 
    5180                 5185                 5190             


Glu Thr  Asp Leu Thr Lys Gly  Pro His Glu Phe Cys  Ser Gln His 
    5195                 5200                 5205             


Thr Met  Leu Val Lys Gln Gly  Asp Asp Tyr Val Tyr  Leu Pro Tyr 
    5210                 5215                 5220             


Pro Asp  Pro Ser Arg Ile Leu  Gly Ala Gly Cys Phe  Val Asp Asp 
    5225                 5230                 5235             


Ile Val  Lys Thr Asp Gly Thr  Leu Met Ile Glu Arg  Phe Val Ser 
    5240                 5245                 5250             


Leu Ala  Ile Asp Ala Tyr Pro  Leu Thr Lys His Pro  Asn Gln Glu 
    5255                 5260                 5265             


Tyr Ala  Asp Val Phe His Leu  Tyr Leu Gln Tyr Ile  Arg Lys Leu 
    5270                 5275                 5280             


His Asp  Glu Leu Thr Gly His  Met Leu Asp Met Tyr  Ser Val Met 
    5285                 5290                 5295             


Leu Thr  Asn Asp Asn Thr Ser  Arg Tyr Trp Glu Pro  Glu Phe Tyr 
    5300                 5305                 5310             


Glu Ala  Met Tyr Thr Pro His  Thr Val Leu Gln Ala  Val Gly Ala 
    5315                 5320                 5325             


Cys Val  Leu Cys Asn Ser Gln  Thr Ser Leu Arg Cys  Gly Ala Cys 
    5330                 5335                 5340             


Ile Arg  Arg Pro Phe Leu Cys  Cys Lys Cys Cys Tyr  Asp His Val 
    5345                 5350                 5355             


Ile Ser  Thr Ser His Lys Leu  Val Leu Ser Val Asn  Pro Tyr Val 
    5360                 5365                 5370             


Cys Asn  Ala Pro Gly Cys Asp  Val Thr Asp Val Thr  Gln Leu Tyr 
    5375                 5380                 5385             


Leu Gly  Gly Met Ser Tyr Tyr  Cys Lys Ser His Lys  Pro Pro Ile 
    5390                 5395                 5400             


Ser Phe  Pro Leu Cys Ala Asn  Gly Gln Val Phe Gly  Leu Tyr Lys 
    5405                 5410                 5415             


Asn Thr  Cys Val Gly Ser Asp  Asn Val Thr Asp Phe  Asn Ala Ile 
    5420                 5425                 5430             


Ala Thr  Cys Asp Trp Thr Asn  Ala Gly Asp Tyr Ile  Leu Ala Asn 
    5435                 5440                 5445             


Thr Cys  Thr Glu Arg Leu Lys  Leu Phe Ala Ala Glu  Thr Leu Lys 
    5450                 5455                 5460             


Ala Thr  Glu Glu Thr Phe Lys  Leu Ser Tyr Gly Ile  Ala Thr Val 
    5465                 5470                 5475             


Arg Glu  Val Leu Ser Asp Arg  Glu Leu His Leu Ser  Trp Glu Val 
    5480                 5485                 5490             


Gly Lys  Pro Arg Pro Pro Leu  Asn Arg Asn Tyr Val  Phe Thr Gly 
    5495                 5500                 5505             


Tyr Arg  Val Thr Lys Asn Ser  Lys Val Gln Ile Gly  Glu Tyr Thr 
    5510                 5515                 5520             


Phe Glu  Lys Gly Asp Tyr Gly  Asp Ala Val Val Tyr  Arg Gly Thr 
    5525                 5530                 5535             


Thr Thr  Tyr Lys Leu Asn Val  Gly Asp Tyr Phe Val  Leu Thr Ser 
    5540                 5545                 5550             


His Thr  Val Met Pro Leu Ser  Ala Pro Thr Leu Val  Pro Gln Glu 
    5555                 5560                 5565             


His Tyr  Val Arg Ile Thr Gly  Leu Tyr Pro Thr Leu  Asn Ile Ser 
    5570                 5575                 5580             


Asp Glu  Phe Ser Ser Asn Val  Ala Asn Tyr Gln Lys  Val Gly Met 
    5585                 5590                 5595             


Gln Lys  Tyr Ser Thr Leu Gln  Gly Pro Pro Gly Thr  Gly Lys Ser 
    5600                 5605                 5610             


His Phe  Ala Ile Gly Leu Ala  Leu Tyr Tyr Pro Ser  Ala Arg Ile 
    5615                 5620                 5625             


Val Tyr  Thr Ala Cys Ser His  Ala Ala Val Asp Ala  Leu Cys Glu 
    5630                 5635                 5640             


Lys Ala  Leu Lys Tyr Leu Pro  Ile Asp Lys Cys Ser  Arg Ile Ile 
    5645                 5650                 5655             


Pro Ala  Arg Ala Arg Val Glu  Cys Phe Asp Lys Phe  Lys Val Asn 
    5660                 5665                 5670             


Ser Thr  Leu Glu Gln Tyr Val  Phe Cys Thr Val Asn  Ala Leu Pro 
    5675                 5680                 5685             


Glu Thr  Thr Ala Asp Ile Val  Val Phe Asp Glu Ile  Ser Met Ala 
    5690                 5695                 5700             


Thr Asn  Tyr Asp Leu Ser Val  Val Asn Ala Arg Leu  Arg Ala Lys 
    5705                 5710                 5715             


His Tyr  Val Tyr Ile Gly Asp  Pro Ala Gln Leu Pro  Ala Pro Arg 
    5720                 5725                 5730             


Thr Leu  Leu Thr Lys Gly Thr  Leu Glu Pro Glu Tyr  Phe Asn Ser 
    5735                 5740                 5745             


Val Cys  Arg Leu Met Lys Thr  Ile Gly Pro Asp Met  Phe Leu Gly 
    5750                 5755                 5760             


Thr Cys  Arg Arg Cys Pro Ala  Glu Ile Val Asp Thr  Val Ser Ala 
    5765                 5770                 5775             


Leu Val  Tyr Asp Asn Lys Leu  Lys Ala His Lys Asp  Lys Ser Ala 
    5780                 5785                 5790             


Gln Cys  Phe Lys Met Phe Tyr  Lys Gly Val Ile Thr  His Asp Val 
    5795                 5800                 5805             


Ser Ser  Ala Ile Asn Arg Pro  Gln Ile Gly Val Val  Arg Glu Phe 
    5810                 5815                 5820             


Leu Thr  Arg Asn Pro Ala Trp  Arg Lys Ala Val Phe  Ile Ser Pro 
    5825                 5830                 5835             


Tyr Asn  Ser Gln Asn Ala Val  Ala Ser Lys Ile Leu  Gly Leu Pro 
    5840                 5845                 5850             


Thr Gln  Thr Val Asp Ser Ser  Gln Gly Ser Glu Tyr  Asp Tyr Val 
    5855                 5860                 5865             


Ile Phe  Thr Gln Thr Thr Glu  Thr Ala His Ser Cys  Asn Val Asn 
    5870                 5875                 5880             


Arg Phe  Asn Val Ala Ile Thr  Arg Ala Lys Val Gly  Ile Leu Cys 
    5885                 5890                 5895             


Ile Met  Ser Asp Arg Asp Leu  Tyr Asp Lys Leu Gln  Phe Thr Ser 
    5900                 5905                 5910             


Leu Glu  Ile Pro Arg Arg Asn  Val Ala Thr Leu Gln  Ala Glu Asn 
    5915                 5920                 5925             


Val Thr  Gly Leu Phe Lys Asp  Cys Ser Lys Val Ile  Thr Gly Leu 
    5930                 5935                 5940             


His Pro  Thr Gln Ala Pro Thr  His Leu Ser Val Asp  Thr Lys Phe 
    5945                 5950                 5955             


Lys Thr  Glu Gly Leu Cys Val  Asp Ile Pro Gly Ile  Pro Lys Asp 
    5960                 5965                 5970             


Met Thr  Tyr Arg Arg Leu Ile  Ser Met Met Gly Phe  Lys Met Asn 
    5975                 5980                 5985             


Tyr Gln  Val Asn Gly Tyr Pro  Asn Met Phe Ile Thr  Arg Glu Glu 
    5990                 5995                 6000             


Ala Ile  Arg His Val Arg Ala  Trp Ile Gly Phe Asp  Val Glu Gly 
    6005                 6010                 6015             


Cys His  Ala Thr Arg Glu Ala  Val Gly Thr Asn Leu  Pro Leu Gln 
    6020                 6025                 6030             


Leu Gly  Phe Ser Thr Gly Val  Asn Leu Val Ala Val  Pro Thr Gly 
    6035                 6040                 6045             


Tyr Val  Asp Thr Pro Asn Asn  Thr Asp Phe Ser Arg  Val Ser Ala 
    6050                 6055                 6060             


Lys Pro  Pro Pro Gly Asp Gln  Phe Lys His Leu Ile  Pro Leu Met 
    6065                 6070                 6075             


Tyr Lys  Gly Leu Pro Trp Asn  Val Val Arg Ile Lys  Ile Val Gln 
    6080                 6085                 6090             


Met Leu  Ser Asp Thr Leu Lys  Asn Leu Ser Asp Arg  Val Val Phe 
    6095                 6100                 6105             


Val Leu  Trp Ala His Gly Phe  Glu Leu Thr Ser Met  Lys Tyr Phe 
    6110                 6115                 6120             


Val Lys  Ile Gly Pro Glu Arg  Thr Cys Cys Leu Cys  Asp Arg Arg 
    6125                 6130                 6135             


Ala Thr  Cys Phe Ser Thr Ala  Ser Asp Thr Tyr Ala  Cys Trp His 
    6140                 6145                 6150             


His Ser  Ile Gly Phe Asp Tyr  Val Tyr Asn Pro Phe  Met Ile Asp 
    6155                 6160                 6165             


Val Gln  Gln Trp Gly Phe Thr  Gly Asn Leu Gln Ser  Asn His Asp 
    6170                 6175                 6180             


Leu Tyr  Cys Gln Val His Gly  Asn Ala His Val Ala  Ser Cys Asp 
    6185                 6190                 6195             


Ala Ile  Met Thr Arg Cys Leu  Ala Val His Glu Cys  Phe Val Lys 
    6200                 6205                 6210             


Arg Val  Asp Trp Thr Ile Glu  Tyr Pro Ile Ile Gly  Asp Glu Leu 
    6215                 6220                 6225             


Lys Ile  Asn Ala Ala Cys Arg  Lys Val Gln His Met  Val Val Lys 
    6230                 6235                 6240             


Ala Ala  Leu Leu Ala Asp Lys  Phe Pro Val Leu His  Asp Ile Gly 
    6245                 6250                 6255             


Asn Pro  Lys Ala Ile Lys Cys  Val Pro Gln Ala Asp  Val Glu Trp 
    6260                 6265                 6270             


Lys Phe  Tyr Asp Ala Gln Pro  Cys Ser Asp Lys Ala  Tyr Lys Ile 
    6275                 6280                 6285             


Glu Glu  Leu Phe Tyr Ser Tyr  Ala Thr His Ser Asp  Lys Phe Thr 
    6290                 6295                 6300             


Asp Gly  Val Cys Leu Phe Trp  Asn Cys Asn Val Asp  Arg Tyr Pro 
    6305                 6310                 6315             


Ala Asn  Ser Ile Val Cys Arg  Phe Asp Thr Arg Val  Leu Ser Asn 
    6320                 6325                 6330             


Leu Asn  Leu Pro Gly Cys Asp  Gly Gly Ser Leu Tyr  Val Asn Lys 
    6335                 6340                 6345             


His Ala  Phe His Thr Pro Ala  Phe Asp Lys Ser Ala  Phe Val Asn 
    6350                 6355                 6360             


Leu Lys  Gln Leu Pro Phe Phe  Tyr Tyr Ser Asp Ser  Pro Cys Glu 
    6365                 6370                 6375             


Ser His  Gly Lys Gln Val Val  Ser Asp Ile Asp Tyr  Val Pro Leu 
    6380                 6385                 6390             


Lys Ser  Ala Thr Cys Ile Thr  Arg Cys Asn Leu Gly  Gly Ala Val 
    6395                 6400                 6405             


Cys Arg  His His Ala Asn Glu  Tyr Arg Leu Tyr Leu  Asp Ala Tyr 
    6410                 6415                 6420             


Asn Met  Met Ile Ser Ala Gly  Phe Ser Leu Trp Val  Tyr Lys Gln 
    6425                 6430                 6435             


Phe Asp  Thr Tyr Asn Leu Trp  Asn Thr Phe Thr Arg  Leu Gln Ser 
    6440                 6445                 6450             


Leu Glu  Asn Val Ala Phe Asn  Val Val Asn Lys Gly  His Phe Asp 
    6455                 6460                 6465             


Gly Gln  Gln Gly Glu Val Pro  Val Ser Ile Ile Asn  Asn Thr Val 
    6470                 6475                 6480             


Tyr Thr  Lys Val Asp Gly Val  Asp Val Glu Leu Phe  Glu Asn Lys 
    6485                 6490                 6495             


Thr Thr  Leu Pro Val Asn Val  Ala Phe Glu Leu Trp  Ala Lys Arg 
    6500                 6505                 6510             


Asn Ile  Lys Pro Val Pro Glu  Val Lys Ile Leu Asn  Asn Leu Gly 
    6515                 6520                 6525             


Val Asp  Ile Ala Ala Asn Thr  Val Ile Trp Asp Tyr  Lys Arg Asp 
    6530                 6535                 6540             


Ala Pro  Ala His Ile Ser Thr  Ile Gly Val Cys Ser  Met Thr Asp 
    6545                 6550                 6555             


Ile Ala  Lys Lys Pro Thr Glu  Thr Ile Cys Ala Pro  Leu Thr Val 
    6560                 6565                 6570             


Phe Phe  Asp Gly Arg Val Asp  Gly Gln Val Asp Leu  Phe Arg Asn 
    6575                 6580                 6585             


Ala Arg  Asn Gly Val Leu Ile  Thr Glu Gly Ser Val  Lys Gly Leu 
    6590                 6595                 6600             


Gln Pro  Ser Val Gly Pro Lys  Gln Ala Ser Leu Asn  Gly Val Thr 
    6605                 6610                 6615             


Leu Ile  Gly Glu Ala Val Lys  Thr Gln Phe Asn Tyr  Tyr Lys Lys 
    6620                 6625                 6630             


Val Asp  Gly Val Val Gln Gln  Leu Pro Glu Thr Tyr  Phe Thr Gln 
    6635                 6640                 6645             


Ser Arg  Asn Leu Gln Glu Phe  Lys Pro Arg Ser Gln  Met Glu Ile 
    6650                 6655                 6660             


Asp Phe  Leu Glu Leu Ala Met  Asp Glu Phe Ile Glu  Arg Tyr Lys 
    6665                 6670                 6675             


Leu Glu  Gly Tyr Ala Phe Glu  His Ile Val Tyr Gly  Asp Phe Ser 
    6680                 6685                 6690             


His Ser  Gln Leu Gly Gly Leu  His Leu Leu Ile Gly  Leu Ala Lys 
    6695                 6700                 6705             


Arg Phe  Lys Glu Ser Pro Phe  Glu Leu Glu Asp Phe  Ile Pro Met 
    6710                 6715                 6720             


Asp Ser  Thr Val Lys Asn Tyr  Phe Ile Thr Asp Ala  Gln Thr Gly 
    6725                 6730                 6735             


Ser Ser  Lys Cys Val Cys Ser  Val Ile Asp Leu Leu  Leu Asp Asp 
    6740                 6745                 6750             


Phe Val  Glu Ile Ile Lys Ser  Gln Asp Leu Ser Val  Val Ser Lys 
    6755                 6760                 6765             


Val Val  Lys Val Thr Ile Asp  Tyr Thr Glu Ile Ser  Phe Met Leu 
    6770                 6775                 6780             


Trp Cys  Lys Asp Gly His Val  Glu Thr Phe Tyr Pro  Lys Leu Gln 
    6785                 6790                 6795             


Ser Ser  Gln Ala Trp Gln Pro  Gly Val Ala Met Pro  Asn Leu Tyr 
    6800                 6805                 6810             


Lys Met  Gln Arg Met Leu Leu  Glu Lys Cys Asp Leu  Gln Asn Tyr 
    6815                 6820                 6825             


Gly Asp  Ser Ala Thr Leu Pro  Lys Gly Ile Met Met  Asn Val Ala 
    6830                 6835                 6840             


Lys Tyr  Thr Gln Leu Cys Gln  Tyr Leu Asn Thr Leu  Thr Leu Ala 
    6845                 6850                 6855             


Val Pro  Tyr Asn Met Arg Val  Ile His Phe Gly Ala  Gly Ser Asp 
    6860                 6865                 6870             


Lys Gly  Val Ala Pro Gly Thr  Ala Val Leu Arg Gln  Trp Leu Pro 
    6875                 6880                 6885             


Thr Gly  Thr Leu Leu Val Asp  Ser Asp Leu Asn Asp  Phe Val Ser 
    6890                 6895                 6900             


Asp Ala  Asp Ser Thr Leu Ile  Gly Asp Cys Ala Thr  Val His Thr 
    6905                 6910                 6915             


Ala Asn  Lys Trp Asp Leu Ile  Ile Ser Asp Met Tyr  Asp Pro Lys 
    6920                 6925                 6930             


Thr Lys  Asn Val Thr Lys Glu  Asn Asp Ser Lys Glu  Gly Phe Phe 
    6935                 6940                 6945             


Thr Tyr  Ile Cys Gly Phe Ile  Gln Gln Lys Leu Ala  Leu Gly Gly 
    6950                 6955                 6960             


Ser Val  Ala Ile Lys Ile Thr  Glu His Ser Trp Asn  Ala Asp Leu 
    6965                 6970                 6975             


Tyr Lys  Leu Met Gly His Phe  Ala Trp Trp Thr Ala  Phe Val Thr 
    6980                 6985                 6990             


Asn Val  Asn Ala Ser Ser Ser  Glu Ala Phe Leu Ile  Gly Cys Asn 
    6995                 7000                 7005             


Tyr Leu  Gly Lys Pro Arg Glu  Gln Ile Asp Gly Tyr  Val Met His 
    7010                 7015                 7020             


Ala Asn  Tyr Ile Phe Trp Arg  Asn Thr Asn Pro Ile  Gln Leu Ser 
    7025                 7030                 7035             


Ser Tyr  Ser Leu Phe Asp Met  Ser Lys Phe Pro Leu  Lys Leu Arg 
    7040                 7045                 7050             


Gly Thr  Ala Val Met Ser Leu  Lys Glu Gly Gln Ile  Asn Asp Met 
    7055                 7060                 7065             


Ile Leu  Ser Leu Leu Ser Lys  Gly Arg Leu Ile Ile  Arg Glu Asn 
    7070                 7075                 7080             


Asn Arg  Val Val Ile Ser Ser  Asp Val Leu Val Asn  Asn 
    7085                 7090                 7095     





<210> 3
<211> 1273
<212> PRT
<213> betacoronavirus SARS coronavirus 2

<400> 3
Met Phe Val Phe Leu Val Leu Leu Pro Leu Val Ser Ser Gln Cys Val
 1               5                  10                  15
Asn Leu Thr Thr Arg Thr Gln Leu Pro Pro Ala Tyr Thr Asn Ser Phe
            20                  25                  30
Thr Arg Gly Val Tyr Tyr Pro Asp Lys Val Phe Arg Ser Ser Val Leu
        35                  40                  45
His Ser Thr Gln Asp Leu Phe Leu Pro Phe Phe Ser Asn Val Thr Trp
    50                  55                  60
Phe His Ala Ile His Val Ser Gly Thr Asn Gly Thr Lys Arg Phe Asp
65                  70                  75                  80
Asn Pro Val Leu Pro Phe Asn Asp Gly Val Tyr Phe Ala Ser Thr Glu
                85                  90                  95
Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe Gly Thr Thr Leu Asp Ser
            100                 105                 110
Lys Thr Gln Ser Leu Leu Ile Val Asn Asn Ala Thr Asn Val Val Ile
        115                 120                 125
Lys Val Cys Glu Phe Gln Phe Cys Asn Asp Pro Phe Leu Gly Val Tyr
    130                 135                 140
Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser Glu Phe Arg Val Tyr
145                 150                 155                 160
Ser Ser Ala Asn Asn Cys Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu
                165                 170                 175
Met Asp Leu Glu Gly Lys Gln Gly Asn Phe Lys Asn Leu Arg Glu Phe
            180                 185                 190
Val Phe Lys Asn Ile Asp Gly Tyr Phe Lys Ile Tyr Ser Lys His Thr
        195                 200                 205
Pro Ile Asn Leu Val Arg Asp Leu Pro Gln Gly Phe Ser Ala Leu Glu
    210                 215                 220
Pro Leu Val Asp Leu Pro Ile Gly Ile Asn Ile Thr Arg Phe Gln Thr
225                 230                 235                 240
Leu Leu Ala Leu His Arg Ser Tyr Leu Thr Pro Gly Asp Ser Ser Ser
                245                 250                 255
Gly Trp Thr Ala Gly Ala Ala Ala Tyr Tyr Val Gly Tyr Leu Gln Pro
            260                 265                 270
Arg Thr Phe Leu Leu Lys Tyr Asn Glu Asn Gly Thr Ile Thr Asp Ala
        275                 280                 285
Val Asp Cys Ala Leu Asp Pro Leu Ser Glu Thr Lys Cys Thr Leu Lys
    290                 295                 300
Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val
305                 310                 315                 320
Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile Thr Asn Leu Cys
                325                 330                 335
Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala
            340                 345                 350
Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp Tyr Ser Val Leu
        355                 360                 365
Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro
    370                 375                 380
Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr Ala Asp Ser Phe
385                 390                 395                 400
Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly
                405                 410                 415
Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp Phe Thr Gly Cys
            420                 425                 430
Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn
        435                 440                 445
Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe
    450                 455                 460
Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys
465                 470                 475                 480
Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly
                485                 490                 495
Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val
            500                 505                 510
Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys Gly Pro Lys
        515                 520                 525
Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn Phe Asn Phe Asn
    530                 535                 540
Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser Asn Lys Lys Phe Leu
545                 550                 555                 560
Pro Phe Gln Gln Phe Gly Arg Asp Ile Ala Asp Thr Thr Asp Ala Val
                565                 570                 575
Arg Asp Pro Gln Thr Leu Glu Ile Leu Asp Ile Thr Pro Cys Ser Phe
            580                 585                 590
Gly Gly Val Ser Val Ile Thr Pro Gly Thr Asn Thr Ser Asn Gln Val
        595                 600                 605
Ala Val Leu Tyr Gln Asp Val Asn Cys Thr Glu Val Pro Val Ala Ile
    610                 615                 620
His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val Tyr Ser Thr Gly Ser
625                 630                 635                 640
Asn Val Phe Gln Thr Arg Ala Gly Cys Leu Ile Gly Ala Glu His Val
                645                 650                 655
Asn Asn Ser Tyr Glu Cys Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala
            660                 665                 670
Ser Tyr Gln Thr Gln Thr Asn Ser Pro Arg Arg Ala Arg Ser Val Ala
        675                 680                 685
Ser Gln Ser Ile Ile Ala Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser
    690                 695                 700
Val Ala Tyr Ser Asn Asn Ser Ile Ala Ile Pro Thr Asn Phe Thr Ile
705                 710                 715                 720
Ser Val Thr Thr Glu Ile Leu Pro Val Ser Met Thr Lys Thr Ser Val
                725                 730                 735
Asp Cys Thr Met Tyr Ile Cys Gly Asp Ser Thr Glu Cys Ser Asn Leu
            740                 745                 750
Leu Leu Gln Tyr Gly Ser Phe Cys Thr Gln Leu Asn Arg Ala Leu Thr
        755                 760                 765
Gly Ile Ala Val Glu Gln Asp Lys Asn Thr Gln Glu Val Phe Ala Gln
    770                 775                 780
Val Lys Gln Ile Tyr Lys Thr Pro Pro Ile Lys Asp Phe Gly Gly Phe
785                 790                 795                 800
Asn Phe Ser Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser
                805                 810                 815
Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr Leu Ala Asp Ala Gly
            820                 825                 830
Phe Ile Lys Gln Tyr Gly Asp Cys Leu Gly Asp Ile Ala Ala Arg Asp
        835                 840                 845
Leu Ile Cys Ala Gln Lys Phe Asn Gly Leu Thr Val Leu Pro Pro Leu
    850                 855                 860
Leu Thr Asp Glu Met Ile Ala Gln Tyr Thr Ser Ala Leu Leu Ala Gly
865                 870                 875                 880
Thr Ile Thr Ser Gly Trp Thr Phe Gly Ala Gly Ala Ala Leu Gln Ile
                885                 890                 895
Pro Phe Ala Met Gln Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr
            900                 905                 910
Gln Asn Val Leu Tyr Glu Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn
        915                 920                 925
Ser Ala Ile Gly Lys Ile Gln Asp Ser Leu Ser Ser Thr Ala Ser Ala
    930                 935                 940
Leu Gly Lys Leu Gln Asp Val Val Asn Gln Asn Ala Gln Ala Leu Asn
945                 950                 955                 960
Thr Leu Val Lys Gln Leu Ser Ser Asn Phe Gly Ala Ile Ser Ser Val
                965                 970                 975
Leu Asn Asp Ile Leu Ser Arg Leu Asp Lys Val Glu Ala Glu Val Gln
            980                 985                 990
Ile Asp Arg Leu Ile Thr Gly Arg Leu Gln Ser Leu Gln Thr Tyr Val
        995                 1000                1005
Thr Gln Gln Leu Ile Arg Ala Ala Glu Ile Arg Ala Ser Ala Asn Leu
    1010                1015                1020
Ala Ala Thr Lys Met Ser Glu Cys Val Leu Gly Gln Ser Lys Arg Val
1025                1030                1035                1040
Asp Phe Cys Gly Lys Gly Tyr His Leu Met Ser Phe Pro Gln Ser Ala
                1045                1050                1055
Pro His Gly Val Val Phe Leu His Val Thr Tyr Val Pro Ala Gln Glu
            1060                1065                1070
Lys Asn Phe Thr Thr Ala Pro Ala Ile Cys His Asp Gly Lys Ala His
        1075                1080                1085
Phe Pro Arg Glu Gly Val Phe Val Ser Asn Gly Thr His Trp Phe Val
    1090                1095                1100
Thr Gln Arg Asn Phe Tyr Glu Pro Gln Ile Ile Thr Thr Asp Asn Thr
1105                1110                1115                1120
Phe Val Ser Gly Asn Cys Asp Val Val Ile Gly Ile Val Asn Asn Thr
                1125                1130                1135
Val Tyr Asp Pro Leu Gln Pro Glu Leu Asp Ser Phe Lys Glu Glu Leu
            1140                1145                1150
Asp Lys Tyr Phe Lys Asn His Thr Ser Pro Asp Val Asp Leu Gly Asp
        1155                1160                1165
Ile Ser Gly Ile Asn Ala Ser Val Val Asn Ile Gln Lys Glu Ile Asp
    1170                1175                1180
Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu Ile Asp Leu
1185                1190                1195                1200
Gln Glu Leu Gly Lys Tyr Glu Gln Tyr Ile Lys Trp Pro Trp Tyr Ile
                1205                1210                1215
Trp Leu Gly Phe Ile Ala Gly Leu Ile Ala Ile Val Met Val Thr Ile
            1220                1225                1230
Met Leu Cys Cys Met Thr Ser Cys Cys Ser Cys Leu Lys Gly Cys Cys
        1235                1240                1245
Ser Cys Gly Ser Cys Cys Lys Phe Asp Glu Asp Asp Ser Glu Pro Val
    1250                1255                1260
Leu Lys Gly Val Lys Leu His Tyr Thr
1265                1270

<210> 4
<211> 220
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence surface glycoprotein RBD
      [SARS-CoV-2 Wuhan seafood market pneumonia virus

<400> 4
Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg
 1               5                  10                  15
Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val
            20                  25                  30
Ala Asp Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys
        35                  40                  45
Cys Tyr Gly Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn
    50                  55                  60
Val Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile
65                  70                  75                  80
Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro
                85                  90                  95
Asp Asp Phe Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp
            100                 105                 110
Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys
        115                 120                 125
Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln
    130                 135                 140
Ala Gly Ser Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe
145                 150                 155                 160
Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln
                165                 170                 175
Pro Tyr Arg Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala
            180                 185                 190
Thr Val Cys Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys
        195                 200                 205
Val Asn Phe Asn Phe Asn Gly Leu Thr Gly Thr Gly
    210                 215                 220

<210> 5
<211> 72
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Receptor Binding Motif (RBM) in
      surface glycoprotein RBD [SARS-CoV-2 Wuhan seafood
      market pneumonia virus]; GenBank: QHD43416.1;
      January 23, 2020

<400> 5
Asn Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu
 1               5                  10                  15
Tyr Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile
            20                  25                  30
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu
        35                  40                  45
Gly Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr
    50                  55                  60
Asn Gly Val Gly Tyr Gln Pro Tyr
65                  70

<210> 6
<211> 330
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 CH1-CH3 LS G1m17
      IgHG1*01 (aa)

<400> 6
Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys
 1               5                  10                  15
Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr
            20                  25                  30
Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser
        35                  40                  45
Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser
    50                  55                  60
Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr
65                  70                  75                  80
Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys
                85                  90                  95
Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys
            100                 105                 110
Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro
        115                 120                 125
Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys
    130                 135                 140
Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp
145                 150                 155                 160
Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu
                165                 170                 175
Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu
            180                 185                 190
His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn
        195                 200                 205
Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly
    210                 215                 220
Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu
225                 230                 235                 240
Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr
                245                 250                 255
Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn
            260                 265                 270
Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe
        275                 280                 285
Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn
    290                 295                 300
Val Phe Ser Cys Ser Val Leu His Glu Ala Leu His Ser His Tyr Thr
305                 310                 315                 320
Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
                325                 330

<210> 7
<211> 330
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 CH1-CH3 LS, ALE
      G1m17 IgHG1*01 (aa)

<400> 7
Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys
 1               5                  10                  15
Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr
            20                  25                  30
Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser
        35                  40                  45
Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser
    50                  55                  60
Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr
65                  70                  75                  80
Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys
                85                  90                  95
Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys
            100                 105                 110
Pro Ala Pro Glu Leu Leu Ala Gly Pro Ser Val Phe Leu Phe Pro Pro
        115                 120                 125
Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys
    130                 135                 140
Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp
145                 150                 155                 160
Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu
                165                 170                 175
Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu
            180                 185                 190
His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn
        195                 200                 205
Lys Ala Leu Pro Leu Pro Glu Glu Lys Thr Ile Ser Lys Ala Lys Gly
    210                 215                 220
Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu
225                 230                 235                 240
Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr
                245                 250                 255
Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn
            260                 265                 270
Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe
        275                 280                 285
Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn
    290                 295                 300
Val Phe Ser Cys Ser Val Leu His Glu Ala Leu His Ser His Tyr Thr
305                 310                 315                 320
Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
                325                 330

<210> 8
<211> 106
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 CL IgLC*01

<400> 8
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
 1               5                  10                  15
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
            20                  25                  30
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
        35                  40                  45
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
    50                  55                  60
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
65                  70                  75                  80
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
                85                  90                  95
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
            100                 105

<210> 9
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 CL (CK) k1m3 IgKC*01

<400> 9
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
 1               5                  10                  15
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
            20                  25                  30
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
        35                  40                  45
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
    50                  55                  60
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
65                  70                  75                  80
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
                85                  90                  95
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
            100                 105

<210> 10
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Linker

<400> 10
Gly Ser Thr Ser Gly Ser Gly Lys Pro Gly Ser Gly Glu Gly Ser Thr
 1               5                  10                  15
Lys Gly


<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Linker

<400> 11
Gly Ser Gly Lys Pro Gly Ser Gly Glu Gly
 1               5                  10

<210> 12
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Linker

<400> 12
Gly Lys Pro Gly Ser Gly Glu Gly
 1               5

<210> 13
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Linker

<400> 13
Ser Gly Lys Pro Gly Ser Gly Glu
 1               5

<210> 14
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Linker

<220>
<221> VARIANT        
<222> 1
<223> Xaa= positively charged amino acid

<220>
<221> VARIANT        
<222> (3)...(5)
<223> Xaa = glycine (G) or serine (S)

<220>
<221> VARIANT        
<222> 6
<223> Xaa = negatively charged amino acid

<400> 14
Xaa Pro Xaa Xaa Xaa Xaa
 1               5

<210> 15
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence linker

<220>
<221> VARIANT        
<222> (2)...(10)
<223> any one or all of amino acids 2-10 can either be
      present or absent.

<220>
<221> VARIANT        
<222> (12)...(110)
<223> any one or all of amino acids 12-110 can either be
      present or absent.

<400> 15
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Ser Gly Gly Gly Gly Gly
 1               5                  10                  15
Gly Gly Gly Gly Gly Ser Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly
            20                  25                  30
Ser Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Ser Gly Gly Gly Gly
        35                  40                  45
Gly Gly Gly Gly Gly Gly Ser Gly Gly Gly Gly Gly Gly Gly Gly Gly
    50                  55                  60
Gly Ser Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Ser Gly Gly Gly
65                  70                  75                  80
Gly Gly Gly Gly Gly Gly Gly Ser Gly Gly Gly Gly Gly Gly Gly Gly
                85                  90                  95
Gly Gly Ser Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Ser
            100                 105                 110

<210> 16
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence linker

<400> 16
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
 1               5                  10                  15

<210> 17
<211> 50
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence linker

<400> 17
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
 1               5                  10                  15
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
            20                  25                  30
Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly
        35                  40                  45
Gly Ser
    50

<210> 18
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence linker

<400> 18
Gly Ser Thr Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Gly
 1               5                  10                  15
Ser Ser


<210> 19
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence linker

<400> 19
Glu Gly Lys Ser Ser Gly Ser Gly Ser Glu Ser Lys Val Asp
 1               5                  10

<210> 20
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence linker

<400> 20
Lys Glu Ser Gly Ser Val Ser Ser Glu Gln Leu Ala Gln Phe Arg Ser
 1               5                  10                  15
Leu Asp


<210> 21
<211> 5
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence linker

<400> 21
Gly Gly Gly Gly Ser
 1               5

<210> 22
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb VH

<400> 22
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Asp His
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Asn Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val His Tyr Cys
                85                  90                  95
Ala Arg Asp Arg Ser Arg Phe Arg Phe Phe Ser Pro Asp Phe Asp Tyr
            100                 105                 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 23
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb CDRH1

<400> 23
Gly Tyr Ile Phe Thr Asp His Tyr
 1               5

<210> 24
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb CDRH2

<400> 24
Ile Asn Pro Asn Ser Gly Gly Thr
 1               5

<210> 25
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb CDRH3

<400> 25
Ala Arg Asp Arg Ser Arg Phe Arg Phe Phe Ser Pro Asp Phe Asp Tyr
 1               5                  10                  15

<210> 26
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb VL(VK)

<400> 26
Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
                85                  90                  95
Leu Gln Thr Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105                 110

<210> 27
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb CDRL1

<400> 27
Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr
 1               5                  10

<210> 28
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb CDRL2

<400> 28
Leu Gly Ser
 1

<210> 29
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb CDRL3

<400> 29
Met Gln Ala Leu Gln Thr Pro Pro Thr
 1               5

<210> 30
<211> 370
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb VH

<400> 30
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata catcttcacc gaccactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtggtgg cacaaactat     180
gcacagaagt ttcagggcag ggtcaccatg accagggaca cgtccatcaa cacagcctac     240
atggagctga gcaggctgag atctgacgac acggccgtgc attactgtgc gagagatcgg     300
tcacgatttc gatttttctc ccccgacttt gactactggg gccagggaac cctggtcacc     360
gtctcctcag                                                            370

<210> 31
<211> 337
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v1 mAb VL(VK)

<400> 31
gaaattgtgc tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc      60
atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg     120
tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc     180
tccggggtcc ctgacaggtt cagtggcagt ggctcaggca cagatttcac actgaaaatc     240
agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct     300
ccaacgttcg gccaagggac caaggtggaa atcaaac                              337

<210> 32
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb VH

<400> 32
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr
            20                  25                  30
Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ala Val Ile Leu Ser Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Arg Ser Pro Leu Val Gly Phe Gly Asp Asn Tyr Gly Met
            100                 105                 110
Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120                 125

<210> 33
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb CDRH1

<400> 33
Gly Phe Thr Phe Ser Thr Tyr Ala
 1               5

<210> 34
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb CDRH2

<400> 34
Ile Leu Ser Asp Gly Ser Asn Lys
 1               5

<210> 35
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb CDRH3

<400> 35
Ala Arg Asp Arg Ser Pro Leu Val Gly Phe Gly Asp Asn Tyr Gly Met
 1               5                  10                  15
Asp Val


<210> 36
<211> 108
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb VL

<400> 36
Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln
 1               5                  10                  15
Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala
            20                  25                  30
Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Tyr
        35                  40                  45
Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
    50                  55                  60
Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu
65                  70                  75                  80
Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Thr Asp Ser Ser Gly Asn Gln
                85                  90                  95
Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105

<210> 37
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb CDRL1

<400> 37
Ala Leu Pro Lys Lys Tyr
 1               5

<210> 38
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb CDRL2

<400> 38
Glu Asp Ser
 1

<210> 39
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb CDRL3

<400> 39
Ser Ser Thr Asp Ser Ser Gly Asn Gln Gly Val
 1               5                  10

<210> 40
<211> 375
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb VH

<400> 40
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc      60
tcctgtgcag cctctggatt caccttcagt acctatgcta tgcactgggt ccgccaggct     120
ccaggcaagg ggctagagtg ggtggcagtt atattatctg atggaagtaa taaatattac     180
gcagactctg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat     240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcga     300
agtcccctcg tgggattcgg ggacaactat ggtatggacg tctggggcca agggaccacg     360
gtcaccgtct cctca                                                      375

<210> 41
<211> 325
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X28-v1 mAb VL

<400> 41
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc      60
acctgctctg gagatgcatt gccaaaaaaa tatgcttatt ggtaccagca gaagtcaggc     120
caggcccctg tgctggtcat ctatgaggac agcaaacgac cctccgggat ccctgagaga     180
ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag     240
gatgaagctg actactactg ttcctcaaca gacagcagtg gtaatcaagg ggtattcggc     300
ggagggacca agctgaccgt cctag                                           325

<210> 42
<211> 124
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb VH

<400> 42
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Gly Ser Tyr
            20                  25                  30
Thr Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Arg Ile Ile Pro Ile Leu Ser Ile Pro Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Phe Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Gly Gly Gly Gly Thr His Ala Val Pro His Tyr Tyr Phe Asp
            100                 105                 110
Ser Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 43
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb CDRH1

<400> 43
Gly Gly Thr Phe Gly Ser Tyr Thr
 1               5

<210> 44
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb CDRH2

<400> 44
Ile Ile Pro Ile Leu Ser Ile Pro
 1               5

<210> 45
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb CDRH3

<400> 45
Ala Arg Gly Gly Gly Gly Thr His Ala Val Pro His Tyr Tyr Phe Asp
 1               5                  10                  15
Ser


<210> 46
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb VL(VK)

<400> 46
Glu Ile Val Met Met Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
            20                  25                  30
Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
        35                  40                  45
Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Met Gln Ser
65                  70                  75                  80
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Phe
                85                  90                  95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 47
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb CDRL1

<400> 47
Gln Ser Val Ser Ser Asn
 1               5

<210> 48
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb CDRL2

<400> 48
Gly Ala Ser
 1

<210> 49
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb CDRL3

<400> 49
Gln Gln Tyr Asn Asn Trp Pro Phe Thr
 1               5

<210> 50
<211> 373
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb VH

<400> 50
gaggtgcagc tggtgcaatc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc      60
tcctgcaagg cttctggagg caccttcggc agctatacta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttagtat accaaactac     180
gcacagaagt tccagggcag agtcacgttt accgcggaca aatccacgag cacagcctac     240
atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaggaggg     300
ggtgggaccc acgcagttcc ccactactac tttgactcct ggggccaggg aaccctggtc     360
accgtctcct cag                                                        373

<210> 51
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v1 mAb VL(VK)

<400> 51
gaaatagtga tgatgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc      60
ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcataaacct     120
ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc     180
aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag catgcagtct     240
gaagattttg cagtttatta ctgtcagcag tataataact ggcctttcac tttcggcgga     300
gggaccaagg tggagatcaa ac                                              322

<210> 52
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb VH

<400> 52
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln
 1               5                  10                  15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Arg
            20                  25                  30
Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu
        35                  40                  45
Trp Ile Gly Arg Ile Tyr Thr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
    50                  55                  60
Leu Arg Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe
65                  70                  75                  80
Ser Leu Lys Leu Gly Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr
                85                  90                  95
Cys Ala Arg Glu Arg Ile Ile Gly Thr Ala His Val Gly Gly Trp Phe
            100                 105                 110
Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 53
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb CDRH1

<400> 53
Gly Gly Ser Ile Ser Ser Arg Ser Tyr Tyr
 1               5                  10

<210> 54
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb CDRH2

<400> 54
Ile Tyr Thr Ser Gly Asn Thr
 1               5

<210> 55
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb CDRH3

<400> 55
Ala Arg Glu Arg Ile Ile Gly Thr Ala His Val Gly Gly Trp Phe Asp
 1               5                  10                  15
Pro


<210> 56
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb VL

<400> 56
Gln Thr Val Val Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln
 1               5                  10                  15
Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asp
            20                  25                  30
Thr Val Asn Trp Tyr Leu Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
        35                  40                  45
Ile Tyr Thr Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln
65                  70                  75                  80
Ser Glu Asp Glu Ala Asn Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu
                85                  90                  95
Asn Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 57
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb CDRL1

<400> 57
Ser Ser Asn Ile Gly Ser Asp Thr
 1               5

<210> 58
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb CDRL2

<400> 58
Thr Asn Asn
 1

<210> 59
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb CDRL3

<400> 59
Ala Ala Trp Asp Asp Ser Leu Asn Gly Trp Val
 1               5                  10

<210> 60
<211> 376
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb VH

<400> 60
caggtgcagc tacaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc      60
acctgcactg tctctggtgg ctccatcagc agtcgaagtt actactggag ctggatccgg     120
cagcccgccg ggaagggact ggagtggatt gggcgtatct ataccagtgg caacaccaac     180
tacaacccct ccctcaggag tcgagtcacc atatcagtgg acacgtccaa gaaccagttc     240
tccctgaagc tgggctctgt gaccgccgca gacacggccg tgtattattg tgcgagagag     300
cgtataattg gaaccgcgca cgtgggtggg tggttcgacc cctggggcca gggaaccctg     360
gtcaccgtct cctcag                                                     376

<210> 61
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v1 mAb VL

<400> 61
cagactgtgg tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc      60
tcttgttctg gaagcagctc caacatcgga agtgatactg taaactggta cctgcagctc     120
ccaggaacgg cccccaaact cctcatctat actaataatc agcggccctc aggggtccct     180
gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag     240
tctgaggatg aggctaatta ttactgtgca gcatgggatg acagcctgaa tggttgggtg     300
ttcggcggag ggaccaagct gaccgtccta g                                    331

<210> 62
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb VH

<400> 62
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Ala Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Arg Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Leu Gly Asp Ser Arg Leu Ser Gly Trp Phe Asp Pro Trp
            100                 105                 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 63
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb CDRH1

<400> 63
Gly Tyr Thr Phe Thr Gly Tyr Tyr
 1               5

<210> 64
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb CDRH2

<400> 64
Ile Asn Pro Asn Ser Gly Ala Thr
 1               5

<210> 65
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb CDRH3

<400> 65
Ala Arg Asp Leu Gly Asp Ser Arg Leu Ser Gly Trp Phe Asp Pro
 1               5                  10                  15

<210> 66
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb VL

<400> 66
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr
            20                  25                  30
Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Tyr Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser
                85                  90                  95
Ser Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 67
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb CDRL1

<400> 67
Ser Ser Asp Val Gly Ser Tyr Asn Leu
 1               5

<210> 68
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb CDRL2

<400> 68
Glu Gly Ser
 1

<210> 69
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb CDRL3

<400> 69
Cys Ser Tyr Ala Gly Ser Ser Thr Trp Val
 1               5                  10

<210> 70
<211> 367
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb VH

<400> 70
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtggtgc cacaaacttt     180
gcacagaagt ttcagggcag ggtcaccatg accagggaca ggtccatcag cacagcctac     240
atggagttga gaagcctgag atctgacgac acggccgttt attactgtgc gagagatctc     300
ggggatagca ggttgagtgg ctggttcgac ccctggggcc agggaaccct ggtcaccgtc     360
tcctcag                                                               367

<210> 71
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v1 mAb VL

<400> 71
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc      60
tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag     120
cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt     180
tcttatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc     240
caggctgagg acgaggctga ttattactgc tgctcatatg caggtagtag cacttgggtg     300
ttcggcggag ggaccaagct gaccgtccta g                                    331

<210> 72
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v2 mAb VH

<400> 72
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Ala Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Arg Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Leu Gly Asp Ser Arg Leu Ser Gly Trp Phe Asp Pro Trp
            100                 105                 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 73
<211> 367
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X55-v2 mAb VH

<400> 73
caggtccagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtggtgc cacaaacttt     180
gcacagaagt ttcagggcag ggtcaccatg accagggaca ggtccatcag cacagcctac     240
atggagttga gaagcctgag atctgacgac acggccgttt attactgtgc gagagatctc     300
ggggatagca ggttgagtgg ctggttcgac ccctggggcc agggaaccct ggtcaccgtc     360
tcctcag                                                               367

<210> 74
<211> 124
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb VH

<400> 74
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Gly Ser Tyr
            20                  25                  30
Thr Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Arg Ile Ile Pro Ile Leu Ser Ile Pro Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Phe Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Gly Gly Gly Gly Thr His Ala Val Pro His Tyr Tyr Phe Asp
            100                 105                 110
Ser Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 75
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb CDRH1

<400> 75
Gly Gly Thr Phe Gly Ser Tyr Thr
 1               5

<210> 76
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb CDRH2

<400> 76
Ile Ile Pro Ile Leu Ser Ile Pro
 1               5

<210> 77
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb CDRH3

<400> 77
Ala Arg Gly Gly Gly Gly Thr His Ala Val Pro His Tyr Tyr Phe Asp
 1               5                  10                  15
Ser


<210> 78
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb VL

<400> 78
Gln Thr Val Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr
            20                  25                  30
Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser
                85                  90                  95
Ser Thr His Val Phe Gly Thr Gly Thr Lys Val Ile Val Leu
            100                 105                 110

<210> 79
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb CDRL1

<400> 79
Ser Ser Asp Val Gly Ser Tyr Asn Leu
 1               5

<210> 80
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb CDRL2

<400> 80
Glu Gly Ser
 1

<210> 81
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb CDRL3

<400> 81
Cys Ser Tyr Ala Gly Ser Ser Thr His Val
 1               5                  10

<210> 82
<211> 373
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb VH

<400> 82
caggtccagc tggtgcaatc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc      60
tcctgcaagg cttctggagg caccttcggc agctatacta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttagtat accaaactac     180
gcacagaagt tccagggcag agtcacgttt accgcggaca aatccacgag cacagcctac     240
atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaggaggg     300
ggtgggaccc acgcagttcc ccactactac tttgactcct ggggccaggg aaccctggtc     360
accgtctcct cag                                                        373

<210> 83
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X56-v1 mAb VL

<400> 83
cagactgtgc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc      60
tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag     120
cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt     180
tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc     240
caggctgagg acgaggctga ttattactgc tgctcatatg caggtagtag cacccatgtc     300
ttcggaactg ggaccaaggt catcgtccta g                                    331

<210> 84
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb VH

<400> 84
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Ile Ile Asn Arg Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr
65                  70                  75                  80
Met Asp Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Gly Ile Ala Ala Arg Val Val Tyr Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 85
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb CDRH1

<400> 85
Gly Tyr Thr Phe Thr Ser Tyr Tyr
 1               5

<210> 86
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb CDRH2

<400> 86
Ile Asn Arg Ser Gly Gly Ser Thr
 1               5

<210> 87
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb CDRH3

<400> 87
Ala Arg Asp Ser Gly Ile Ala Ala Arg Val Val Tyr
 1               5                  10

<210> 88
<211> 106
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb VL(VK)

<400> 88
Asn Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln His Asp Asn Leu Phe Thr
                85                  90                  95
Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105

<210> 89
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb CDRL1

<400> 89
Gln Asp Ile Ser Asn Tyr
 1               5

<210> 90
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb CDRL2

<400> 90
Asp Ala Ser
 1

<210> 91
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb CDRL3

<400> 91
Gln Gln His Asp Asn Leu Phe Thr
 1               5

<210> 92
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb VH

<400> 92
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt      60
tcctgcaagg catctggata caccttcacc agctactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaata atcaaccgta gtggtggtag cacaagctac     180
gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac     240
atggacctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagattcg     300
gggatagcag ccagggttgt ctactggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 93
<211> 319
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v1 mAb VL(VK)

<400> 93
aacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca     120
gggaaagtcc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca     180
aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct     240
gaagatattg caacatatta ctgtcaacag catgataatc ttttcacttt cggccctggg     300
accaaagtgg atatcaaac                                                  319

<210> 94
<211> 106
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v2 mAb VL(VK)

<400> 94
Asp Ile Val Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln His Asp Asn Leu Phe Thr
                85                  90                  95
Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105

<210> 95
<211> 319
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X58-v2 mAb VL(VK)

<400> 95
Gly Ala Cys Ala Thr Cys Gly Thr Gly Ala Thr Gly Ala Cys Cys Cys
 1               5                  10                  15
Ala Gly Thr Cys Thr Cys Cys Ala Thr Cys Cys Thr Cys Cys Cys Thr
            20                  25                  30
Gly Thr Cys Thr Gly Cys Ala Thr Cys Thr Gly Thr Ala Gly Gly Ala
        35                  40                  45
Gly Ala Cys Ala Gly Ala Gly Thr Cys Ala Cys Cys Ala Thr Cys Ala
    50                  55                  60
Cys Thr Thr Gly Cys Cys Ala Gly Gly Cys Gly Ala Gly Thr Cys Ala
65                  70                  75                  80
Gly Gly Ala Cys Ala Thr Thr Ala Gly Cys Ala Ala Cys Thr Ala Thr
                85                  90                  95
Thr Thr Ala Ala Ala Thr Thr Gly Gly Thr Ala Thr Cys Ala Gly Cys
            100                 105                 110
Ala Gly Ala Ala Ala Cys Cys Ala Gly Gly Gly Ala Ala Ala Gly Thr
        115                 120                 125
Cys Cys Cys Thr Ala Ala Gly Cys Thr Cys Cys Thr Gly Ala Thr Cys
    130                 135                 140
Thr Ala Cys Gly Ala Thr Gly Cys Ala Thr Cys Cys Ala Ala Thr Thr
145                 150                 155                 160
Thr Gly Gly Ala Ala Ala Cys Ala Gly Gly Gly Gly Thr Cys Cys Cys
                165                 170                 175
Ala Thr Cys Ala Ala Gly Gly Thr Thr Cys Ala Gly Thr Gly Gly Ala
            180                 185                 190
Ala Gly Thr Gly Gly Ala Thr Cys Thr Gly Gly Gly Ala Cys Ala Gly
        195                 200                 205
Ala Thr Thr Thr Thr Ala Cys Thr Thr Thr Cys Ala Cys Cys Ala Thr
    210                 215                 220
Cys Ala Gly Cys Ala Gly Cys Cys Thr Gly Cys Ala Gly Cys Cys Thr
225                 230                 235                 240
Gly Ala Ala Gly Ala Thr Ala Thr Thr Gly Cys Ala Ala Cys Ala Thr
                245                 250                 255
Ala Thr Thr Ala Cys Thr Gly Thr Cys Ala Ala Cys Ala Gly Cys Ala
            260                 265                 270
Thr Gly Ala Thr Ala Ala Thr Cys Thr Thr Thr Thr Cys Ala Cys Thr
        275                 280                 285
Thr Thr Cys Gly Gly Cys Cys Cys Thr Gly Gly Gly Ala Cys Cys Ala
    290                 295                 300
Ala Ala Gly Thr Gly Gly Ala Thr Ala Thr Cys Ala Ala Ala Cys
305                 310                 315

<210> 96
<211> 116
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb VH

<400> 96
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ala Asn
            20                  25                  30
Tyr Met Ser Trp Val Arg Gln Thr Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Val Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Leu Ala Ala Ala Ala Gly Pro Trp Gly Gln Gly Thr Leu Val
            100                 105                 110
Thr Val Ser Ser
        115

<210> 97
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb CDRH1

<400> 97
Gly Phe Thr Val Ser Ala Asn Tyr
 1               5

<210> 98
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb CDRH2

<400> 98
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 99
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb CDRH3

<400> 99
Ala Arg Asp Leu Ala Ala Ala Ala Gly Pro
 1               5                  10

<210> 100
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb VL(VK)

<400> 100
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Arg Asn Asp
            20                  25                  30
Leu Gly Trp Phe Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Asp Tyr Asn Tyr Pro Arg
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105

<210> 101
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb CDRL1

<400> 101
Gln Gly Ile Arg Asn Asp
 1               5

<210> 102
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb CDRL2

<400> 102
Ala Ala Ser
 1

<210> 103
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb CDRL3

<400> 103
Leu Gln Asp Tyr Asn Tyr Pro Arg Thr
 1               5

<210> 104
<211> 349
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb VH

<400> 104
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc      60
tcctgtgcag cctctgggtt caccgtcagt gccaactaca tgagctgggt ccgccagact     120
ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac atactacgca     180
gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtacctt     240
caaatgaaca gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agatttagct     300
gcagctgctg ggccctgggg ccagggaacc ctggtcaccg tctcctcag                 349

<210> 105
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X71-v1 mAb VL(VK)

<400> 105
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggcaagtca gggcattaga aatgatttag gctggtttca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tacaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tggcacagat ttcactctca ccatcagcag cctgcagcct     240
gaagattttg caacttatta ctgtctacaa gattacaatt accctcggac ttttggccag     300
gggaccaagc tggagatcaa ac                                              322

<210> 106
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb VH

<400> 106
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ser Phe Thr Asn Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Ile Ile Asn Ala Ser Gly Gly Ser Thr Arg Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Gly Ile Ala Ala Arg Val Val Tyr Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 107
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb CDRH1

<400> 107
Gly Tyr Ser Phe Thr Asn Tyr Tyr
 1               5

<210> 108
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb CDRH2

<400> 108
Ile Asn Ala Ser Gly Gly Ser Thr
 1               5

<210> 109
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb CDRH3

<400> 109
Ala Arg Asp Ser Gly Ile Ala Ala Arg Val Val Tyr
 1               5                  10

<210> 110
<211> 106
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb VL(VK)

<400> 110
Ala Ile Arg Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln His Asp Asp Leu Phe Thr
                85                  90                  95
Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105

<210> 111
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb CDRL1

<400> 111
Gln Asp Ile Ser Asn Tyr
 1               5

<210> 112
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb CDRL2

<400> 112
Asp Ala Ser
 1

<210> 113
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb CDRL3

<400> 113
Gln Gln His Asp Asp Leu Phe Thr
 1               5

<210> 114
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb VH

<400> 114
caggtccagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt      60
tcctgcaagg catctgggta cagcttcacc aactactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaata atcaacgcta gtggtggtag cacaaggtac     180
gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac     240
atggagttga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
gggatagcag ccagggttgt ctactggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 115
<211> 319
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v1 mAb VL(VK)

<400> 115
gccatccgga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca     180
aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct     240
gaagatattg cgacatatta ctgtcaacaa catgatgatc ttttcacttt cggccctggg     300
accaaagtgg atatcaaac                                                  319

<210> 116
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v2 mAb VH

<400> 116
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt      60
tcctgcaagg catctgggta cagcttcacc aactactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaata atcaacgcta gtggtggtag cacaaggtac     180
gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac     240
atggagttga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
gggatagcag ccagggttgt ctactggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 117
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v3 mAb VH

<400> 117
caggtacagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt      60
tcctgcaagg catctgggta cagcttcacc aactactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaata atcaacgcta gtggtggtag cacaaggtac     180
gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac     240
atggagttga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
gggatagcag ccagggttgt ctactggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 118
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X76-v4 mAb VH

<400> 118
caggtacagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt      60
tcctgcaagg catctgggta cagcttcacc aactactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaata atcaacgcta gtggtggtag cacaaggtac     180
gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac     240
atggagttga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
gggatagcag ccagggttgt ctactggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 119
<211> 118
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb VH

<400> 119
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Phe Ile Val Ser Ser Asn
            20                  25                  30
Tyr Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Phe Pro Val Arg Arg Gly Val Asn Ile Trp Gly Gln Gly Thr
            100                 105                 110
Leu Val Thr Val Ser Ser
        115

<210> 120
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb CDRH1

<400> 120
Gly Phe Ile Val Ser Ser Asn Tyr
 1               5

<210> 121
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb CDRH2

<400> 121
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 122
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb CDRH3

<400> 122
Ala Arg Asp Phe Pro Val Arg Arg Gly Val Asn Ile
 1               5                  10

<210> 123
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb VL(VK)

<400> 123
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Val Asn Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Ile Ala Thr Tyr Tyr Cys His Gln Tyr Asp Asn Leu Pro Pro
                85                  90                  95
Ala Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 124
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb CDRL1

<400> 124
Gln Asp Ile Val Asn Tyr
 1               5

<210> 125
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb CDRL2

<400> 125
Asp Ala Ser
 1

<210> 126
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb CDRL3

<400> 126
His Gln Tyr Asp Asn Leu Pro Pro Ala
 1               5

<210> 127
<211> 355
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb VH

<400> 127
gaggtgcaac tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc      60
tcctgtgcag tctctggatt catcgtcagt agcaactaca tgacttgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac attctacgca     180
gactccgtga agggccgatt caccatttcc agagacaatt ccaagaacac gctgtatctt     240
caaatgaaca gcctgagagc tgaggacacg gctgtgtatt attgtgcgag agatttcccc     300
gtacgtcggg gagttaatat ctggggccag ggaaccctgg tcaccgtctc ctcag          355

<210> 128
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X11-v1 mAb VL(VK)

<400> 128
gacatccagt tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc aggcgagtca ggacattgtc aactatttaa attggtatca acagaaacca     120
gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca     180
aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct     240
gaagatattg caacatatta ctgtcaccag tatgataatc tccctccggc tttcggcgga     300
gggaccaagg tggagatcaa ac                                              322

<210> 129
<211> 128
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb VH

<400> 129
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
            20                  25                  30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Ser Ala Tyr Lys Gly Asn Thr Asn Tyr Ala Gln Lys Leu
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Trp Ile Gly Tyr
            100                 105                 110
Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Ile Val Ser Ser
        115                 120                 125

<210> 130
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb CDRH1

<400> 130
Gly Tyr Thr Phe Thr Asn Tyr Gly
 1               5

<210> 131
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb CDRH2

<400> 131
Ile Ser Ala Tyr Lys Gly Asn Thr
 1               5

<210> 132
<211> 21
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb CDRH3

<400> 132
Ala Arg Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Trp Ile Gly Tyr
 1               5                  10                  15
Tyr Gly Met Asp Val
            20

<210> 133
<211> 113
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb VL

<400> 133
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln
 1               5                  10                  15
Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly
            20                  25                  30
Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu
        35                  40                  45
Leu Ile Tyr Gly Asn Thr Asn Arg Pro Ser Gly Val Pro Asp Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser
                85                  90                  95
Leu Ser Gly Ser Glu Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val
            100                 105                 110
Leu


<210> 134
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb CDRL1

<400> 134
Ser Ser Asn Ile Gly Ala Gly Tyr Asp
 1               5

<210> 135
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb CDRL2

<400> 135
Gly Asn Thr
 1

<210> 136
<211> 13
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb CDRL3

<400> 136
Gln Ser Tyr Asp Ser Ser Leu Ser Gly Ser Glu Val Val
 1               5                  10

<210> 137
<211> 384
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb VH

<400> 137
caggtccagc tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggtta cacctttacc aactatggta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcagcgctt acaagggtaa cacaaactat     180
gcacagaaac tccagggcag agtcaccatg accacagaca catccacgag cacagcctac     240
atggagctga ggagcctgag atctgacgac acggccgtgt attactgtgc gagacccgat     300
tatcaggtcc tggggtacga tttttggatt gggtactacg gtatggacgt ctggggccaa     360
gggaccacgg tcatcgtctc ctca                                            384

<210> 138
<211> 340
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v1 mAb VL

<400> 138
cagtctgtgt tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc      60
tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag     120
cttccaggaa cagcccccaa actcctcatc tatggtaaca ccaatcggcc ctcaggggtc     180
cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc     240
caggctgagg atgaggctga ttattactgc cagtcttatg acagcagcct gagtggttcg     300
gaggtggtgt tcggcggagg gaccaagctg accgtcctag                           340

<210> 139
<211> 127
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309 mAb VH

<400> 139
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Pro Phe Thr Ser Tyr
            20                  25                  30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Ser Thr Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Thr Thr Gly Tyr
65                  70                  75                  80
Met Glu Leu Arg Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Tyr Thr Arg Gly Ala Trp Phe Gly Glu Ser Leu Ile Gly
            100                 105                 110
Gly Phe Asp Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 140
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309 mAb CDRH1

<400> 140
Gly Tyr Pro Phe Thr Ser Tyr Gly
 1               5

<210> 141
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309 mAb CDRH2

<400> 141
Ile Ser Thr Tyr Asn Gly Asn Thr
 1               5

<210> 142
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309 mAb CDRH3

<400> 142
Ala Arg Asp Tyr Thr Arg Gly Ala Trp Phe Gly Glu Ser Leu Ile Gly
 1               5                  10                  15
Gly Phe Asp Asn
            20

<210> 143
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309 mAb VL(VK)

<400> 143
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Thr Val Ser Ser Thr
            20                  25                  30
Ser Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln His Asp Thr Ser Leu
                85                  90                  95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 144
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309 mAb CDRL1

<400> 144
Gln Thr Val Ser Ser Thr Ser
 1               5

<210> 145
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309 mAb CDRL2

<400> 145
Gly Ala Ser
 1

<210> 146
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309 mAb CDRL3

<400> 146
Gln Gln His Asp Thr Ser Leu Thr
 1               5

<210> 147
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v2 mAb CDRH1

<400> 147
Gly Tyr Ile Phe Thr Asp His Tyr Met His
 1               5                  10

<210> 148
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v2 mAb CDRH2

<400> 148
Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln
 1               5                  10                  15
Gly


<210> 149
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v2 mAb CDRH3

<400> 149
Asp Arg Ser Arg Phe Arg Phe Phe Ser Pro Asp Phe Asp Tyr
 1               5                  10

<210> 150
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v3 mAb VH

<400> 150
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Asp His
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Phe Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Asn Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val His Tyr Cys
                85                  90                  95
Ala Arg Asp Arg Ser Arg Phe Arg Phe Phe Ser Pro Asp Phe Asp Tyr
            100                 105                 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 151
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v3 mAb CDRH2

<400> 151
Phe Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln
 1               5                  10                  15
Gly


<210> 152
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v4 mAb CDRL1

<400> 152
Arg Ser Ser Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr Leu Asp
 1               5                  10                  15

<210> 153
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v4 mAb CDRL2

<400> 153
Leu Gly Ser Asn Arg Ala Ser
 1               5

<210> 154
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v5 mAb VL(VK)

<400> 154
Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Gln Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
                85                  90                  95
Leu Gln Thr Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105                 110

<210> 155
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v5 mAb CDRL1

<400> 155
Arg Ser Ser Gln Ser Leu Leu His Ser Gln Gly Tyr Asn Tyr Leu Asp
 1               5                  10                  15

<210> 156
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v6 mAb CDRL1

<400> 156
Gln Ser Leu Leu His Ser Gln Gly Tyr Asn Tyr
 1               5                  10

<210> 157
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v7 mAb VL(VK)

<400> 157
Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Asn Ala Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
                85                  90                  95
Leu Gln Thr Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105                 110

<210> 158
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v7 mAb CDRL1

<400> 158
Arg Ser Ser Gln Ser Leu Leu His Ser Asn Ala Tyr Asn Tyr Leu Asp
 1               5                  10                  15

<210> 159
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X16-v8 mAb CDRL1

<400> 159
Gln Ser Leu Leu His Ser Asn Ala Tyr Asn Tyr
 1               5                  10

<210> 160
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v2 mAb CDRH1

<400> 160
Gly Gly Thr Phe Gly Ser Tyr Thr Ile Ser
 1               5                  10

<210> 161
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v2 mAb CDRH2

<400> 161
Arg Ile Ile Pro Ile Leu Ser Ile Pro Asn Tyr Ala Gln Lys Phe Gln
 1               5                  10                  15
Gly


<210> 162
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v2 mAb CDRH3

<400> 162
Gly Gly Gly Gly Thr His Ala Val Pro His Tyr Tyr Phe Asp Ser
 1               5                  10                  15

<210> 163
<211> 124
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v3 mAb VH

<400> 163
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Gly Ser Tyr
            20                  25                  30
Thr Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Arg Ile Ile Pro Ile Leu Ser Ile Pro Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Phe Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Gly Gly Gly Gly Thr His Ala Val Pro His Tyr Tyr Phe Glu
            100                 105                 110
Ser Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 164
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v3 mAb CDRH3

<400> 164
Ala Arg Gly Gly Gly Gly Thr His Ala Val Pro His Tyr Tyr Phe Glu
 1               5                  10                  15
Ser


<210> 165
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v4 mAb CDRH3

<400> 165
Gly Gly Gly Gly Thr His Ala Val Pro His Tyr Tyr Phe Glu Ser
 1               5                  10                  15

<210> 166
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v5 mAb CDRL1

<400> 166
Arg Ala Ser Gln Ser Val Ser Ser Asn Leu Ala
 1               5                  10

<210> 167
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v5 mAb CDRL2

<400> 167
Gly Ala Ser Thr Arg Ala Thr
 1               5

<210> 168
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v6 mAb VH(VK)

<400> 168
Glu Ile Val Met Met Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
            20                  25                  30
Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
        35                  40                  45
Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Met Gln Ser
65                  70                  75                  80
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Phe Pro Phe
                85                  90                  95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 169
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X30-v6 mAb CDRL3

<400> 169
Gln Gln Tyr Asn Asn Phe Pro Phe Thr
 1               5

<210> 170
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v2 mAb CDRH1

<400> 170
Gly Tyr Thr Phe Thr Asn Tyr Gly Ile Ser
 1               5                  10

<210> 171
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v2 mAb CDRH2

<400> 171
Trp Ile Ser Ala Tyr Lys Gly Asn Thr Asn Tyr Ala Gln Lys Leu Gln
 1               5                  10                  15
Gly


<210> 172
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v2 mAb CDRH3

<400> 172
Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Trp Ile Gly Tyr Tyr Gly
 1               5                  10                  15
Met Asp Val


<210> 173
<211> 128
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v3 mAb VH

<400> 173
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
            20                  25                  30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Phe Ile Ser Ala Tyr Lys Gly Asn Thr Asn Tyr Ala Gln Lys Leu
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Trp Ile Gly Tyr
            100                 105                 110
Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Ile Val Ser Ser
        115                 120                 125

<210> 174
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v3 mAb CDRH1

<400> 174
Phe Ile Ser Ala Tyr Lys Gly Asn Thr Asn Tyr Ala Gln Lys Leu Gln
 1               5                  10                  15
Gly


<210> 175
<211> 128
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v4 mAb VH

<400> 175
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
            20                  25                  30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Ser Ala Tyr Lys Gly Asn Thr Asn Tyr Ala Gln Lys Leu
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Phe Ile Gly Tyr
            100                 105                 110
Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Ile Val Ser Ser
        115                 120                 125

<210> 176
<211> 21
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v4 mAb CDRH3

<400> 176
Ala Arg Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Phe Ile Gly Tyr
 1               5                  10                  15
Tyr Gly Met Asp Val
            20

<210> 177
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v5 mAb CDRH3

<400> 177
Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Phe Ile Gly Tyr Tyr Gly
 1               5                  10                  15
Met Asp Val


<210> 178
<211> 128
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v6 mAb VH

<400> 178
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
            20                  25                  30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Phe Ile Ser Ala Tyr Lys Gly Asn Thr Asn Tyr Ala Gln Lys Leu
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Phe Ala Gly Tyr
            100                 105                 110
Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Ile Val Ser Ser
        115                 120                 125

<210> 179
<211> 21
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v6 mAb CDRH3

<400> 179
Ala Arg Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Phe Ala Gly Tyr
 1               5                  10                  15
Tyr Gly Met Asp Val
            20

<210> 180
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v7 mAb CDRH3

<400> 180
Pro Asp Tyr Gln Val Leu Gly Tyr Asp Phe Phe Ala Gly Tyr Tyr Gly
 1               5                  10                  15
Met Asp Val


<210> 181
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v8 mAb CDRL1

<400> 181
Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly Tyr Asp Val His
 1               5                  10

<210> 182
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X35-v8 mAb CDRL2

<400> 182
Gly Asn Thr Asn Arg Pro Ser
 1               5

<210> 183
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v2 mAb CDRH1

<400> 183
Gly Gly Ser Ile Ser Ser Arg Ser Tyr Tyr Trp Ser
 1               5                  10

<210> 184
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v2 mAb CDRH2

<400> 184
Arg Ile Tyr Thr Ser Gly Asn Thr Asn Tyr Asn Pro Ser Leu Arg Ser
 1               5                  10                  15

<210> 185
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v2 mAb CDRH3

<400> 185
Glu Arg Ile Ile Gly Thr Ala His Val Gly Gly Trp Phe Asp Pro
 1               5                  10                  15

<210> 186
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v3 mAb VH

<400> 186
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln
 1               5                  10                  15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Arg
            20                  25                  30
Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu
        35                  40                  45
Trp Ile Gly Arg Ile Tyr Thr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
    50                  55                  60
Leu Arg Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe
65                  70                  75                  80
Ser Leu Lys Leu Gly Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr
                85                  90                  95
Cys Ala Arg Glu Arg Ile Ile Gly Thr Ala His Val Gly Gly Phe Phe
            100                 105                 110
Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 187
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v3 mAb CDRH3

<400> 187
Ala Arg Glu Arg Ile Ile Gly Thr Ala His Val Gly Gly Phe Phe Asp
 1               5                  10                  15
Pro


<210> 188
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v4 mAb CDRH3

<400> 188
Glu Arg Ile Ile Gly Thr Ala His Val Gly Gly Phe Phe Asp Pro
 1               5                  10                  15

<210> 189
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v5 mAb VH

<400> 189
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln
 1               5                  10                  15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Arg
            20                  25                  30
Ser Tyr Tyr Phe Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu
        35                  40                  45
Trp Ile Gly Arg Ile Tyr Thr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
    50                  55                  60
Leu Arg Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe
65                  70                  75                  80
Ser Leu Lys Leu Gly Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr
                85                  90                  95
Cys Ala Arg Glu Arg Ile Ile Gly Thr Ala His Val Gly Gly Trp Phe
            100                 105                 110
Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 190
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v5 mAb CDRH1

<400> 190
Gly Gly Ser Ile Ser Ser Arg Ser Tyr Tyr Phe Ser
 1               5                  10

<210> 191
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v6 mAb VH

<400> 191
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln
 1               5                  10                  15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Arg
            20                  25                  30
Ser Tyr Tyr Phe Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu
        35                  40                  45
Trp Ile Gly Arg Ile Tyr Thr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
    50                  55                  60
Leu Arg Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe
65                  70                  75                  80
Ser Leu Lys Leu Gly Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr
                85                  90                  95
Cys Ala Arg Glu Arg Ile Ile Gly Thr Ala His Val Gly Gly Phe Phe
            100                 105                 110
Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 192
<211> 13
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v7 mAb CDRL1

<400> 192
Ser Gly Ser Ser Ser Asn Ile Gly Ser Asp Thr Val Asn
 1               5                  10

<210> 193
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v7 mAb CDRL2

<400> 193
Thr Asn Asn Gln Arg Pro Ser
 1               5

<210> 194
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v8 mAb VL

<400> 194
Gln Thr Val Val Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln
 1               5                  10                  15
Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asp
            20                  25                  30
Thr Val Asn Trp Tyr Leu Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
        35                  40                  45
Ile Tyr Thr Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln
65                  70                  75                  80
Ser Glu Asp Glu Ala Asn Tyr Tyr Cys Ala Ala Phe Asp Asp Ser Leu
                85                  90                  95
Asn Gly Phe Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 195
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v8 mAb CDRL3

<400> 195
Ala Ala Phe Asp Asp Ser Leu Asn Gly Phe Val
 1               5                  10

<210> 196
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v9 mAb VL

<400> 196
Gln Thr Val Val Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln
 1               5                  10                  15
Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asp
            20                  25                  30
Thr Val Asn Trp Tyr Leu Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
        35                  40                  45
Ile Tyr Thr Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln
65                  70                  75                  80
Ser Glu Asp Glu Ala Asn Tyr Tyr Cys Ala Ala Phe Asp Asp Ser Leu
                85                  90                  95
Asn Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 197
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X47-v9 mAb CDRL3

<400> 197
Ala Ala Phe Asp Asp Ser Leu Asn Gly Trp Val
 1               5                  10

<210> 198
<211> 120
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb VH

<400> 198
Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Val Ser Ser Asn
            20                  25                  30
Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Met Gly Gly Gln Pro Gly Gly Tyr Phe Asp Tyr Trp Gly Gln
            100                 105                 110
Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 199
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb CDRH1

<400> 199
Gly Phe Ile Val Ser Ser Asn Tyr
 1               5

<210> 200
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb CDRH2

<400> 200
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 201
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb CDRH3

<400> 201
Ala Arg Asp Met Gly Gly Gln Pro Gly Gly Tyr Phe Asp Tyr
 1               5                  10

<210> 202
<211> 106
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb VL(VK)

<400> 202
Asp Ile Val Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Phe Ser Ser Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Lys Ala Ser Asn Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Thr Tyr Ala Thr
                85                  90                  95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 203
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb CDRL1

<400> 203
Gln Ser Phe Ser Ser Trp
 1               5

<210> 204
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb CDRL2

<400> 204
Lys Ala Ser
 1

<210> 205
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb CDRL3

<400> 205
Gln Gln Tyr Asn Thr Tyr Ala Thr
 1               5

<210> 206
<211> 361
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb VH

<400> 206
gaggtgcatc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc      60
tcctgtgcag cctctggatt catcgtcagt agcaactaca tgagctgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagtac attctacgca     180
gactccgtga agggcagatt caccatctcc agagacaatt ccaagaacac ggtgtatctt     240
caaatgaaca gcctgagagt cgaggacacg gctgtgtatt actgtgcgcg ggacatgggg     300
gggcagcctg gaggctactt tgactactgg ggccagggaa ccctggtcac cgtctcctca     360
g                                                                     361

<210> 207
<211> 319
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H30-v1 mAb VL(VK)

<400> 207
gacatcgtga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggccagtca gagttttagt agctggttgg cctggtatca gcagaaacca     120
gggaaggccc ctaagctcct gatctataag gcatctaatt tagaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagaa ttcactctca ctatcagcag cctgcagcct     240
gatgattttg caacttatta ctgccaacag tataatactt atgcgacgtt cggccaaggg     300
accaaggtgg aaatcaagc                                                  319

<210> 208
<211> 117
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb VH

<400> 208
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Ser Ser Asn
            20                  25                  30
Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Leu Ile Tyr Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Pro Pro His Arg Ser Gly Gly Val Trp Gly Gln Gly Thr Leu
            100                 105                 110
Val Thr Val Ser Ser
        115

<210> 209
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb CDRH1

<400> 209
Gly Leu Thr Val Ser Ser Asn Tyr
 1               5

<210> 210
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb CDRH2

<400> 210
Ile Tyr Ser Gly Gly Thr Thr
 1               5

<210> 211
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb CDRH3

<400> 211
Ala Arg Asp Pro Pro His Arg Ser Gly Gly Val
 1               5                  10

<210> 212
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb VL(VK)

<400> 212
Ala Ile Trp Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Tyr Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Ser Asp Asn Leu Pro Ile
                85                  90                  95
Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys
            100                 105

<210> 213
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb CDRL1

<400> 213
Gln Asp Ile Asn Asn Tyr
 1               5

<210> 214
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb CDRL2

<400> 214
Asp Ala Ser
 1

<210> 215
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb CDRL3

<400> 215
Gln Gln Ser Asp Asn Leu Pro Ile Thr
 1               5

<210> 216
<211> 352
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb VH

<400> 216
gaggtgcagc tggtggagtc tgggggaggt ttggtccagc ctggggggtc cctgagactc      60
tcctgtgcag cctctggatt gaccgtcagt agcaactaca tgagctgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtctcactt atttatagcg gtggtaccac atactacgca     180
gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac actatatctt     240
caaatgaaca gcctgagaac tgaggacacg gctgtgtatt actgtgcgag agaccctccc     300
caccgcagtg gcggggtctg gggccaggga accctggtca ccgtctcctc ag             352

<210> 217
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H37-v1 mAb VL(VK)

<400> 217
gccatctgga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcagaaacca     120
gggaaagccc ctaaactcct gatctacgat gcatccaatt tggaaacagg ggtcccatca     180
aggttcagtg gaagtggatc tgggacatat tttactttca ccatcagcag cctgcagcct     240
gaagatattg caacatatta ctgtcaacag tctgataatc tcccgatcac attcggccaa     300
gggacacgac tggagattaa ac                                              322

<210> 218
<211> 126
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb VH

<400> 218
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Ile Ser Gly Ala Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Val Ala Ser Ser Gly Trp Tyr Glu Leu Glu Ile Leu Tyr Gly
            100                 105                 110
Val Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120                 125

<210> 219
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb CDRH1

<400> 219
Gly Tyr Thr Phe Thr Gly Tyr Tyr
 1               5

<210> 220
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb CDRH2

<400> 220
Ile Asn Pro Ile Ser Gly Ala Thr
 1               5

<210> 221
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb CDRH3

<400> 221
Ala Arg Val Ala Ser Ser Gly Trp Tyr Glu Leu Glu Ile Leu Tyr Gly
 1               5                  10                  15
Val Asp Val


<210> 222
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb VL

<400> 222
Gln Ser Val Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
            20                  25                  30
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Glu Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
                85                  90                  95
Ser Thr Gln Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu
            100                 105                 110

<210> 223
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb CDRL1

<400> 223
Ser Ser Asp Val Gly Gly Tyr Asn Tyr
 1               5

<210> 224
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb CDRL2

<400> 224
Glu Val Ser
 1

<210> 225
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb CDRL3

<400> 225
Ser Ser Tyr Thr Ser Ser Ser Thr Gln Val
 1               5                  10

<210> 226
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb VH

<400> 226
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctactata tgcactgggt gcgacaggcc     120
cctggacagg ggcttgagtg gatgggatgg atcaacccta tcagtggtgc cacaaactat     180
gcacagaagt ttcagggcag ggtcaccatg accagggaca cgtccatcag cacagcctac     240
atggagctga gcaggctgag atctgacgac acggccgtgt attactgtgc gagagtagct     300
agcagtggct ggtatgaact ggaaattctc tacggtgtgg acgtctgggg ccaagggacc     360
acggtcaccg tctcctca                                                   378

<210> 227
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H40-v1 mAb VL

<400> 227
cagtctgtgc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc      60
tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacag     120
cacccaggca aagcccccaa actcatgatt tatgaggtca gtaatcggcc ctcaggggtt     180
tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc     240
caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cactcaggtc     300
ttcggaactg ggaccaaggt caccgtccta g                                    331

<210> 228
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb VH

<400> 228
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Ala Thr Ser Phe Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Ser Gly Tyr Leu Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp
            100                 105                 110
Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 229
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb CDRH1

<400> 229
Gly Tyr Thr Phe Thr Gly Tyr Tyr
 1               5

<210> 230
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb CDRH2

<400> 230
Ile Asn Pro Asn Ser Gly Gly Thr
 1               5

<210> 231
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb CDRH3

<400> 231
Ala Ser Ser Gly Tyr Leu Gly Tyr Tyr Tyr Tyr Gly Met Asp Val
 1               5                  10                  15

<210> 232
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb VL(VK)

<400> 232
Ala Ile Trp Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Asn Val Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
                85                  90                  95
Leu Gln Thr Pro His Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105                 110

<210> 233
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb CDRL1

<400> 233
Gln Ser Leu Leu His Ser Asn Val Tyr Asn Tyr
 1               5                  10

<210> 234
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb CDRL2

<400> 234
Leu Gly Ser
 1

<210> 235
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb CDRL3

<400> 235
Met Gln Ala Leu Gln Thr Pro His Thr
 1               5

<210> 236
<211> 366
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb VH

<400> 236
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctactata tacactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtggtgg cacaaacttt     180
gcacagaagt ttcagggcag ggtcaccatg accagggcca cgtccttcag cacagcctac     240
atggagctga gcagtctgag atctgacgac acggccgtgt attactgtgc gagtagtggt     300
tacctcggtt attactacta cggtatggac gtctggggcc aagggaccac ggtcaccgtc     360
tcctca                                                                366

<210> 237
<211> 337
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v1 mAb VL(VK)

<400> 237
gccatctgga tgacccagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc      60
atctcctgca ggtctagtca gagcctcctg catagtaatg tatacaacta tttggattgg     120
tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc     180
tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc     240
agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct     300
cacacttttg gccaggggac caagctggag atcaaac                              337

<210> 238
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v2 mAb VL(VK)

<400> 238
Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Asn Val Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
                85                  90                  95
Leu Gln Thr Pro His Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105                 110

<210> 239
<211> 337
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v2 mAb VL(VK)

<400> 239
gatattgtga tgacccagac tccactctcc ctgcccgtca cccctggaga gccggcctcc      60
atctcctgca ggtctagtca gagcctcctg catagtaatg tatacaacta tttggattgg     120
tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc     180
tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc     240
agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct     300
cacacttttg gccaggggac caagctggag atcaaac                              337

<210> 240
<211> 118
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb VH

<400> 240
Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Val Ile Thr Val Ser Ser Asn
            20                  25                  30
Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Leu Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Phe Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Leu Asp Ile Ala Gly Gly Met Asp Val Trp Gly Gln Gly Thr
            100                 105                 110
Thr Val Thr Val Ser Ser
        115

<210> 241
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb CDRH1

<400> 241
Val Ile Thr Val Ser Ser Asn Tyr
 1               5

<210> 242
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb CDRH2

<400> 242
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 243
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb CDRH3

<400> 243
Ala Arg Asp Leu Asp Ile Ala Gly Gly Met Asp Val
 1               5                  10

<210> 244
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb VL(VK)

<400> 244
Asp Ile Val Met Thr Gln Thr Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Gly Gln Thr Ile Ser Asn Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105

<210> 245
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb CDRL1

<400> 245
Gln Thr Ile Ser Asn Tyr
 1               5

<210> 246
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb CDRL2

<400> 246
Ala Ala Ser
 1

<210> 247
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb CDRL3

<400> 247
Gln Gln Ser Tyr Ser Thr Pro Tyr Thr
 1               5

<210> 248
<211> 354
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb VH

<400> 248
gaggtgcatc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc      60
tcctgtgcag cctctgtaat caccgtcagt agcaactaca tgagctgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtctcactt atttatagcg gtggtagcac atactacgca     180
gactccgtga agggccgatt caccatctcc agagacaatt tcaagaacac gctgtatctt     240
caaatgaaca gcctgagagc tgaggacacg gctgtgtatt actgtgcgag agatctggat     300
atagcaggcg gtatggacgt ctggggccaa gggaccacgg tcaccgtctc ctca           354

<210> 249
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v1 mAb VL(VK)

<400> 249
gatattgtga tgacccagac tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggcaggtca gaccattagc aactatttaa attggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct     240
gaagattttg caacttacta ctgtcaacag agttacagta ccccgtacac ttttggccag     300
gggaccaagc tggagatcaa ac                                              322

<210> 250
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v2 mAb VL(VK)

<400> 250
Asp Ile Gly Met Thr Gln Thr Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Gly Gln Thr Ile Ser Asn Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105

<210> 251
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v2 mAb VL(VK)

<400> 251
gatattggga tgacccagac tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggcaggtca gaccattagc aactatttaa attggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct     240
gaagattttg caacttacta ctgtcaacag agttacagta ccccgtacac ttttggccag     300
gggaccaagc tggagatcaa ac                                              322

<210> 252
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v3 mAb VL(VK)

<400> 252
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Gly Gln Thr Ile Ser Asn Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105

<210> 253
<211> 321
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v3 mAb VL(VK)

<400> 253
gacatccagt tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggcaggtca gaccattagc aactatttaa attggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct     240
gaagattttg caacttacta ctgtcaacag agttacagta ccccgtacac ttttggccag     300
gggaccaagc tggagatcaa a                                               321

<210> 254
<211> 121
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H62-v3 mAb VL(VK)

<400> 254
Glu Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
 1               5                  10                  15
Thr Leu Ser Leu Thr Cys Ser Val Ser Gly Gly Ser Ile Ser Ser Tyr
            20                  25                  30
Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu Trp Ile
        35                  40                  45
Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Asn Tyr Asn Ser Ser Leu Lys
    50                  55                  60
Ser Arg Val Thr Ile Ser Leu Asp Thr Ser Lys Asn Gln Phe Ser Leu
65                  70                  75                  80
Lys Leu Ser Ser Val Ala Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg His Asp Pro Phe Arg Ala Val Thr Gly His Phe Asp Tyr Trp Gly
            100                 105                 110
Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 255
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb CDRH1

<400> 255
Gly Gly Ser Ile Ser Ser Tyr Tyr
 1               5

<210> 256
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb CDRH2

<400> 256
Ile Tyr Tyr Ser Gly Ser Thr
 1               5

<210> 257
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb CDRH3

<400> 257
Ala Arg His Asp Pro Phe Arg Ala Val Thr Gly His Phe Asp Tyr
 1               5                  10                  15

<210> 258
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb VL

<400> 258
Gln Thr Val Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys
 1               5                  10                  15
Thr Val Thr Ile Ser Cys Thr Arg Ser Ser Gly Ser Ile Ala Ser Asn
            20                  25                  30
Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ser Pro Thr Ile Val
        35                  40                  45
Ile Tyr Glu Asp Ser Arg Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Ser Ile Ser Arg
65                  70                  75                  80
Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Tyr Arg
                85                  90                  95
Asn Thr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 259
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb CDRL1

<400> 259
Ser Gly Ser Ile Ala Ser Asn Tyr
 1               5

<210> 260
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb CDRL2

<400> 260
Glu Asp Ser
 1

<210> 261
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb CDRL3

<400> 261
Gln Ser Tyr Tyr Arg Asn Thr Val Val
 1               5

<210> 262
<211> 364
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb VH

<400> 262
gaggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc      60
acctgctctg tctctggtgg ctccatcagt agttactact ggagctggat ccggcagccc     120
ccagggaagg cactggagtg gattggatat atctattaca gtgggagcac caactacaat     180
tcatccctca agagtcgagt caccatatca ctagacacgt ccaagaacca gttctccctg     240
aagctgagct ctgtggccgc cgcagacacg gccgtgtatt actgtgcgag acatgaccct     300
ttcagggcag tgactgggca ctttgactac tggggccagg gaaccctggt caccgtctcc     360
tcag                                                                  364

<210> 263
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v1 mAb VL

<400> 263
cagactgtgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc      60
tcctgcaccc gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccaacagcgc     120
ccgggcagtt cccccaccat tgtgatctat gaggatagcc gaagaccctc tggggtccct     180
gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcag catctctaga     240
ctgaagactg aggacgaggc tgactactac tgtcagtctt attatagaaa cactgtggta     300
ttcggcggag ggaccaagct gaccgtccta g                                    331

<210> 264
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb VH

<400> 264
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Leu His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Ile Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Val Asp Tyr Asp Ile Leu Thr Gly Tyr Tyr Trp Gly Trp Phe
            100                 105                 110
Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 265
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb CDRH1

<400> 265
Gly Tyr Thr Phe Thr Gly Tyr Tyr
 1               5

<210> 266
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb CDRH2

<400> 266
Ile Asn Pro Ile Ser Gly Gly Thr
 1               5

<210> 267
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb CDRH3

<400> 267
Ala Arg Val Asp Tyr Asp Ile Leu Thr Gly Tyr Tyr Trp Gly Trp Phe
 1               5                  10                  15
Asp Pro


<210> 268
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb VL

<400> 268
Gln Thr Val Val Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
            20                  25                  30
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
                85                  90                  95
Ser Thr Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu
            100                 105                 110

<210> 269
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb CDRL1

<400> 269
Ser Ser Asp Val Gly Gly Tyr Asn Tyr
 1               5

<210> 270
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb CDRL2

<400> 270
Asp Val Ser
 1

<210> 271
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb CDRL3

<400> 271
Ser Ser Tyr Thr Ser Ser Ser Thr Tyr Val
 1               5                  10

<210> 272
<211> 376
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb VH

<400> 272
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctactatc tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta tcagtggtgg cacaaactat     180
gcacagaagt ttcagggcag ggtcaccatg accagggaca cgtccatcag cacagcctac     240
atggagctga gcaggctgag atctgacgac acggccgtgt attactgtgc gagagtggat     300
tacgatattt tgactggtta ttactggggc tggttcgacc cctggggcca gggaaccctg     360
gtcaccgtct cctcag                                                     376

<210> 273
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H70-v1 mAb VL

<400> 273
cagactgtgg tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc      60
tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacag     120
cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt     180
tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc     240
caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cacttatgtc     300
ttcggaactg ggaccaaggt caccgtccta g                                    331

<210> 274
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb VH

<400> 274
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Gly
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Val Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Val Thr Arg Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 275
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb CDRH1

<400> 275
Gly Phe Ser Leu Ser Thr Gly Gly Val Gly
 1               5                  10

<210> 276
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb CDRH2

<400> 276
Ile Tyr Trp Asp Asp Asp Lys
 1               5

<210> 277
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb CDRH3

<400> 277
Ala Arg His Thr Val Thr Arg Ile Phe Asp Tyr
 1               5                  10

<210> 278
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb VL

<400> 278
Gln Ser Val Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Phe
            20                  25                  30
Leu Tyr Val Ser Trp Tyr Gln Gln Leu Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Glu Val Ser Asp Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Thr Ser
                85                  90                  95
Ser Thr Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105

<210> 279
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb CDRL1

<400> 279
Ser Ser Asp Val Gly Gly Phe Leu Tyr
 1               5

<210> 280
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb CDRL2

<400> 280
Glu Val Ser
 1

<210> 281
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb CDRL3

<400> 281
Ser Ser Tyr Thr Thr Ser Ser Thr Val
 1               5

<210> 282
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb VH

<400> 282
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg      60
acctgcacct tctctgggtt ctcactcagc actggtggag tgggtgtggg ctggatccgt     120
cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc     180
tacagcccat ctctgaagag caggctcacc atcaccaagg acacttccaa aaaccaggtg     240
gtccttacaa tgaccaacgt ggaccctgtg gacacagcca catattactg tgcacgccat     300
acggtgacta ggatatttga ctactggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 283
<211> 328
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H71-v1 mAb VL

<400> 283
cagtctgtgc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc      60
tcctgcactg gaaccagcag tgacgttggt ggttttctct atgtctcctg gtaccaacaa     120
ctcccaggca aagcccccaa actcatgatt tatgaggtca gtgatcggcc ctcaggggtt     180
tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc     240
caggctgagg acgaggctga ttattactgc agctcatata caaccagcag cacggtgttc     300
ggcggaggga ccaagttgac cgtcctag                                        328

<210> 284
<211> 124
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb VH

<400> 284
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Glu Leu Leu Val Pro Gly Ala Met Ser Pro Tyr Gly Met Asp
            100                 105                 110
Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 285
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb CDRH1

<400> 285
Gly Tyr Thr Phe Thr Gly Tyr Tyr
 1               5

<210> 286
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb CDRH2

<400> 286
Ile Asn Pro Asn Ser Gly Gly Thr
 1               5

<210> 287
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb CDRH3

<400> 287
Ala Arg Glu Leu Leu Val Pro Gly Ala Met Ser Pro Tyr Gly Met Asp
 1               5                  10                  15
Val


<210> 288
<211> 108
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb VL(VK)

<400> 288
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Arg Tyr
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
        35                  40                  45
Tyr Asp Ala Ser Asn Arg Ala Ala Gly Ile Pro Ala Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro
65                  70                  75                  80
Glu Asp Phe Val Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro
                85                  90                  95
Leu Ala Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 289
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb CDRL1

<400> 289
Gln Ser Val Ser Arg Tyr
 1               5

<210> 290
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb CDRL2

<400> 290
Asp Ala Ser
 1

<210> 291
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb CDRL3

<400> 291
Gln Gln Arg Ser Asn Trp Pro Pro Leu Ala
 1               5                  10

<210> 292
<211> 372
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb VH

<400> 292
caggtccagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctactata tacactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtggtgg cacaaactat     180
gcacagaagt ttcagggcag ggtcaccatg accagggaca cgtccatcag cacagcctac     240
atggagctga gcaggctgag atctgacgac acggccgtgt attactgtgc gagggaatta     300
ttagtaccag gtgctatgtc cccttacggt atggacgtct ggggccaagg gaccacggtc     360
accgtctcct ca                                                         372

<210> 293
<211> 325
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H73-v1 mAb VL(VK)

<400> 293
gaaatagtga tgacgcagtc tccagccacc ctgtctttgt ctccagggga aagagccacc      60
ctctcctgca gggccagtca gagtgttagc aggtacttag cctggtacca acagaaacct     120
ggccaggctc ccaggctcct catctatgat gcatccaaca gggccgctgg catcccagcc     180
aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct     240
gaagattttg tagtttatta ctgtcagcag cgtagcaact ggcctccgct cgctttcggc     300
ggagggacca aggtggagat caaac                                           325

<210> 294
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v2 mAb VL

<400> 294
Ser Tyr Glu Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys
 1               5                  10                  15
Thr Val Thr Ile Ser Cys Thr Arg Ser Ser Gly Ser Ile Ala Ser Asn
            20                  25                  30
Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ser Pro Thr Ile Val
        35                  40                  45
Ile Tyr Glu Asp Ser Arg Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Ser Ile Ser Arg
65                  70                  75                  80
Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Tyr Arg
                85                  90                  95
Asn Thr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 295
<211> 330
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v2 mAb VL

<400> 295
tcctatgagc tgacacagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc      60
tcctgcaccc gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccaacagcgc     120
ccgggcagtt cccccaccat tgtgatctat gaggatagcc gaagaccctc tggggtccct     180
gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcag catctctaga     240
ctgaagactg aggacgaggc tgactactac tgtcagtctt attatagaaa cactgtggta     300
ttcggcggag ggaccaagct gaccgtccta                                      330

<210> 296
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v3 mAb VL

<400> 296
Gln Pro Val Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys
 1               5                  10                  15
Thr Val Thr Ile Ser Cys Thr Arg Ser Ser Gly Ser Ile Ala Ser Asn
            20                  25                  30
Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ser Pro Thr Ile Val
        35                  40                  45
Ile Tyr Glu Asp Ser Arg Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Ser Ile Ser Arg
65                  70                  75                  80
Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Tyr Arg
                85                  90                  95
Asn Thr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 297
<211> 330
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H66-v3 mAb VL

<400> 297
cagcctgtgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc      60
tcctgcaccc gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccaacagcgc     120
ccgggcagtt cccccaccat tgtgatctat gaggatagcc gaagaccctc tggggtccct     180
gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcag catctctaga     240
ctgaagactg aggacgaggc tgactactac tgtcagtctt attatagaaa cactgtggta     300
ttcggcggag ggaccaagct gaccgtccta                                      330

<210> 298
<211> 129
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb VH

<400> 298
Gln Val Arg Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
 1               5                  10                  15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser
            20                  25                  30
Thr Tyr Phe Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu
        35                  40                  45
Trp Ile Gly Ser Ile Ser Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser
    50                  55                  60
Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Ser Gln Phe
65                  70                  75                  80
Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr
                85                  90                  95
Cys Ala Arg Arg Gly Gly Tyr Cys Ser Arg Val Asn Cys Tyr Asn Arg
            100                 105                 110
Tyr Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser
        115                 120                 125
Ser


<210> 299
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb CDRH1

<400> 299
Gly Gly Ser Ile Ser Ser Ser Thr Tyr Phe
 1               5                  10

<210> 300
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb CDRH2

<400> 300
Ile Ser Tyr Ser Gly Ser Thr
 1               5

<210> 301
<211> 21
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb CDRH3

<400> 301
Ala Arg Arg Gly Gly Tyr Cys Ser Arg Val Asn Cys Tyr Asn Arg Tyr
 1               5                  10                  15
Trp Tyr Phe Asp Leu
            20

<210> 302
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb VL(VK)

<400> 302
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Val Ser Cys Arg Ala Ser Gln Asp Ile Ser Ser Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Phe Cys Gln Gln Ala Asn Ser Phe Pro Val
                85                  90                  95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105

<210> 303
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb CDRL1

<400> 303
Gln Asp Ile Ser Ser Trp
 1               5

<210> 304
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb CDRL2

<400> 304
Ala Ala Ser
 1

<210> 305
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb CDRL3

<400> 305
Gln Gln Ala Asn Ser Phe Pro Val Thr
 1               5

<210> 306
<211> 388
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb VH

<400> 306
caggtgcggc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc      60
acctgcactg tctctggtgg ctccatcagc agtagtactt acttctgggg ctggatccgc     120
cagcccccag ggaaggggct ggagtggatt gggagtatct cttatagtgg gagcacctac     180
tacaacccgt ccctcaagag tcgagtcacc atatccgttg acacgtccaa gagccagttc     240
tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagacgg     300
gggggatatt gtagtcgtgt taactgctac aatcgctact ggtacttcga tctctggggc     360
cgtggcaccc tggtcactgt ctcctcag                                        388

<210> 307
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v1 mAb VL(VK)

<400> 307
gacatccagt tgacgcagtc tccatcttct gtgtctgcat ctgtaggaga cagagtcacc      60
gtcagttgtc gggcgagtca ggatattagc agctggttag cctggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagat ttcactctca ctatcagcag cctgcagcct     240
gaagattttg caacttactt ttgtcaacag gctaacagtt tccctgtcac tttcggccct     300
gggaccaaag tggatatcaa ac                                              322

<210> 308
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v2 mAb VL(VK)

<400> 308
Asp Ile Val Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Val Ser Cys Arg Ala Ser Gln Asp Ile Ser Ser Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Phe Cys Gln Gln Ala Asn Ser Phe Pro Val
                85                  90                  95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105

<210> 309
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v2 mAb VL(VK)

<400> 309
gacatcgtga tgacccagtc tccatcttct gtgtctgcat ctgtaggaga cagagtcacc      60
gtcagttgtc gggcgagtca ggatattagc agctggttag cctggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagat ttcactctca ctatcagcag cctgcagcct     240
gaagattttg caacttactt ttgtcaacag gctaacagtt tccctgtcac tttcggccct     300
gggaccaaag tggatatcaa ac                                              322

<210> 310
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v3 mAb VL(VK)

<400> 310
Asn Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Val Ser Cys Arg Ala Ser Gln Asp Ile Ser Ser Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Phe Cys Gln Gln Ala Asn Ser Phe Pro Val
                85                  90                  95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105

<210> 311
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N12-v3 mAb VL(VK)

<400> 311
aacatccaga tgacccagtc tccatcttct gtgtctgcat ctgtaggaga cagagtcacc      60
gtcagttgtc gggcgagtca ggatattagc agctggttag cctggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagat ttcactctca ctatcagcag cctgcagcct     240
gaagattttg caacttactt ttgtcaacag gctaacagtt tccctgtcac tttcggccct     300
gggaccaaag tggatatcaa ac                                              322

<210> 312
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb VH

<400> 312
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Pro Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ala Ile Ser Gly Ser Gly Asn Tyr Thr Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Pro Gly Gly Leu Ser Asn Phe Asp Phe Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 313
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb CDRH1

<400> 313
Gly Phe Thr Phe Ser Ser Tyr Pro
 1               5

<210> 314
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb CDRH2

<400> 314
Ile Ser Gly Ser Gly Asn Tyr Thr
 1               5

<210> 315
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb CDRH3

<400> 315
Ala Lys Asp Pro Gly Gly Leu Ser Asn Phe Asp Phe
 1               5                  10

<210> 316
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb VL(VK)

<400> 316
Asn Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Thr Tyr
            20                  25                  30
Leu Asn Trp Phe Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Arg
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Thr Tyr Ser Thr Pro Arg
                85                  90                  95
Ile Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105

<210> 317
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb CDRL1

<400> 317
Gln Ser Ile Ser Thr Tyr
 1               5

<210> 318
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb CDRL2

<400> 318
Ala Ala Ser
 1

<210> 319
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb CDRL3

<400> 319
Gln Gln Thr Tyr Ser Thr Pro Arg Ile
 1               5

<210> 320
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb VH

<400> 320
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc      60
tcctgtgcag cctctggatt cacctttagc agttatccta tgagctgggt ccgccaggct     120
ccaggtaagg ggctggagtg ggtctcagct attagtggta gtggtaatta cacatactac     180
gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgttgtat     240
ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gaaagatccc     300
ggtgggttgt cgaactttga cttctggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 321
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v1 mAb VL(VK)

<400> 321
aacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggcaagtca gagcattagc acctatttaa attggtttca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccgtca     180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctacaacgt     240
gaagattttg caacttacta ctgtcaacag acttacagta cccctcgaat ttttggccag     300
gggaccaagc tggagatcaa ac                                              322

<210> 322
<211> 127
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb VH

<400> 322
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
 1               5                  10                  15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser
            20                  25                  30
Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile
        35                  40                  45
Gly Tyr Leu Tyr Tyr Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys
    50                  55                  60
Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu
65                  70                  75                  80
Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Pro Gly Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Leu Asp
            100                 105                 110
Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 125

<210> 323
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb CDRH1

<400> 323
Gly Gly Ser Ile Ser Ser Ser Tyr
 1               5

<210> 324
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb CDRH2

<400> 324
Leu Tyr Tyr Ser Gly Ser Thr
 1               5

<210> 325
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb CDRH3

<400> 325
Ala Arg Asp Pro Gly Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Leu
 1               5                  10                  15
Asp Ala Phe Asp
            20

<210> 326
<211> 108
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb VL(VK)

<400> 326
Ala Ile Trp Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Val Ser Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Thr Tyr Asn Thr Leu Ser
                85                  90                  95
Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 327
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb CDRL1

<400> 327
Gln Ser Ile Val Ser Tyr
 1               5

<210> 328
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb CDRL2

<400> 328
Ala Ala Ser
 1

<210> 329
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb CDRL3

<400> 329
Gln Gln Thr Tyr Asn Thr Leu Ser Leu Thr
 1               5                  10

<210> 330
<211> 382
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb VH

<400> 330
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc      60
acctgcactg tctctggtgg ctccatcagt agttcctact ggagctggat ccggcagccc     120
ccagggaagg gactggagtg gattggctat ctctattaca gtgggagcac caactacaac     180
ccctccctca agagtcgagt caccatatca gtagacacgt ccaagaacca gttctccctg     240
aagctgacct ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag agaccccggg     300
ccgtattact atgatagtag tggttattac ctggatgctt ttgatatctg gggccaaggg     360
acaatggtca ccgtctcttc ag                                              382

<210> 331
<211> 325
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N25-v1 mAb VL(VK)

<400> 331
gccatctgga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggcaagtca gagcattgtc agctatttaa attggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct     240
gaagattttg caacttacta ctgtcaacag acttacaata ccctttcgct cactttcggc     300
ggagggacca aggtggagat caaac                                           325

<210> 332
<211> 128
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb VH

<400> 332
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Phe Ser Tyr
            20                  25                  30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ala Phe Ile Arg Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Ser Pro Arg Val Thr Ser Gly Gly Tyr Tyr Ser Tyr Tyr
            100                 105                 110
Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120                 125

<210> 333
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb CDRH1

<400> 333
Gly Phe Thr Phe Phe Ser Tyr Gly
 1               5

<210> 334
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb CDRH2

<400> 334
Ile Arg Tyr Asp Gly Ser Asn Lys
 1               5

<210> 335
<211> 21
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb CDRH3

<400> 335
Ala Lys Asp Ser Pro Arg Val Thr Ser Gly Gly Tyr Tyr Ser Tyr Tyr
 1               5                  10                  15
Tyr Gly Met Asp Val
            20

<210> 336
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb VL(VK)

<400> 336
Asp Ile Val Met Thr Gln Thr Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Ser Ser Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Arg Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Pro Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu
                85                  90                  95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 337
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb CDRL1

<400> 337
Gln Asn Ile Ser Ser Tyr
 1               5

<210> 338
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb CDRL2

<400> 338
Pro Ala Ser
 1

<210> 339
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb CDRL3

<400> 339
Gln Gln Ser Tyr Ser Thr Pro Leu Thr
 1               5

<210> 340
<211> 384
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb VH

<400> 340
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc      60
tcctgtgcag cgtctggatt caccttcttt agctatggaa tgcactgggt ccgccaggcc     120
ccgggcaagg ggctggagtg ggtggcattt atacggtatg atggaagtaa taaatactat     180
gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat     240
ctgcaaatga acagcctgag agctgaggac acagctgtgt attactgtgc gaaagactct     300
cctcgggtta ccagtggcgg atattactcc tactactacg gtatggacgt ctggggccaa     360
gggaccacgg tcaccgtctc ctca                                            384

<210> 341
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N28-v1 mAb VL(VK)

<400> 341
gatattgtga tgacccagac tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggcaagtca gaacattagc agttatttaa attggtatca gcagaaacca     120
cggaaagccc ctaaactcct gatctatcct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct     240
gaagattttg caacttacta ctgtcaacag agttacagta cgccgctcac tttcggcgga     300
gggaccaagg tggagatcaa ac                                              322

<210> 342
<211> 127
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309-v2 mAb VH

<400> 342
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Pro Phe Thr Ser Tyr
            20                  25                  30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Ser Thr Tyr Gln Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Thr Thr Gly Tyr
65                  70                  75                  80
Met Glu Leu Arg Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Tyr Thr Arg Gly Ala Trp Phe Gly Glu Ser Leu Ile Gly
            100                 105                 110
Gly Phe Asp Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 343
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309-v2 mAb CDRH1

<400> 343
Gly Tyr Pro Phe Thr Ser Tyr Gly
 1               5

<210> 344
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309-v2 mAb CDRH2

<400> 344
Ile Ser Thr Tyr Gln Gly Asn Thr
 1               5

<210> 345
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309-v2 mAb CDRH3

<400> 345
Ala Arg Asp Tyr Thr Arg Gly Ala Trp Phe Gly Glu Ser Leu Ile Gly
 1               5                  10                  15
Gly Phe Asp Asn
            20

<210> 346
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309-v2 mAb VL(VK)

<400> 346
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Thr Val Ser Ser Thr
            20                  25                  30
Ser Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln His Asp Thr Ser Leu
                85                  90                  95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 347
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309-v2 mAb CDRL1

<400> 347
Gln Thr Val Ser Ser Thr Ser
 1               5

<210> 348
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309-v2 mAb CDRL2

<400> 348
Gly Ala Ser
 1

<210> 349
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S309-v2 mAb CDRL3

<400> 349
Gln Gln His Asp Thr Ser Leu Thr
 1               5

<210> 350
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v3 mAb VH

<400> 350
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Phe Ile Asn Pro Asn Ser Gly Gly Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Ala Thr Ser Phe Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Ser Gly Tyr Leu Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp
            100                 105                 110
Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 351
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v4 mAb VH

<400> 351
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Phe Ile Asn Pro Asn Ala Gly Gly Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Ala Thr Ser Phe Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Ser Gly Tyr Leu Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp
            100                 105                 110
Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 352
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v4 mAb CDRH2

<400> 352
Ile Asn Pro Asn Ala Gly Gly Thr
 1               5

<210> 353
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v5 mAb VH

<400> 353
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Phe Ile Asn Pro Ala Ser Gly Gly Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Ala Thr Ser Phe Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Ser Gly Tyr Ala Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp
            100                 105                 110
Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 354
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v5 mAb CDRH3

<400> 354
Ala Ser Ser Gly Tyr Ala Gly Tyr Tyr Tyr Tyr Gly Met Asp Val
 1               5                  10                  15

<210> 355
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v6 mAb VL(VK)

<400> 355
Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
                85                  90                  95
Leu Gln Thr Pro His Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105                 110

<210> 356
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v6 mAb CDRL1

<400> 356
Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr
 1               5                  10

<210> 357
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v7 mAb VL(VK)

<400> 357
Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Asn Val Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Ile Gln Ala
                85                  90                  95
Leu Gln Thr Pro His Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105                 110

<210> 358
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H58-v7 mAb CDRL3

<400> 358
Ile Gln Ala Leu Gln Thr Pro His Thr
 1               5

<210> 359
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v2 mAb VH

<400> 359
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Pro Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ala Ile Ser Gly Ser Gly Gln Tyr Thr Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Pro Gly Gly Leu Ser Asn Phe Asp Phe Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 360
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v2 mAb CDRH2

<400> 360
Ile Ser Gly Ser Gly Gln Tyr Thr
 1               5

<210> 361
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v3 mAb VH

<400> 361
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Pro Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ala Ile Ser Gly Ser Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Pro Gly Gly Leu Ser Asn Phe Asp Phe Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 362
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v3 mAb CDRH2

<400> 362
Ile Ser Gly Ser Gly Gly Tyr Thr
 1               5

<210> 363
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v4 mAb VH

<400> 363
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Pro Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ala Ile Ser Gly Ser Gly Asn Tyr Ala Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Pro Gly Gly Leu Ser Asn Phe Asp Phe Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 364
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v4 mAb CDRH2

<400> 364
Ile Ser Gly Ser Gly Asn Tyr Ala
 1               5

<210> 365
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v5 mAb VH

<400> 365
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Pro Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ala Ile Ser Gly Ser Gly Asn Pro Thr Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Pro Gly Gly Leu Ser Asn Phe Asp Phe Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 366
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v5 mAb CDRH2

<400> 366
Ile Ser Gly Ser Gly Asn Pro Thr
 1               5

<210> 367
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v6 mAb VH

<400> 367
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Pro Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ala Ile Ser Gly Ser Gly Asn Tyr Ala Tyr Tyr Ala Asp Ala Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Pro Gly Gly Leu Ser Asn Phe Asp Phe Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 368
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2N22-v7 mAb VH

<400> 368
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Pro Ile Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ala Ile Ser Gly Ser Gly Asn Tyr Ala Tyr Tyr Ala Asp Ala Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Pro Gly Gly Leu Ser Asn Phe Asp Phe Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 369
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb VH

<400> 369
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Glu Ala Leu Glu
        35                  40                  45
Trp Leu Ala Leu Ile Phe Trp Asp Asp Asp Lys Arg Tyr Arg Pro Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala His Arg Arg Thr Ser Tyr Gly Ser Tyr Tyr Phe Asp Tyr Trp
            100                 105                 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 370
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb CDRH1

<400> 370
Gly Phe Ser Leu Ser Thr Ser Gly Val Gly
 1               5                  10

<210> 371
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb CDRH2

<400> 371
Ile Phe Trp Asp Asp Asp Lys
 1               5

<210> 372
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb CDRH3

<400> 372
Ala His Arg Arg Thr Ser Tyr Gly Ser Tyr Tyr Phe Asp Tyr
 1               5                  10

<210> 373
<211> 106
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb VL(VK)

<400> 373
Asp Ile Glu Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Arg Ala Ser Asn Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Pro Thr
                85                  90                  95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 374
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb CDRL1

<400> 374
Gln Ser Ile Ser Asn Trp
 1               5

<210> 375
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb CDRL2

<400> 375
Arg Ala Ser
 1

<210> 376
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb CDRL3

<400> 376
Gln Gln Tyr Asn Ser Tyr Pro Thr
 1               5

<210> 377
<211> 367
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb VH

<400> 377
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg      60
acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt     120
cagcccccag gagaggccct ggagtggctt gcactcattt tttgggatga tgataagcgc     180
tacaggccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg     240
gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacaga     300
cgtaccagct atggttctta ctactttgac tattggggcc agggaaccct ggtcaccgtc     360
tcctcag                                                               367

<210> 378
<211> 319
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E6-v1 mAb VL(VK)

<400> 378
gacatcgaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggccagtca gagtattagt aactggttgg cctggtatca gcagaaacca     120
gggagagccc ctaagctcct aatctatagg gcgtctaatt tagaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct     240
gatgattttg caacttatta ctgccaacag tataatagtt atccgacgtt cggccaaggg     300
accaaggtgg aaatcaaac                                                  319

<210> 379
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb VH

<400> 379
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Ser Ser Asn
            20                  25                  30
Tyr Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ile Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Asn Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Pro Ile Val Gly Ser Arg Ala Gly Met Asp Val Trp Gly Gln Gly
            100                 105                 110
Thr Thr Val Thr Val Ser Ser
        115

<210> 380
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb CDRH1

<400> 380
Gly Leu Thr Val Ser Ser Asn Tyr
 1               5

<210> 381
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb CDRH2

<400> 381
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 382
<211> 13
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb CDRH3

<400> 382
Ala Arg Pro Ile Val Gly Ser Arg Ala Gly Met Asp Val
 1               5                  10

<210> 383
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb VH(VK)

<400> 383
Glu Ile Val Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Lys Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Ala Phe Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Val Ala Thr Tyr Tyr Cys His Gln Tyr Asp Asn Leu Pro Leu
                85                  90                  95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 384
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb CDRL1

<400> 384
Gln Asp Ile Asn Lys Tyr
 1               5

<210> 385
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb CDRL2

<400> 385
Asp Ala Ser
 1

<210> 386
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb CDRL3

<400> 386
His Gln Tyr Asp Asn Leu Pro Leu Thr
 1               5

<210> 387
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb VH

<400> 387
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc      60
tcctgtgcag cctctggatt aactgtcagt agcaactaca tgacctgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtctcaatt atttatagcg gtggtagcac attctacgca     180
gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgaatctt     240
caaatgaaca gcctgagagt tgaggacacg gctgtgtatt actgtgcgag acccatagtg     300
ggatccagag ccggtatgga cgtctggggc caagggacca cggtcaccgt ctcctca        357

<210> 388
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E7-v1 mAb VL(VK)

<400> 388
gaaatagtga tgacgcagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc aggcgagtca agacattaac aagtatttaa attggtatca gcagaaacca     120
gggaaagccc ctaaactcct tatctacgat gcatccaatt tggaaacagg ggtcccatca     180
aggttcagtg gaagtgggtc tgggacagat tttgctttca ccatcagcag cctgcagcct     240
gaagatgttg caacatatta ctgtcaccag tatgataatc tcccgctcac tttcggcgga     300
gggaccaagg tggagatcaa ac                                              322

<210> 389
<211> 117
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb VH

<400> 389
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Ser Ser Asn
            20                  25                  30
Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Glu Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Leu Asn Ser Leu Arg Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Leu Glu Ile His Gly Met Asp Val Trp Gly Gln Gly Thr Thr
            100                 105                 110
Val Thr Val Ser Ser
        115

<210> 390
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb CDRH1

<400> 390
Gly Leu Thr Val Ser Ser Asn Tyr
 1               5

<210> 391
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb CDRH2

<400> 391
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 392
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb CDRH3

<400> 392
Ala Arg Asp Leu Glu Ile His Gly Met Asp Val
 1               5                  10

<210> 393
<211> 108
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb VL(VK)

<400> 393
Glu Ile Val Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Asn Tyr
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Gln Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Pro
                85                  90                  95
Val Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105

<210> 394
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb CDRL1

<400> 394
Gln Gly Ile Ser Asn Tyr
 1               5

<210> 395
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb CDRL2

<400> 395
Ala Ala Ser
 1

<210> 396
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb CDRL3

<400> 396
Gln Gln Leu Asn Ser Tyr Pro Pro Val Thr
 1               5                  10

<210> 397
<211> 351
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb VH

<400> 397
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc      60
tcctgtgcag cctctgggtt aaccgtcagt agcaactaca tgagctgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac attctacgca     180
gaatccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctt     240
caattgaaca gcctgagagc cgcggacacg gccgtgtatt actgtgcgag agatcttgag     300
attcacggta tggacgtctg gggccaaggg accacggtca ccgtctcctc a              351

<210> 398
<211> 325
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E9-v1 mAb VL(VK)

<400> 398
gaaattgtgc tgactcagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggccagtca gggcattagc aattatttag cctggtatca gcaaaaacca     120
gggaaagccc ctcagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct     240
gaagattttg caacttatta ctgtcaacag cttaatagtt accctccggt cactttcggc     300
cctgggacca aagtggatat caaac                                           325

<210> 399
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb VH

<400> 399
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 400
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb CDRH1

<400> 400
Gly Phe Thr Phe Thr Ser Ser Ala
 1               5

<210> 401
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb CDRH2

<400> 401
Ile Val Val Gly Ser Gly Asn Thr
 1               5

<210> 402
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb CDRH3

<400> 402
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Gly Phe Asp Ile
 1               5                  10                  15

<210> 403
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb VL(VK)

<400> 403
Asp Ile Val Leu Thr Gln Thr Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
            20                  25                  30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Gly Leu Thr
                85                  90                  95
Gly Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 404
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb CDRL1

<400> 404
Gln Ser Val Ser Ser Ser Tyr
 1               5

<210> 405
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb CDRL2

<400> 405
Gly Ala Ser
 1

<210> 406
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb CDRL3

<400> 406
Gln Gln Tyr Val Gly Leu Thr Gly Trp Thr
 1               5                  10

<210> 407
<211> 370
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb VH

<400> 407
caggtgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgagggtc      60
tcctgcaagg cttctggatt cacctttact agctctgctg tacagtgggt gcgacaggct     120
cgtggacaac gccttgagtg ggtgggatgg atcgtcgttg gcagtggtaa cacaaactac     180
gcacagaagt tccacgaaag agtcaccatt accagggaca tgtccacaag cacagcctac     240
atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc gtcaccttat     300
tgtagtggtg gtagctgctc tgatggtttt gatatctggg gccaagggac aatggtcacc     360
gtctcttcag                                                            370

<210> 408
<211> 328
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb VL(VK)

<400> 408
gatattgtgt tgacgcagac tccaggcacc ctgtctttgt ctccagggga aagagccacc      60
ctctcctgca gggccagtca gagtgttagc agcagttact tagcctggta ccagcagaaa     120
cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca     180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag     240
cctgaagatt ttgcagtgta ttactgtcag cagtatgttg gcttaacagg gtggacgttc     300
ggccaaggga ccaaggtgga aatcaaac                                        328

<210> 409
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb VH

<400> 409
Gln Val Gln Leu Val Gln Ser Gly Thr Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ile Ser Tyr
            20                  25                  30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Ser Pro Tyr Asn Gly Asn Thr His Tyr Ala Lys Arg Val
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Asn Thr Ser Tyr
65                  70                  75                  80
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Gly Glu Leu Leu Gly Trp Phe Asp Pro Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 410
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb CDRH1

<400> 410
Gly Tyr Thr Phe Ile Ser Tyr Gly
 1               5

<210> 411
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb CDRH2

<400> 411
Ile Ser Pro Tyr Asn Gly Asn Thr
 1               5

<210> 412
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb CDRH3

<400> 412
Ala Arg Asp Gly Glu Leu Leu Gly Trp Phe Asp Pro
 1               5                  10

<210> 413
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb VL

<400> 413
His Thr Glu Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Asn Tyr
            20                  25                  30
Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Ala Gly Thr Lys Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser
                85                  90                  95
Ser Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 414
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb CDRL1

<400> 414
Ser Ser Asp Val Gly Asn Tyr Asn Leu
 1               5

<210> 415
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb CDRL2

<400> 415
Ala Gly Thr
 1

<210> 416
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb CDRL3

<400> 416
Cys Ser Tyr Ala Gly Ser Ser Thr Trp Val
 1               5                  10

<210> 417
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb VH

<400> 417
caggtgcagc tggtgcagtc tggaactgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggtta cacctttatc agctatggta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcagccctt acaatggtaa cacacattat     180
gcaaagaggg tccagggcag agtcaccatg accacagaca catccacgaa cacatcctac     240
atggagctga ggagcctgag atctgacgac acggccgtgt attactgtgc gagagatgga     300
gaactcctcg gctggttcga tccctggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 418
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E13-v1 mAb VL

<400> 418
cacactgagc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc      60
tcctgcactg gaaccagcag tgatgttggg aattataacc ttgtctcctg gtaccaacag     120
cacccaggca aagcccccaa actcatgatt tatgcgggca ctaagcggcc ctcaggggtt     180
tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc     240
caggctgagg acgaggctga ctattactgc tgctcatatg caggtagtag cacttgggtg     300
ttcggcggag ggaccaagct gaccgtccta g                                    331

<210> 419
<211> 127
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb VH

<400> 419
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Thr Val Ile Ser Ser Asp Gly Ser Asn Lys Tyr Tyr Ala Glu Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Leu Pro Val Ile Val Ala Thr Met Trp His Tyr Tyr Asn
            100                 105                 110
Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120                 125

<210> 420
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb CDRH1

<400> 420
Gly Phe Thr Phe Ser Ser Tyr Ala
 1               5

<210> 421
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb CDRH2

<400> 421
Ile Ser Ser Asp Gly Ser Asn Lys
 1               5

<210> 422
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb CDRH3

<400> 422
Ala Arg Asp Leu Pro Val Ile Val Ala Thr Met Trp His Tyr Tyr Asn
 1               5                  10                  15
Gly Met Asp Val
            20

<210> 423
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb VL(VK)

<400> 423
Asp Ile Arg Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Glu Gly Ile Ser Ser Trp
            20                  25                  30
Leu Gly Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Gly Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Phe Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Lys Ser Phe Pro Ile
                85                  90                  95
Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys
            100                 105

<210> 424
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb CDRL1

<400> 424
Glu Gly Ile Ser Ser Trp
 1               5

<210> 425
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb CDRL2

<400> 425
Gly Ala Ser
 1

<210> 426
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb CDRL3

<400> 426
Gln Gln Ala Lys Ser Phe Pro Ile Thr
 1               5

<210> 427
<211> 381
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb VH

<400> 427
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc      60
tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct     120
ccaggcaagg ggctggagtg ggtgacagtt atttcatctg atggaagcaa taaatactac     180
gcggagtccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat     240
ctgcaaatga acagcctgag agctgaggac acggctctat attactgtgc gagagacctt     300
cctgttatag tggctacgat gtggcactac tataacggaa tggacgtctg gggccaaggg     360
accacggtca ccgtctcctc g                                               381

<210> 428
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E14-v1 mAb VL(VK)

<400> 428
gacatccgga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc      60
atcacttgtc gggcgagtga aggtattagc agctggttag gctggtatca gcagaaacca     120
gggaaggccc ctaaactcct gatctacggt gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagcg gcagtggatt tgggacagat ttcactctca ccatcagcag tctgcagcct     240
gaagattttg caacttacta ttgtcaacag gctaagagtt tcccgatcac cttcggccaa     300
gggacacgac tggagattaa ac                                              322

<210> 429
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2K4-v1 mAb VH

<400> 429
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Thr Gln Lys Phe
    50                  55                  60
Gln Gly Trp Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Ser Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Leu Ala Tyr Ser Tyr Val Thr Gly Ala Phe Asp Ile Trp
            100                 105                 110
Gly His Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 430
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2K4-v1 mAb CDRH1

<400> 430
Gly Tyr Thr Phe Thr Gly Tyr Tyr
 1               5

<210> 431
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2K4-v1 mAb CDRH2

<400> 431
Ile Asn Pro Asn Ser Gly Gly Thr
 1               5

<210> 432
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2K4-v1 mAb CDRH3

<400> 432
Ala Arg Asp Leu Ala Tyr Ser Tyr Val Thr Gly Ala Phe Asp Ile
 1               5                  10                  15

<210> 433
<211> 367
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2K4-v1 mAb VH

<400> 433
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtggtgg cacaaactat     180
acacagaagt ttcagggctg ggtcaccatg accagggaca cgtccatcag cacagcctac     240
atggagctga gcaggctgag ctctgacgac acggccgtgt attactgtgc gagagatctc     300
gcatacagct atgtcacggg ggcttttgat atctggggcc acgggacaat ggtcaccgtc     360
tcttcag                                                               367

<210> 434
<211> 117
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb VH

<400> 434
Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ile Ile Val Ser Arg Asn
            20                  25                  30
Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Met Met Asn Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met
            100                 105                 110
Val Thr Val Ser Ser
        115

<210> 435
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb CDRH1

<400> 435
Gly Ile Ile Val Ser Arg Asn Tyr
 1               5

<210> 436
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb CDRH2

<400> 436
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 437
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb CDRH3

<400> 437
Ala Arg Asp Met Met Asn Asp Ala Phe Asp Ile
 1               5                  10

<210> 438
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb VH(VK)

<400> 438
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ser Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Pro
                85                  90                  95
Glu Val Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys
            100                 105

<210> 439
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb CDRL1

<400> 439
Gln Gly Ile Ser Ser Tyr
 1               5

<210> 440
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb CDRL2

<400> 440
Ser Ala Ser
 1

<210> 441
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb CDRL3

<400> 441
Gln Gln Leu Asn Ser Tyr Pro Pro Glu Val Thr
 1               5                  10

<210> 442
<211> 352
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb VH

<400> 442
gaggtgcatc tggtggagtc tgggggaggt ttggtccagc cgggggggtc cctgagactc      60
tcctgtgcag cctctggaat catcgtcagt aggaattaca tgagctgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagtac attctacgca     180
gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctt     240
caaatgaaca gcctgagagc tggggacacg gctgtgtatt actgtgcgag ggatatgatg     300
aatgatgctt ttgatatctg gggccaaggg acaatggtca ccgtctcttc ag             352

<210> 443
<211> 328
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X193-v1 mAb VL(VK)

<400> 443
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca     120
gggaaagccc ctaagctcct gatctattct gcatccactt tgcaaagtgg ggtcccatcg     180
aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct     240
gaagattttg caacttatta ctgtcaacag cttaatagtt accctccgga ggtcaccttc     300
ggccaaggga cacgactgga gattaaac                                        328

<210> 444
<211> 129
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb VH

<400> 444
Glu Val His Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Lys Ile Gly Gly Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Asn Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Leu Gln Pro Ser Tyr Cys Thr Asp Gly Val Cys Trp Pro
            100                 105                 110
Asp Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
        115                 120                 125
Ser


<210> 445
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb CDRH1

<400> 445
Gly Tyr Thr Phe Thr Asp Tyr Tyr
 1               5

<210> 446
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb CDRH2

<400> 446
Ile Asn Pro Lys Ile Gly Gly Thr
 1               5

<210> 447
<211> 22
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb CDRH3

<400> 447
Ala Lys Asp Leu Gln Pro Ser Tyr Cys Thr Asp Gly Val Cys Trp Pro
 1               5                  10                  15
Asp Asp Ala Phe Asp Ile
            20

<210> 448
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb VL(VK)

<400> 448
Ala Ile Arg Met Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly
 1               5                  10                  15
Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Asp Gly Lys Thr Tyr Leu Tyr Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Glu Val Ser Asn Arg Phe Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ser
                85                  90                  95
Ile Gln Leu Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105                 110

<210> 449
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb CDRL1

<400> 449
Gln Ser Leu Leu His Ser Asp Gly Lys Thr Tyr
 1               5                  10

<210> 450
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb CDRL2

<400> 450
Glu Val Ser
 1

<210> 451
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb CDRL3

<400> 451
Met Gln Ser Ile Gln Leu Pro Pro Thr
 1               5

<210> 452
<211> 388
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb VH

<400> 452
gaggtgcatc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc gactactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta agattggtgg cacaaactat     180
gcacagaagt ttcagggcag ggtcaccatg accagggaca cgtccatcaa cacagcctac     240
atggaactga gcaggctgag atctgacgac acggccgtat attactgtgc gaaagatcta     300
caaccttcat attgtactga tggtgtatgc tggcccgatg atgcttttga tatctggggc     360
caagggacaa tggtcaccgt ctcttcag                                        388

<210> 453
<211> 337
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X195-v1 mAb VL(VK)

<400> 453
gccatccgga tgacccagac tccactctct ctgtccgtca cccctggaca gccggcctcc      60
atctcctgca agtctagtca gagcctcctg catagtgatg gaaagaccta tttgtattgg     120
tacctgcaga agccaggcca gtctccacag ctcctgatct atgaagtttc caaccgcttc     180
tctggagtgc cagataggtt cagtggcagc gggtcaggga cagatttcac actgaaaatc     240
agccgggtgg aggctgagga tgttggggtt tattactgca tgcaaagtat acagcttcct     300
ccgacgttcg gccaagggac caaggtggaa atcaaac                              337

<210> 454
<211> 118
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb VH

<400> 454
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Thr Gly Ile Thr Val Ser Arg Asn
            20                  25                  30
Tyr Ile Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ile Ile Tyr Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Leu Asn Val Val Gly Gly Phe Asp Ile Trp Gly Gln Gly Thr
            100                 105                 110
Met Val Thr Val Ser Ser
        115

<210> 455
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb CDRH1

<400> 455
Gly Ile Thr Val Ser Arg Asn Tyr
 1               5

<210> 456
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb CDRH2

<400> 456
Ile Tyr Ser Gly Gly Thr Thr
 1               5

<210> 457
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb CDRH3

<400> 457
Ala Arg Asp Leu Asn Val Val Gly Gly Phe Asp Ile
 1               5                  10

<210> 458
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb VL(VK)

<400> 458
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Ser Ser Ser
            20                  25                  30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro
                85                  90                  95
Pro Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys
            100                 105

<210> 459
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb CDRL1

<400> 459
Gln Ser Ile Ser Ser Ser Tyr
 1               5

<210> 460
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb CDRL2

<400> 460
Gly Ala Ser
 1

<210> 461
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb CDRL3

<400> 461
Gln Gln Tyr Gly Ser Ser Pro Pro Ile Thr
 1               5                  10

<210> 462
<211> 355
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb VH

<400> 462
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc      60
tcctgtgcag ccactgggat caccgtcagt aggaactaca taaactgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtctcaatt atttatagcg gtggtactac atactacgca     180
gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctt     240
caaatgaaca gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agatttaaac     300
gtagtgggtg gttttgatat ctggggccaa gggacaatgg tcaccgtctc ttcag          355

<210> 463
<211> 328
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X219-v1 mAb VL(VK)

<400> 463
gaaatagtga tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc      60
ctctcctgca gggccagtca gagtattagc agcagctact tagcctggta ccagcagaaa     120
cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca     180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag     240
cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctcc gatcaccttc     300
ggccaaggga cacgactgga gattaaac                                        328

<210> 464
<211> 126
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb VH

<400> 464
Gln Val Gln Leu Val Gln Ser Gly Thr Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Thr Phe
            20                  25                  30
Ser Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Arg Ile Ile Pro Ile Leu Lys Ile Ala Asp Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Glu Ala Gly Phe Phe Glu Glu Tyr Gly Ser Gly Ser Ser Gly
            100                 105                 110
Leu Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 465
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb CDRH1

<400> 465
Gly Gly Thr Phe Ser Thr Phe Ser
 1               5

<210> 466
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb CDRH2

<400> 466
Ile Ile Pro Ile Leu Lys Ile Ala
 1               5

<210> 467
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb CDRH3

<400> 467
Ala Arg Glu Ala Gly Phe Phe Glu Glu Tyr Gly Ser Gly Ser Ser Gly
 1               5                  10                  15
Leu Asp Pro


<210> 468
<211> 111
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb VL(VK)

<400> 468
Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Asn Leu Ser Leu Leu His Ser
            20                  25                  30
Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ile Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
                85                  90                  95
Leu Gln Thr Pro Arg Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105                 110

<210> 469
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb CDRL1

<400> 469
Leu Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr
 1               5                  10

<210> 470
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb CDRL2

<400> 470
Leu Gly Ser
 1

<210> 471
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb CDRL3

<400> 471
Met Gln Ala Leu Gln Thr Pro Arg
 1               5

<210> 472
<211> 379
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb VH

<400> 472
caggtccagc tggtgcaatc tgggactgag gtgaagaagc ctgggtcctc ggtgaaggtc      60
tcctgcaagg cttctggagg caccttcagc acctttagta tcaactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttaaaat agcagactac     180
gcacagaagt tccagggcag agtcacgatt accgcggaca aatccacgag cacagcctac     240
atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagaggca     300
ggcttcttcg aggagtatgg ttcggggagt tcagggctcg acccctgggg ccagggaacc     360
ctggtcaccg tctcctcag                                                  379

<210> 473
<211> 334
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X244-v1 mAb VL(VK)

<400> 473
gaaattgtgt tgacacagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc      60
atctcctgca ggtctaatct gagtctcctg catagtaatg gatacaacta tttggattgg     120
tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc     180
tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttat actgaaaatc     240
agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct ccaaactcct     300
cgtttcggcg gagggaccaa ggtggagatc aaac                                 334

<210> 474
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb VH

<400> 474
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ile Tyr
            20                  25                  30
Glu Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Tyr Ile Thr Ser Gly Gly His Thr Ile Phe Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Asn Pro Ser Ser Gly Tyr Phe Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 475
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb CDRH1

<400> 475
Gly Phe Thr Phe Ser Ile Tyr Glu
 1               5

<210> 476
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb CDRH2

<400> 476
Ile Thr Ser Gly Gly His Thr Ile
 1               5

<210> 477
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb CDRH3

<400> 477
Ala Ser Asn Pro Ser Ser Gly Tyr Phe Phe Asp Tyr
 1               5                  10

<210> 478
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb VL(VK)

<400> 478
Ala Ile Arg Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Pro Tyr
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Leu Asp Ile Lys
            100                 105

<210> 479
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb CDRL1

<400> 479
Gln Ser Ile Ser Ser Trp
 1               5

<210> 480
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb CDRL2

<400> 480
Lys Ala Ser
 1

<210> 481
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb CDRL3

<400> 481
Gln Gln Tyr Asn Ser Tyr Pro Tyr Thr
 1               5

<210> 482
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb VH

<400> 482
caggtacagc tggtggagtc tgggggaggc ttggtccagc ctggagggtc cctgaggctc      60
tcctgtgcag cctctggatt caccttcagt atttatgaaa tgaactgggt ccgccaggct     120
ccagggaagg ggctggagtg ggtttcatac attactagtg gtggtcatac catattctac     180
gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat     240
ctgcaaatga acagcctgcg agccgaggac acggctgttt attactgtgc gagcaacccg     300
agtagtggtt atttttttga ctactggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 483
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X246-v1 mAb VL(VK)

<400> 483
gccatccgga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggccagtca gagtattagt agctggttgg cctggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct     240
gatgattttg caacttatta ctgccaacag tataatagtt atccctacac ttttggccag     300
gggaccaagc tggacatcaa ac                                              322

<210> 484
<211> 117
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb VH

<400> 484
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ile Ile Val Ser Ser Asn
            20                  25                  30
Tyr Met Asn Trp Val Arg Gln Ala Pro Gly Arg Gly Leu Glu Trp Val
        35                  40                  45
Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Ser Ser Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Met Asn Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Leu Gly Glu Ser Gly Met Asp Val Trp Gly Gln Gly Thr Thr
            100                 105                 110
Val Thr Val Ser Ser
        115

<210> 485
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb CDRH1

<400> 485
Gly Ile Ile Val Ser Ser Asn Tyr
 1               5

<210> 486
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb CDRH2

<400> 486
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 487
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb CDRH3

<400> 487
Ala Arg Asp Leu Gly Glu Ser Gly Met Asp Val
 1               5                  10

<210> 488
<211> 106
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb VL(VK)

<400> 488
Ala Ile Arg Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Ser Ala Ala Ser Asn Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Phe Pro Arg
                85                  90                  95
Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105

<210> 489
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb CDRL1

<400> 489
Gln Gly Ile Ser Ser Trp
 1               5

<210> 490
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb CDRL2

<400> 490
Ala Ala Ser
 1

<210> 491
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb CDRL3

<400> 491
Gln Gln Ala Asn Ser Phe Pro Arg
 1               5

<210> 492
<211> 351
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb VH

<400> 492
gaggtgcagc tggtggagtc tggagggggc ttgatccagc ctggggggtc cctgagactc      60
tcctgtgcag cctctgggat catcgtcagt agcaactaca tgaactgggt ccgccaggct     120
ccagggaggg ggctggagtg ggtctcagtt atttatagcg gtggtagcac attctacgca     180
gactccgtga agggccgatt caccatctcc agagacagtt ccaagaacac actgtatctt     240
caaatgaacg gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agatctggga     300
gagagcggta tggacgtctg gggccaaggg accacggtca ccgtctcctc a              351

<210> 493
<211> 319
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X256-v1 mAb VL(VK)

<400> 493
gccatccgga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc      60
atcacttgtc gggcgagtca gggtattagc agctggttag cctggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctctgct gcatccaatt tgcaaagtgg ggtcccatct     180
aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct     240
gaagattttg caacttacta ttgtcaacag gctaacagtt tccctcggtt cggccctggg     300
accaaagtgg atatcaaac                                                  319

<210> 494
<211> 128
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb VH

<400> 494
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ala Phe Arg Ile Tyr
            20                  25                  30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ala Leu Ile Trp Phe Asp Gly Asn Asn Lys Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Ser Ser Lys Asn Thr Leu Phe
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys
                85                  90                  95
Ala Arg Ala Met Cys Pro Gly Glu Thr Gly Asn Leu Leu Gly Ile Cys
            100                 105                 110
Tyr Ala Pro Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 495
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb CDRH1

<400> 495
Gly Phe Ala Phe Arg Ile Tyr Gly
 1               5

<210> 496
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb CDRH2

<400> 496
Ile Trp Phe Asp Gly Asn Asn Lys
 1               5

<210> 497
<211> 21
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb CDRH3

<400> 497
Ala Arg Ala Met Cys Pro Gly Glu Thr Gly Asn Leu Leu Gly Ile Cys
 1               5                  10                  15
Tyr Ala Pro Asp Tyr
            20

<210> 498
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb VL

<400> 498
Gln Ser Ala Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln
 1               5                  10                  15
Arg Val Thr Ile Ser Cys Ser Gly Ser Thr Ser Asn Ile Gly Ser Asn
            20                  25                  30
His Val Cys Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
        35                  40                  45
Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg
65                  70                  75                  80
Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Arg Leu
                85                  90                  95
Ser Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 499
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb CDRL1

<400> 499
Thr Ser Asn Ile Gly Ser Asn His
 1               5

<210> 500
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb CDRL2

<400> 500
Ser Asn Asn
 1

<210> 501
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb CDRL3

<400> 501
Ala Ala Trp Asp Asp Arg Leu Ser Gly Trp Val
 1               5                  10

<210> 502
<211> 385
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb VH

<400> 502
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc      60
tcctgtgcag cgtctggatt cgccttcaga atctatggca tgcactgggt ccgccaggct     120
ccaggcaagg ggctggagtg ggtggcactt atatggtttg atggaaataa taaatactat     180
gccgactccg tgaagggccg attcaccatc tccagagaca gttccaagaa cacactgttt     240
ctgcaaatga acagcctgag agccgaggac acggctctgt attactgtgc gagagcgatg     300
tgcccaggcg aaacgggaaa tcttctgggt atctgctacg cccctgacta ctggggccag     360
ggaaccctgg tcaccgtctc ctcag                                           385

<210> 503
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X269-v1 mAb VL

<400> 503
cagtctgccc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc      60
tcttgttctg gaagcacctc caacatcgga agtaatcatg tatgctggta ccagcagctc     120
ccaggaacgg cccccaaact cctcatctat agtaataatc aacggccctc aggggtccct     180
gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccgg     240
tccgaggatg aggctgatta ttactgtgca gcatgggatg acagactgag tggctgggtg     300
ttcggcggag ggaccaagct gaccgtccta g                                    331

<210> 504
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb VH

<400> 504
Gln Val Arg Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
 1               5                  10                  15
Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Tyr Ser Ile Ser Ser Gly
            20                  25                  30
Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp
        35                  40                  45
Ile Gly Ser Ile Tyr Glu Ser Gly Ser Thr Tyr Asn Asn Pro Ser Leu
    50                  55                  60
Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser
65                  70                  75                  80
Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Leu Trp Glu Gly Asp Tyr Tyr Arg Val Gly Asp Tyr Trp
            100                 105                 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 505
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb CDRH1

<400> 505
Gly Tyr Ser Ile Ser Ser Gly Tyr Tyr
 1               5

<210> 506
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb CDRH2

<400> 506
Ile Tyr Glu Ser Gly Ser Thr
 1               5

<210> 507
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb CDRH3

<400> 507
Ala Arg Asp Leu Trp Glu Gly Asp Tyr Tyr Arg Val Gly Asp Tyr
 1               5                  10                  15

<210> 508
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb VL

<400> 508
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln
 1               5                  10                  15
Lys Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Val Gly Asn Asn
            20                  25                  30
Tyr Val Ser Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
        35                  40                  45
Ile Tyr Asp Asn Thr Lys Arg Pro Ser Trp Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Lys Ser Gly Thr Ser Ala Thr Leu Asp Ile Thr Gly Leu Gln
65                  70                  75                  80
Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Gly Thr Trp Asp Ser Ser Leu
                85                  90                  95
Ser Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105

<210> 509
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb CDRL1

<400> 509
Ser Ser Asn Val Gly Asn Asn Tyr
 1               5

<210> 510
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb CDRL2

<400> 510
Asp Asn Thr
 1

<210> 511
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb CDRL3

<400> 511
Gly Thr Trp Asp Ser Ser Leu Ser Val Val
 1               5                  10

<210> 512
<211> 367
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb VH

<400> 512
caggtgcggc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc      60
acctgcgctg tctctggtta ctccatcagc agtggttact actggggctg gatccggcag     120
cccccaggga aggggctgga gtggattggg agtatctatg agagtgggag cacctacaac     180
aacccgtccc tcaagagtcg agtcaccatg tcagtagaca cgtccaagaa ccagttctcc     240
ctgaagctga cctctgtgac cgccgcagac acggccgtat attactgtgc gagagacctc     300
tgggaaggtg actactaccg agtgggggac tactggggcc agggaaccct ggtcaccgtc     360
tcctcag                                                               367

<210> 513
<211> 328
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X278-v1 mAb VL

<400> 513
cagtctgtgt tgacgcagcc gccctcagtg tctgcggccc caggacagaa ggtcaccatc      60
tcctgctctg gaagcagctc caacgttggg aataattatg tatcctggta ccagcagctc     120
ccaggaacag cccccaaact cctcatttat gacaatacta agcgaccctc atggattcct     180
gaccgattct ctggctccaa gtctggcacg tcagccaccc tggacatcac cggactccag     240
actggggacg aggccgatta ttactgcgga acatgggata gcagtctgag tgttgtcttc     300
ggcggaggga ccaagctgac cgtcctag                                        328

<210> 514
<211> 120
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb VH

<400> 514
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Ile Ile Asn Pro Ser Gly Thr Ser Thr Ser Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr
65                  70                  75                  80
Leu Asp Leu Ser Ser Leu Arg Ser Gly Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Thr Gly Ser Trp Glu Leu Pro Ser Tyr Phe Asp Tyr Trp Gly Gln
            100                 105                 110
Gly Thr Leu Ile Thr Val Ser Ser
        115                 120

<210> 515
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb CDRH1

<400> 515
Gly Tyr Thr Phe Thr Ser Tyr Tyr
 1               5

<210> 516
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb CDRH2

<400> 516
Ile Asn Pro Ser Gly Thr Ser Thr
 1               5

<210> 517
<211> 13
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb CDRH3

<400> 517
Ala Thr Gly Ser Trp Glu Leu Pro Ser Tyr Phe Asp Tyr
 1               5                  10

<210> 518
<211> 108
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb VL(VK)

<400> 518
Asp Ile Val Met Met Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Tyr Ser Ser
            20                  25                  30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45
Ile Ser Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Ala Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro
                85                  90                  95
Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 519
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb CDRL1

<400> 519
Gln Ser Ile Tyr Ser Ser Tyr
 1               5

<210> 520
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb CDRL2

<400> 520
Gly Ala Ser
 1

<210> 521
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb CDRL3

<400> 521
Gln Gln Tyr Gly Ser Ser Pro Pro Thr
 1               5

<210> 522
<211> 361
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb VH

<400> 522
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt      60
tcctgcaagg catctggata caccttcacc agctactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaata atcaacccta gtggtactag cacaagctac     180
gcacagaagt tccagggcag agtcactatg accagggaca cgtccacgag cacagtctac     240
ttggacctga gcagcctgag atctggtgac acggccgtgt attactgtgc gaccgggtcg     300
tgggagctac cttcctactt tgactactgg ggccagggaa ccctgatcac cgtctcctca     360
g                                                                     361

<210> 523
<211> 325
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M7-v1 mAb VL(VK)

<400> 523
gacatcgtga tgatgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc      60
ctctcctgca gggccagtca gagtatttac agcagctatt tagcctggta ccagcagaaa     120
cctggccagg ctcccaggct cctcatctct ggtgcatcca gcagggccac tggcatccca     180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag     240
cctgcggatt ttgcagtgta ttactgtcag cagtatggta gctcacctcc gacgttcggc     300
caagggacca aggtggaaat caaac                                           325

<210> 524
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb VH

<400> 524
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Ile Ser Ser Gly Thr Ser Tyr Ala Gln Thr Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Ser Asp Thr Ser Ile Thr Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Ala Ala Pro Phe Tyr Asp Phe Trp Ser Gly Tyr Ser Tyr Phe
            100                 105                 110
Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 525
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb CDRH1

<400> 525
Gly Tyr Thr Phe Thr Gly Tyr Tyr
 1               5

<210> 526
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb CDRH2

<400> 526
Ile Asn Pro Ile Ser Ser Gly Thr
 1               5

<210> 527
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb CDRH3

<400> 527
Ala Arg Ala Ala Pro Phe Tyr Asp Phe Trp Ser Gly Tyr Ser Tyr Phe
 1               5                  10                  15
Asp Tyr


<210> 528
<211> 108
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb VL(VK)

<400> 528
Glu Ile Val Met Met Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
            20                  25                  30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Ala
                85                  90                  95
Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 529
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb CDRL1

<400> 529
Gln Ser Val Ser Ser Ser Tyr
 1               5

<210> 530
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb CDRL2

<400> 530
Gly Ala Ser
 1

<210> 531
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb CDRL3

<400> 531
Gln Gln Tyr Gly Ser Ser Ala Trp Thr
 1               5

<210> 532
<211> 376
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb VH

<400> 532
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctactata tgcactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta tcagtagtgg cacaagctat     180
gcacagacat ttcagggcag ggtcaccatg accagtgaca cgtccatcac cacagcctac     240
atggagctca gcaggctgag atctgacgac acggccgtat attactgtgc gagagcagcc     300
ccgttttacg atttttggag tggttattct tactttgact actggggcca gggaaccctg     360
gtcaccgtct cctcag                                                     376

<210> 533
<211> 325
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M11-v1 mAb VL(VK)

<400> 533
gaaatagtga tgatgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc      60
ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa     120
cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca     180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag     240
cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcagcgtg gacgttcggc     300
caagggacca aggtggaaat caaac                                           325

<210> 534
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb VH

<400> 534
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Met Val Leu Pro Gly Arg
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr
            20                  25                  30
Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ala Val Ile Ser Tyr Asp Gly Ser Thr Lys Tyr Phe Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Thr Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Ser Glu Thr Cys Ser Ser Phe Thr Cys Tyr Cys Asp Tyr
            100                 105                 110
Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 535
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb CDRH1

<400> 535
Gly Phe Thr Phe Ser Asn Tyr Ala
 1               5

<210> 536
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb CDRH2

<400> 536
Ile Ser Tyr Asp Gly Ser Thr Lys
 1               5

<210> 537
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb CDRH3

<400> 537
Ala Lys Asp Ser Glu Thr Cys Ser Ser Phe Thr Cys Tyr Cys Asp Tyr
 1               5                  10                  15

<210> 538
<211> 113
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb VL(VK)

<400> 538
Asp Ile Val Leu Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly
 1               5                  10                  15
Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser
            20                  25                  30
Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln
        35                  40                  45
Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val
    50                  55                  60
Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr
65                  70                  75                  80
Ile Gly Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln
                85                  90                  95
Tyr Tyr Asn Thr Pro Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile
            100                 105                 110
Lys


<210> 539
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb CDRL1

<400> 539
Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr
 1               5                  10

<210> 540
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb CDRL2

<400> 540
Trp Ala Ser
 1

<210> 541
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb CDRL3

<400> 541
Gln Gln Tyr Tyr Asn Thr Pro Phe Thr
 1               5

<210> 542
<211> 370
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb VH

<400> 542
gaggtgcaac tggtggagtc tgggggaggc atggtcctgc ctgggaggtc cctgagactc      60
tcctgtgcag cctctggatt caccttcagt aactatgcca tgcactgggt ccgccaggct     120
ccaggcaagg ggctggagtg ggtggcagtt atatcgtatg atggaagtac taaatacttt     180
gcagactccg tgaagggccg attcaccatc tccagagaca cttccaagaa cacgctgtat     240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagattca     300
gagacttgta gtagtttcac ctgctattgc gactactggg gccggggaac cctggtcacc     360
gtctcctcag                                                            370

<210> 543
<211> 340
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M16-v1 mAb VL(VK)

<400> 543
gatattgtgc tgactcagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc      60
atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct     120
tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg     180
gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc     240
atcggcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttataatact     300
cccttcactt tcggccctgg gaccaaagtg gatatcaaac                           340

<210> 544
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb VH

<400> 544
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Thr Val Ile Trp Tyr Asp Gly Ser Asn Arg Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asp Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Ala Val Ala Gly Glu Trp Tyr Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115

<210> 545
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb CDRH1

<400> 545
Gly Phe Thr Phe Ser Ser Tyr Gly
 1               5

<210> 546
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb CDRH2

<400> 546
Ile Trp Tyr Asp Gly Ser Asn Arg
 1               5

<210> 547
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb CDRH3

<400> 547
Ala Arg Ala Val Ala Gly Glu Trp Tyr Phe Asp Tyr
 1               5                  10

<210> 548
<211> 108
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb VL

<400> 548
Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln
 1               5                  10                  15
Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Ala Lys His Tyr Ala
            20                  25                  30
Tyr Trp Tyr Arg Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr
        35                  40                  45
Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
    50                  55                  60
Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu
65                  70                  75                  80
Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ile Gly Ser Ser
                85                  90                  95
Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105

<210> 549
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb CDRL1

<400> 549
Ala Leu Ala Lys His Tyr
 1               5

<210> 550
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb CDRL2

<400> 550
Lys Asp Ser
 1

<210> 551
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb CDRL3

<400> 551
Gln Ser Ala Asp Ser Ile Gly Ser Ser Trp Val
 1               5                  10

<210> 552
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb VH

<400> 552
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc      60
tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct     120
ccaggcaagg ggctggagtg ggtgacagtt atttggtatg atggaagtaa tcgatactat     180
gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat     240
ctgcaaatgg acagcctgag agccgaggac acggctgttt attactgtgc gagagcagtg     300
gccggggaat ggtactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag       358

<210> 553
<211> 325
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2M28-v1 mAb VL

<400> 553
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc      60
acctgctccg gagatgcatt ggcaaaacac tatgcttatt ggtaccggca gaagccaggc     120
caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga     180
ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa     240
gacgaggctg actattactg tcaatcagca gacagcattg gtagttcttg ggtgttcggc     300
ggagggacca agctgaccgt cctag                                           325

<210> 554
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb VH

<400> 554
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Phe Ser Ser Tyr
            20                  25                  30
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ala Phe Met Arg Tyr Asp Glu Thr Asn Lys Tyr Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Asp Arg Leu Leu Gly Gly Pro Tyr Tyr Asp Ser Ile Gly Leu
            100                 105                 110
Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 555
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb CDRH1

<400> 555
Gly Phe Asn Phe Ser Ser Tyr Gly
 1               5

<210> 556
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb CDRH2

<400> 556
Met Arg Tyr Asp Glu Thr Asn Lys
 1               5

<210> 557
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb CDRH3

<400> 557
Ala Lys Asp Arg Leu Leu Gly Gly Pro Tyr Tyr Asp Ser Ile Gly Leu
 1               5                  10                  15
Asp Tyr


<210> 558
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb VL(VK)

<400> 558
Asp Ile Val Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Thr Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Phe Pro Tyr
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105

<210> 559
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb CDRL1

<400> 559
Gln Gly Ile Ser Ser Trp
 1               5

<210> 560
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb CDRL2

<400> 560
Thr Ala Ser
 1

<210> 561
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb CDRL3

<400> 561
Gln Gln Gly Tyr Ser Phe Pro Tyr Thr
 1               5

<210> 562
<211> 376
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb VH

<400> 562
gaggtgcagc tgttggagtc tgggggaggc gtggtccagc ctggggggtc cctgagactc      60
tcctgtgcag cgtctggatt caacttcagt agctatggca tgcactgggt ccgccaggct     120
ccaggcaagg ggctggagtg ggtggcattt atgcggtatg atgaaactaa taaatactat     180
gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat     240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatcgg     300
ctattaggag gtccatatta tgatagcatt gggcttgact actggggcca gggaaccctg     360
gtcaccgtct cctcag                                                     376

<210> 563
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2L49-v1 mAb VL(VK)

<400> 563
gatattgtga tgactcagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc      60
atcacttgtc gggcgagtca gggtattagc agctggttag cctggtatca gcagaaacca     120
ggtaaagccc ctaagctctt gatctatact gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagcg gcagtgaatc tgggacagat ttcactctca ccatcagcag cctgcagcct     240
gaagattttg caacttacta ttgtcaacag ggttacagtt tcccgtacac ttttggccag     300
gggaccaagc tggagatcaa ac                                              322

<210> 564
<211> 125
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb VH

<400> 564
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ala Gln Pro Gly Arg
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Phe Ser Phe Asp Asp Tyr
            20                  25                  30
Ala Met His Trp Val Arg Gln Val Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Gly Ile Ser Trp Asn Ser Gly Asn Ile Gly Tyr Ala Asp Ser Ala
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Leu Tyr Tyr Cys
                85                  90                  95
Val Lys Asp Lys His Tyr Asp Ser Ser Gly Tyr Val Val Asn Gly Phe
            100                 105                 110
Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Pro
        115                 120                 125

<210> 565
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb CDRH1

<400> 565
Gly Phe Ser Phe Asp Asp Tyr Ala
 1               5

<210> 566
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb CDRH2

<400> 566
Ile Ser Trp Asn Ser Gly Asn Ile
 1               5

<210> 567
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb CDRH3

<400> 567
Val Lys Asp Lys His Tyr Asp Ser Ser Gly Tyr Val Val Asn Gly Phe
 1               5                  10                  15
Asp Tyr


<210> 568
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb VL(VK)

<400> 568
Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Ser Ser Tyr
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Arg Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu His Ser Tyr Pro Ala
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 569
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb CDRL1

<400> 569
Gln Asp Ile Ser Ser Tyr
 1               5

<210> 570
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb CDRL2

<400> 570
Ala Ala Ser
 1

<210> 571
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb CDRL3

<400> 571
Gln Gln Leu His Ser Tyr Pro Ala Thr
 1               5

<210> 572
<211> 376
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb VH

<400> 572
gaggtgcagc tggtggagtc ggggggaggc ttggcacagc ctggcaggtc cctgagactc      60
tcctgtgcag tctctggatt cagctttgat gattatgcca tgcactgggt ccggcaagtt     120
ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtaa cataggctat     180
gcggactctg cgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat     240
ctgcaaatga acagtctgag acctgaggac acggccttgt attactgtgt aaaagataaa     300
cattatgata gtagtggtta cgtagtaaat ggatttgact actggggcca gggaaccctg     360
gtcaccgtct ccccag                                                     376

<210> 573
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D65-v1 mAb VL(VK)

<400> 573
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggccagtca ggacattagc agttatttgg cctggtatca gcaaaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagaa ttcactctca caatccgcag cctgcagcct     240
gaagattttg caacttatta ctgtcaacag cttcacagtt accctgcgac gttcggccaa     300
gggaccaagg tggaaatcaa ac                                              322

<210> 574
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb VH

<400> 574
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Ser Phe Ser Gly Phe Ser Leu Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Ala Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Thr
    50                  55                  60
Leu Arg Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Leu His Gln Ile Met Thr Val Phe Asp Leu Trp Gly Arg Gly
            100                 105                 110
Ala Leu Val Thr Val Ser Ser
        115

<210> 575
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb CDRH1

<400> 575
Gly Phe Ser Leu Thr Thr Ser Gly Val Gly
 1               5                  10

<210> 576
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb CDRH2

<400> 576
Ile Tyr Trp Asp Asp Asp Lys
 1               5

<210> 577
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb CDRH3

<400> 577
Ala Leu His Gln Ile Met Thr Val Phe Asp Leu
 1               5                  10

<210> 578
<211> 111
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb VL

<400> 578
Gln Ser Val Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Asp Tyr
            20                  25                  30
Asn Tyr Val Ser Trp Tyr Gln His His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Gln Val Thr Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Thr Ser Tyr Thr Thr Ser
                85                  90                  95
Ser Thr Leu Val Glu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110

<210> 579
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb CDRL1

<400> 579
Ser Ser Asp Val Gly Asp Tyr Asn Tyr
 1               5

<210> 580
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb CDRL2

<400> 580
Gln Val Thr
 1

<210> 581
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb CDRL3

<400> 581
Thr Ser Tyr Thr Thr Ser Ser Thr Leu Val Glu
 1               5                  10

<210> 582
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb VH

<400> 582
cagatcacct tgaaggagtc tggtcctacc ctggtgaaac ccacacagac cctcacgctg      60
acctgcagtt tctctgggtt ctcactcacc actagtggag tgggtgtggc ctggatccgt     120
cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgacaagcgc     180
tacagcccaa ctctgaggag caggctcacc atcaccaagg acacctccaa gaaccaggtg     240
gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcactacac     300
cagattatga cggtcttcga tctctggggc cgtggcgccc tggtcactgt ctcctcag       358

<210> 583
<211> 334
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D97-v1 mAb VL

<400> 583
cagtctgtgc tgactcagcc tgcctccgtg tctgggtctc ctggccagtc gatcaccatc      60
tcctgcactg gaaccagcag tgacgttggt gattataact atgtgtcctg gtaccaacac     120
cacccaggca aagcccccaa actcatgatt tatcaggtca ctaatcggcc ctcaggggtt     180
tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc     240
caggctgagg acgaggctga ttattactgc acttcctata caaccagtag tactctcgtg     300
gaattcggcg gagggaccaa gttgaccgtc ttag                                 334

<210> 584
<211> 126
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb VH

<400> 584
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Ser Ser Ser
            20                  25                  30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Gly Ile Ile Pro Met Val Gly Thr Ala Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Arg Tyr Cys Ser Gly Gly Ser Cys Tyr Ser Val Trp
            100                 105                 110
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 585
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb
      CDRH1

<400> 585
Gly Gly Pro Phe Ser Ser Ser Ala
 1               5

<210> 586
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb CDRH2

<400> 586
Ile Ile Pro Met Val Gly Thr Ala
 1               5

<210> 587
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb CDRH3

<400> 587
Ala Arg Asp Ser Arg Tyr Cys Ser Gly Gly Ser Cys Tyr Ser Val Trp
 1               5                  10                  15
Phe Asp Pro


<210> 588
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb VL(VK)

<400> 588
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Val Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Arg
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Val Glu Met Lys
            100                 105

<210> 589
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb CDRL1

<400> 589
Gln Ser Ile Ser Ser Tyr
 1               5

<210> 590
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb CDRL2

<400> 590
Ala Ala Ser
 1

<210> 591
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb CDRL3

<400> 591
Gln Gln Ser Tyr Ser Thr Pro Arg Thr
 1               5

<210> 592
<211> 379
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb VH

<400> 592
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtt      60
tcctgcaagg cttctggagg ccccttcagc agctctgcta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaggg atcatcccta tggtaggtac agcaaactat     180
gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac     240
atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
cgctattgta gtggtggtag ctgctactcc gtctggttcg acccctgggg ccagggaacc     360
ctggtcaccg tctcctcag                                                  379

<210> 593
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2D106-v1 mAb VL(VK)

<400> 593
gacatccagt tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      60
atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca     120
gggaaagccc ctaaggtcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctccaacct     240
gaagattttg caacttacta ctgtcaacag agttacagta cccctcgaac gttcggccaa     300
gggaccaagg tggaaatgaa ac                                              322

<210> 594
<211> 131
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb VH

<400> 594
Gln Val Gln Leu Val Gln Ser Gly Ala Asp Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Ile Ser Gly Gly Arg Asn Tyr Thr Arg Lys Phe
    50                  55                  60
Gln Gly Arg Ile Thr Met Asn Arg Asp Thr Ser Ile Thr Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Gly Gly Met Asp Tyr Gly Ser Gly Ser Tyr Phe Ser
            100                 105                 110
Pro Pro Arg Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr
        115                 120                 125
Val Ser Ser
    130

<210> 595
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb CDRH1

<400> 595
Gly Tyr Thr Phe Thr Gly Tyr Phe
 1               5

<210> 596
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb CDRH2

<400> 596
Ile Asn Pro Ile Ser Gly Gly Arg
 1               5

<210> 597
<211> 24
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb CDRH3

<400> 597
Ala Arg Asp Ser Gly Gly Met Asp Tyr Gly Ser Gly Ser Tyr Phe Ser
 1               5                  10                  15
Pro Pro Arg Tyr Gly Met Asp Val
            20

<210> 598
<211> 110
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb VL

<400> 598
Gln Ser Val Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Ala Ser Ser Asp Val Gly Ala Tyr
            20                  25                  30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Glu Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Ala Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
                85                  90                  95
Asn Thr Val Val Phe Gly Gly Gly Thr Ser Leu Thr Val Leu
            100                 105                 110

<210> 599
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb CDRL1

<400> 599
Ser Ser Asp Val Gly Ala Tyr Asn Phe
 1               5

<210> 600
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb CDRL2

<400> 600
Glu Val Ser
 1

<210> 601
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb CDRL3

<400> 601
Ser Ser Tyr Thr Ser Ser Asn Thr Val Val
 1               5                  10

<210> 602
<211> 393
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb VH

<400> 602
caggtgcagc tggtgcagtc tggggctgac gtgaagaagc ctggggcctc agtgaaggtc      60
tcctgcaagg cttctggata caccttcacc ggctacttta tacactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta tcagtggtgg cagaaactat     180
acacggaagt ttcagggcag gatcaccatg aacagggaca cgtccatcac cacagcctac     240
atggagctga gcaggctgag atctgacgac acggccgtgt attactgtgc gagagattcg     300
ggggggatgg actatggttc ggggagttat ttttcccccc cccgatacgg tatggacgtc     360
tggggccaag ggaccacggt caccgtctcc tca                                  393

<210> 603
<211> 331
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X149-v1 mAb VL

<400> 603
cagtctgtgc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc      60
tcctgcactg gagccagcag tgacgttggt gcttataact ttgtctcctg gtaccaacag     120
cacccaggca aagcccccaa actcatgatt tatgaggtca gtaatcggcc ctcaggggtt     180
tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc     240
caggctgagg acgaggctgc ttattactgc agctcatata caagcagtaa cactgtggta     300
ttcggcggag ggaccagcct gaccgtccta g                                    331

<210> 604
<211> 117
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb VH

<400> 604
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ile Thr Val Ser Ser Asn
            20                  25                  30
Tyr Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Arg
    50                  55                  60
Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu
65                  70                  75                  80
Gln Met Asn Ser Leu Arg Pro Asp Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Arg Asp Leu Asn Glu Leu Gly Ile Asp Cys Trp Gly Gln Gly Thr Leu
            100                 105                 110
Val Thr Val Ser Ser
        115

<210> 605
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb CDRH1

<400> 605
Gly Ile Thr Val Ser Ser Asn Tyr
 1               5

<210> 606
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb CDRH2

<400> 606
Ile Tyr Ser Gly Gly Ser Thr
 1               5

<210> 607
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb CDRH3

<400> 607
Ala Arg Asp Leu Asn Glu Leu Gly Ile Asp Cys
 1               5                  10

<210> 608
<211> 106
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb VL(VK)

<400> 608
Asp Ile Val Met Thr Gln Thr Pro Ser Ser Val Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Arg Trp
            20                  25                  30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Arg Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Tyr Ala Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Phe Pro Phe
                85                  90                  95
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 609
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb CDRL1

<400> 609
Gln Gly Ile Ser Arg Trp
 1               5

<210> 610
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb CDRL2

<400> 610
Ala Ala Ser
 1

<210> 611
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb CDRL3

<400> 611
Gln Gln Ala Asn Ser Phe Pro Phe
 1               5

<210> 612
<211> 352
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb VH

<400> 612
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc      60
tcctgtgcag cctctggtat caccgtcagt agcaattata tgacctgggt ccgccaggct     120
ccagggaagg ggctggaatg ggtctcagtt atttatagcg gtggcagcac attctacgca     180
gactccgtga ggggccgatt caccatctcc agagacaatt ccaagaacac cctgtatctt     240
caaatgaaca gcctgagacc tgacgacacg gctgtgtatt actgtgcgag agatctgaac     300
gagctgggga ttgactgctg gggccaggga accctggtca ccgtctcctc ag             352

<210> 613
<211> 319
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2X179-v1 mAb VL(VK)

<400> 613
gatattgtga tgacccagac tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc      60
atcacttgtc gggcgagtca gggtattagc cgctggttag cctggtatca gcagaaacca     120
gggaaagccc ctaagctcct gatctatgct gcatccactt tacaaagtgg ggtcccatca     180
aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcaggag cctgcagcct     240
gaagattatg caacttacta ttgtcaacag gctaacagtt tccctttttt cggcggaggg     300
accaaggtgg agatcaaac                                                  319

<210> 614
<211> 120
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb VH

<400> 614
Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
 1               5                  10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ile Asn Tyr
            20                  25                  30
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ala Ile Gly Leu Ser Gly Gly Ser Thr Asn Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Ser
65                  70                  75                  80
Leu Glu Met Asn Asn Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Thr Lys Gly Arg Gly Gly Tyr Phe Asp Pro Phe Asp Pro Trp Gly Gln
            100                 105                 110
Gly Thr Leu Val Thr Val Ser Ser
        115                 120

<210> 615
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb CDRH1

<400> 615
Gly Phe Thr Phe Ile Asn Tyr Ala
 1               5

<210> 616
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb CDRH2

<400> 616
Ile Gly Leu Ser Gly Gly Ser Thr
 1               5

<210> 617
<211> 13
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb CDRH3

<400> 617
Thr Lys Gly Arg Gly Gly Tyr Phe Asp Pro Phe Asp Pro
 1               5                  10

<210> 618
<211> 107
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb VL(VK)

<400> 618
Asp Ile Val Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr
            20                  25                  30
Leu Asn Trp Tyr Gln Gln Ile Pro Gly Lys Ala Pro Asn Leu Leu Ile
        35                  40                  45
His Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ser Pro Pro
                85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105

<210> 619
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb CDRL1

<400> 619
Gln Ser Ile Ser Ser Tyr
 1               5

<210> 620
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb CDRL2

<400> 620
Ala Ala Ser
 1

<210> 621
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb CDRL3

<400> 621
Gln Gln Ser Tyr Ser Ser Pro Pro Thr
 1               5

<210> 622
<211> 361
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb VH

<400> 622
gaggtgcatc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc      60
tcctgtgcag cctctggatt cacctttatc aactatgcca tgagctgggt ccgccaggct     120
ccagggaagg ggctggaatg ggtctcagct attggtctta gtggtggtag tacaaactac     180
gcagactccg tgaagggccg gttcaccatc tccagagaca actccaagaa cacgctgtct     240
ttggaaatga acaacctgcg agccgaggac acggccgtat attactgtac aaaagggagg     300
ggaggatatt ttgacccgtt cgacccctgg ggccagggaa ccctggtcac cgtctcctca     360
g                                                                     361

<210> 623
<211> 322
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2H101-v1 mAb VL(VK)

<400> 623
gacatcgtga tgacccagtc tccatcctcc ctgtctgcat ctgttgggga cagagtcacc      60
atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagatacca     120
gggaaagccc ctaacctcct gatccatgct gcatccagtt tgcaaagtgg ggtcccatca     180
aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct     240
gaagattttg caacttacta ctgtcagcag agttacagtt cccctcccac ttttggccag     300
gggaccaagc tggagatcaa ac                                              322

<210> 624
<211> 126
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v2  VH

<400> 624
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Ser Ser Ser
            20                  25                  30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Gly Ile Ile Pro Ile Val Gly Thr Ala Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Arg Tyr Cys Ser Gly Gly Ser Cys Tyr Ser Val Trp
            100                 105                 110
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 625
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v2  CDRH2

<400> 625
Ile Ile Pro Ile Val Gly Thr Ala
 1               5

<210> 626
<211> 126
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v3  VH

<400> 626
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Ser Ser Ser
            20                  25                  30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Gly Ile Ile Pro Met Val Gly Thr Ala Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Arg Tyr Cys Ser Gly Gly Ser Cys Tyr Ser Val Phe
            100                 105                 110
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 627
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v3  CDRH3

<400> 627
Ala Arg Asp Ser Arg Tyr Cys Ser Gly Gly Ser Cys Tyr Ser Val Phe
 1               5                  10                  15
Phe Asp Pro


<210> 628
<211> 126
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v4 VH

<400> 628
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Ser Ser Ser
            20                  25                  30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Gly Ile Ile Pro Ile Val Gly Thr Ala Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Arg Tyr Cys Ser Gly Gly Ser Cys Tyr Ser Val Phe
            100                 105                 110
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 629

<400> 629
 000

<210> 630
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v1 VH

<400> 630
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 631
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v1 CDRH1

<400> 631
Gly Phe Ser Val Thr Thr Ser Gly Val Gly
 1               5                  10

<210> 632
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v1 CDRH2

<400> 632
Ile Tyr Trp Asp Asp Asp Lys
 1               5

<210> 633
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v1 CDRH3

<400> 633
Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr
 1               5                  10

<210> 634
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v2 VH

<400> 634
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Asp Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 635
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v2 CDRH2

<400> 635
Ile Tyr Phe Asp Asp Asp Lys
 1               5

<210> 636
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v3 VH

<400> 636
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Asp Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 637
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v3 CDRH2

<400> 637
Ile Tyr Tyr Asp Asp Asp Lys
 1               5

<210> 638
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v4 VH

<400> 638
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Glu Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 639
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v4 CDRH2

<400> 639
Ile Tyr Trp Glu Asp Asp Lys
 1               5

<210> 640
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v5 VH

<400> 640
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Asn Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 641
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v5 CDRH2

<400> 641
Ile Tyr Trp Asn Asp Asp Lys
 1               5

<210> 642
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v6 VH

<400> 642
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Asp Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 643
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_24_v6 CDRH2

<400> 643
Ile Tyr Trp Asp Glu Asp Lys
 1               5

<210> 644
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v7 VH

<400> 644
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Asp Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 645
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v7 CDRH2

<400> 645
Ile Tyr Trp Asp Asn Asp Lys
 1               5

<210> 646
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v8 VH

<400> 646
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Glu Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 647
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v8 CDRH2

<400> 647
Ile Tyr Phe Glu Asp Asp Lys
 1               5

<210> 648
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v9 VH

<400> 648
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Asn Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 649
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v9 CDRH2

<400> 649
Ile Tyr Phe Asn Asp Asp Lys
 1               5

<210> 650
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v10 VH

<400> 650
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Glu Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 651
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v10 CDRH2

<400> 651
Ile Tyr Tyr Glu Asp Asp Lys
 1               5

<210> 652
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v11 VH

<400> 652
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Asn Asp Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 653
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v11 CDRH2

<400> 653
Ile Tyr Tyr Asn Asp Asp Lys
 1               5

<210> 654
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v12 VH

<400> 654
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Asp Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 655
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v12 CDRH2

<400> 655
Ile Tyr Phe Asp Glu Asp Lys
 1               5

<210> 656
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v13 VH

<400> 656
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Asp Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 657
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v13 CDRH2

<400> 657
Ile Tyr Phe Asp Asn Asp Lys
 1               5

<210> 658
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v14 VH

<400> 658
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Asp Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 659
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v14 CDRH2

<400> 659
Ile Tyr Tyr Asp Glu Asp Lys
 1               5

<210> 660
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v15 VH

<400> 660
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Asp Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 661
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v15 CDRH2

<400> 661
Ile Tyr Tyr Asp Asn Asp Lys
 1               5

<210> 662
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v16 VH

<400> 662
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Glu Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 663
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v16 CDRH2

<400> 663
Ile Tyr Trp Glu Glu Asp Lys
 1               5

<210> 664
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v17 VH

<400> 664
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Glu Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 665
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v17 CDRH2

<400> 665
Ile Tyr Trp Glu Asn Asp Lys
 1               5

<210> 666
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v18 VH

<400> 666
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Asn Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 667
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v18 CDRH2

<400> 667
Ile Tyr Trp Asn Glu Asp Lys
 1               5

<210> 668
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v19 VH

<400> 668
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Trp Asn Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 669
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v19 CDRH2

<400> 669
Ile Tyr Trp Asn Asn Asp Lys
 1               5

<210> 670
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v20 VH

<400> 670
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Glu Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 671
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v20 CDRH2

<400> 671
Ile Tyr Phe Glu Glu Asp Lys
 1               5

<210> 672
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v21 VH

<400> 672
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Glu Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 673
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v21 CDRH2

<400> 673
Ile Tyr Phe Glu Asn Asp Lys
 1               5

<210> 674
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v22 VH

<400> 674
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Asn Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 675
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence S2X324_v22 CDRH2

<400> 675
Ile Tyr Phe Asn Glu Asp Lys
 1               5

<210> 676
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v23 VH

<400> 676
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Phe Asn Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 677
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v23 CDRH2

<400> 677
Ile Tyr Phe Asn Asn Asp Lys
 1               5

<210> 678
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v24 VH

<400> 678
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Glu Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 679
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v24 CDRH2

<400> 679
Ile Tyr Tyr Glu Glu Asp Lys
 1               5

<210> 680
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v25 VH

<400> 680
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Glu Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 681
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v25 CDRH2

<400> 681
Ile Tyr Tyr Glu Asn Asp Lys
 1               5

<210> 682
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v26 VH

<400> 682
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Asn Glu Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 683
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2__v26 CDRH2

<400> 683
Ile Tyr Tyr Asn Glu Asp Lys
 1               5

<210> 684
<211> 119
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v27 VH

<400> 684
Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln
 1               5                  10                  15
Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Thr Thr Ser
            20                  25                  30
Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu
        35                  40                  45
Tyr Leu Ala Leu Ile Tyr Tyr Asn Asn Asp Lys Arg Tyr Ser Thr Ser
    50                  55                  60
Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val
65                  70                  75                  80
Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr
                85                  90                  95
Cys Ala Arg His Thr Ile Pro Ser Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Ile Leu Val Thr Val Ser Ser
        115

<210> 685
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence S2X324_v27 CDRH2

<400> 685
Ile Tyr Tyr Asn Asn Asp Lys
 1               5

<210> 686
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2 VL

<400> 686
Gln Pro Val Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15
Ser Ile Thr Ile Ser Cys Thr Ala Thr Ser Ser Asp Val Gly Asn Tyr
            20                  25                  30
Asn Tyr Val Ser Trp Tyr Gln His His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Glu Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
                85                  90                  95
Ser Leu Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105

<210> 687
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2 CDRL1

<400> 687
Ser Ser Asp Val Gly Asn Tyr Asn Tyr
 1               5

<210> 688
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2 CDRL2

<400> 688
Glu Val Ser
 1

<210> 689
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2 CDRL3

<400> 689
Ser Ser Tyr Thr Ser Ser Ser Leu Leu
 1               5

<210> 690
<211> 358
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2 VH

<400> 690
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg      60
acctgcacct tctctgggtt ctcagtcact actagtggag tgggtgtggg ctggatccgt     120
cagcccccag gaaaggccct ggagtacctt gcactcattt attgggatga tgataagcgc     180
tacagtacat ctctgaagag caggctcact atcaccaagg acacctccaa aaaccaggtg     240
gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacgccat     300
actatacctt cgatctttga ctactggggc cagggaatcc tggtcaccgt ctcctcag       358

<210> 691
<211> 328
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2 VL

<400> 691
cagcctgtgc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc      60
tcctgcactg caaccagcag tgacgttggt aattataact atgtctcctg gtaccaacac     120
cacccaggca aagcccccaa actcatgatt tatgaggtca gtaatcggcc ctcaggggtt     180
tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc     240
caggctgagg acgaggctga ttattattgc agctcatata caagcagcag tctactattc     300
ggcggaggga ccaagctgac cgtcctag                                        328

<210> 692
<211> 131
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 VH

<400> 692
Glu Val Gln Leu Val Gln Ser Gly Ala Ala Val Lys Lys Thr Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Glu Tyr Ile Phe Thr Glu Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Arg Thr His Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Thr Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Cys Leu Ala Gly Glu Trp Gly Tyr Cys Ser Thr Thr Ser Cys Lys
            100                 105                 110
Arg Gly Ile Asp Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr
        115                 120                 125
Val Ser Ser
    130

<210> 693
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 CDRH1

<400> 693
Glu Tyr Ile Phe Thr Glu Tyr Tyr
 1               5

<210> 694
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 CDRH2

<400> 694
Ile Asn Pro Asn Ser Gly Arg Thr
 1               5

<210> 695
<211> 24
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 CDRH3

<400> 695
Ala Cys Leu Ala Gly Glu Trp Gly Tyr Cys Ser Thr Thr Ser Cys Lys
 1               5                  10                  15
Arg Gly Ile Asp Gly Met Asp Val
            20

<210> 696
<211> 112
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 VL

<400> 696
Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
 1               5                  10                  15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
            20                  25                  30
Asn Gly Tyr Asn Tyr Leu Asn Trp Tyr Leu Gln Lys Pro Gly Gln Ser
        35                  40                  45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
    50                  55                  60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65                  70                  75                  80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
                85                  90                  95
Leu Gln Thr Met Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Arg
            100                 105                 110

<210> 697
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 CDRL1

<400> 697
Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr
 1               5                  10

<210> 698
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 CDRL2

<400> 698
Leu Gly Ser
 1

<210> 699
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 CDRL3

<400> 699
Met Gln Ala Leu Gln Thr Met Tyr Thr
 1               5

<210> 700
<211> 393
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 VH

<400> 700
gaggtgcaac tggtgcagtc tggggctgcg gtgaagaaga ctggggcctc agtgaaggtc      60
tcctgcaagg cttctgaata catcttcacc gaatactata tacactgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtggtcg cacacactat     180
gcacagaagt ttcagggcag ggtcaccatg accagggaca cgtccatcac cacagcctac     240
atggagctga gtagcctgag atctgacgac acggccgtgt attactgtgc gtgccttgcg     300
ggtgagtggg gatattgtag tacgaccagc tgcaaaagag ggattgacgg tatggacgtc     360
tggggccaag ggaccacggt caccgtctcc tca                                  393

<210> 701
<211> 337
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_3_v1 VL

<400> 701
gaaattgtgt tgacgcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc      60
atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttgaattgg     120
tacctgcaga agccagggca gtctccacaa ctcctgatct atttgggttc taatcgggcc     180
tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc     240
agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactatg     300
tacacttttg gccaggggac caagctggag atcagac                              337

<210> 702
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence S2D106-v1 mAb VH (nt-CO)

<400> 702
gaagtgcaac tagtgcaaag tggtgcagaa gtgaagaagc ctggctcttc tgtgaaagtg      60
tcttgcaagg cctctggcgg cccattttcc agctctgcca tctcctgggt cagacaggct     120
cccggccaag gactggagtg gatgggcgga atcatcccta tggtgggcac cgccaactac     180
gcccagaagt tccagggcag agtgaccatc accgctgatg agtccacctc tacagcctac     240
atggaactgt cctccctgag atccgaggac accgctgtgt actactgtgc tcgggactct     300
cggtattgct ccggcggcag ctgctactcc gtgtggttcg acccttgggg ccagggcaca     360
ctggtgaccg tgtccagc                                                   378

<210> 703
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v2  VH
      (nt-CO)

<400> 703
gaagtgcaac tagtgcaaag tggtgcagaa gtcaagaagc caggctccag cgttaaagtg      60
tcttgcaagg cctctggcgg acctttctcc tccagcgcca tctcctgggt gcggcaggct     120
cctggccaag gcctggagtg gatgggcggc atcatcccca tcgtgggcac cgccaactac     180
gcccagaagt tccagggcag agtgaccatc acagccgacg agtctacctc caccgcttat     240
atggaactgt cttctctgcg gtccgaggac accgctgtgt actactgtgc tagagattct     300
agatactgct ccggcggcag ctgctactcc gtgtggtttg acccttgggg ccagggaacc     360
ctggtgacag tgtcctct                                                   378

<210> 704
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v3  VH
      (nt-CO)

<400> 704
gaagtgcaac tagtgcaaag tggtgcagaa gtcaagaagc ctggatcttc tgtgaaagtg      60
tcctgcaagg cctctggcgg accatttagc tcctctgcca tctcctgggt gcggcaggct     120
cctggccaag gcctggagtg gatgggcggc atcatcccca tggtgggcac cgccaactac     180
gcccagaagt tccagggcag agtgaccatc accgctgacg agtccacctc cacagcctac     240
atggaactgt ccagcctgag atccgaggac accgctgtgt actactgtgc tagagattct     300
cggtattgct ccggcggctc ttgctactcc gtgttcttcg acccttgggg ccagggcacc     360
ctggtgaccg tgtctagc                                                   378

<210> 705
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v4  VH
      (nt-CO)

<400> 705
gaagtgcaac tagtgcaaag tggtgcagaa gtcaagaagc ctggctcctc tgtgaaagtg      60
tcctgcaagg cctctggcgg cccatttagc agctctgcca tctcctgggt gcggcaggct     120
cctggacaag gcctggagtg gatgggcggc atcatcccca tcgtgggcac agctaactac     180
gcccagaagt tccagggcag agtgaccatc accgccgacg agtccacatc taccgcctac     240
atggaactgt cctccctgag atccgaggac accgctgtgt actactgtgc tagagattct     300
cggtattgct ccggcggatc ttgctactcc gtgttcttcg acccttgggg ccagggcacc     360
ctggtgaccg tgtctagc                                                   378

<210> 706
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v1 VH (nt -
      CO)

<400> 706
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacccagac cctgacactg      60
acctgtacct tttctggctt ctccgtgacc acctctggag tcggcgtggg ctggatccgg     120
cagcctccag gcaaggccct ggagtacctg gctctgatct actgggacga cgataaacgg     180
tatagcacta gcctgaagtc cagactgaca atcaccaagg atacatccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gacaccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtgaccgt gtcctct        357

<210> 707
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v2 VH (nt -
      CO)

<400> 707
caaatcactc taaaggaaag tggtccaact ctggtgaagc ctacccagac cctgacactg      60
acctgtactt tttctggctt ctccgtgacc acctccggcg tgggagtggg ctggatcaga     120
cagcctccag gcaaggccct cgagtacctg gctctgatct acttcgatga tgacaagcgg     180
tatagcacct ctctgaaatc tcggctgaca atcaccaagg acacatccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gacaccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 708
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v3 VH (nt -
      CO)

<400> 708
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacccagac cctgacactg      60
acctgtactt ttagcggctt ctccgtgacc acctctggag tcggcgtggg ctggatccgg     120
cagcctcctg gcaaagctct ggagtacctg gccctgatct actacgacga tgacaagcgg     180
tatagcacat ctctgaagtc cagactgacc atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggacccagtg gatacagcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtgaccgt gtcctct        357

<210> 709
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v4 VH (nt -
      CO)

<400> 709
caaatcactc taaaggaaag tggtccaact ctggtgaaac caacacagac cctgacactg      60
acctgtactt ttagcggctt ctccgtgacc acctctggcg tgggagtggg ctggatcaga     120
cagcctcctg gcaaggccct ggaatatctc gctctgatct actgggagga cgacaagcgg     180
tactccacca gcctgaagtc tcggctgacc atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gatacagcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtcctct        357

<210> 710
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v5 VH (nt -
      CO)

<400> 710
caaatcactc taaaggaaag tggtccaact ctggtgaagc ctacacagac cctgacactg      60
acctgtactt tttctggctt ctccgtgacc accagcggcg tgggcgtggg ctggatccgg     120
cagcctccag gaaaagctct cgagtacctg gccctgatct actggaacga cgacaagcgg     180
tactccacct ctctgaagtc cagactgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gataccgcta cctactactg cgccagacac     300
accatcccca gcatcttcga ctattggggc cagggcatcc tggtcaccgt gtcctct        357

<210> 711
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v6 VH (nt -
      CO)

<400> 711
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacccagac cctgacactg      60
acctgtactt ttagcggctt ctccgtgacc acatctggcg tgggagtggg ctggatcaga     120
cagcctccag gcaaggccct ggaatacctg gctctgatct actgggacga ggacaagcgg     180
tattccacct ctctgaaatc tcggctgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 712
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v7 VH (nt -
      CO)

<400> 712
caaatcactc taaaggaaag tggtccaact ctggtgaaac caacccagac cctgacactg      60
acctgtacct tttctggctt ctccgtgacc accagcggcg tgggagtggg ctggatccgg     120
cagcctcctg gcaaggccct cgagtacctg gctctgatct actgggacaa cgacaagcgg     180
tatagcactt ctctgaagtc cagactgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gatacagcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtcctct        357

<210> 713
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v8 VH (nt -
      CO)

<400> 713
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacacagac cctgacactg      60
acctgtactt tttctggctt ctccgtgacc accagcggcg tgggagtggg ctggatcaga     120
cagcctccag gcaaggccct ggaatacctg gctctgatct acttcgagga cgacaagcgg     180
tattccacct ctctgaaatc tcggctgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 714
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v9 VH (nt -
      CO)

<400> 714
caaatcactc taaaggaaag tggtccaact ctggtgaaac caacccagac cctgacactg      60
acctgtacct tctccggctt ttctgtgacc acctctggcg tgggagtggg ctggatccgg     120
cagcctcctg gcaaggccct cgagtacctg gctctgatct acttcaacga cgacaagcgg     180
tatagcacta gcctgaagtc cagactgaca atcaccaagg atacatccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gacaccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtcctct        357

<210> 715
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v10 VH (nt -
      CO)

<400> 715
caaatcactc taaaggaaag tggtccaact ctggtgaagc ctacccagac cctgacactc      60
acatgtacct tttctggctt ctccgtgacc actagcggcg tgggagtggg ctggatccgg     120
caaccacctg gcaaagctct ggaatacctg gccctgatct actacgagga cgacaagcgg     180
tattctacct ctctgaagtc cagactgacc atcaccaagg atacatccaa gaaccaggtg     240
gtgctgacca tgaccaacat ggatcctgtg gacaccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 716
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v11 VH (nt -
      CO)

<400> 716
caaatcactc taaaggaaag tggtccaact ctggtgaagc ctacccagac cctgacactg      60
acctgtacct tttctggctt ctccgtgacc acatctggag tgggcgtggg ctggatcaga     120
cagcctccag gcaaggccct cgagtacctg gctctgatct actacaacga cgacaagcgg     180
tattccacct ctctgaaaag ccggctgact atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gatacagcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 717
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v12 VH (nt -
      CO)

<400> 717
caaatcactc taaaggaaag tggtccaact ctcgtgaaac caacccagac cctgacactg      60
acctgtacct tttctggctt ctccgtgaca actagcggag tcggcgtggg ctggatccgg     120
cagcctcctg gcaaggccct ggaatacctg gctctgatct acttcgatga ggacaagcgg     180
tatagcacct ctctgaagtc cagactgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtgaccgt gtcctct        357

<210> 718
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v13 VH (nt -
      CO)

<400> 718
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacccagac cctgacactg      60
acctgtacct tttctggctt ctccgtgacc accagcggcg tcggcgtggg ctggatccgg     120
cagcctccag gaaaagctct ggagtacctg gccctgatct acttcgacaa cgacaagcgg     180
tattctactt ctctgaagtc cagactgacc atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gataccgcta cctactactg cgccagacac     300
acaatcccct ccatcttcga ctactggggc cagggcatcc tggtgaccgt gtccagc        357

<210> 719
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v14 VH (nt -
      CO)

<400> 719
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacccagac cctgacactg      60
acatgtactt tttctggctt ctccgtgacc accagcggag tcggcgtggg ctggatcaga     120
cagcctccag gcaaggccct ggaatacctg gctctgatct actacgacga ggacaagcgg     180
tattccacct ctctgaaatc tcggctgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtgaccgt gtccagc        357

<210> 720
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v15 VH (nt -
      CO)

<400> 720
caaatcactc taaaggaaag tggtccaact ctggtgaagc ccacacagac cctgacactg      60
acctgcacct tttctggctt ctccgtgacc acctccggcg tgggagtggg ctggatcaga     120
cagcctccag gcaaagctct cgagtacctg gccctgatct actacgacaa cgacaagcgg     180
tactccacct ctctgaagtc tcggctgact atcaccaagg atacaagcaa gaaccaagtg     240
gtgctgacca tgaccaacat ggatcctgtg gacaccgcta cctactattg tgccagacac     300
accatccctt ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 721
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v16 VH (nt -
      CO)

<400> 721
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacacagac cctgacactg      60
acctgtacct tttctggctt ctccgtgacc acaagcggag tcggcgtggg ctggatccgg     120
cagcctccag gcaaagctct ggaatacctg gccctgatct actgggagga ggacaagcgg     180
tattccacct ctctgaagtc cagactgact atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ctatcttcga ctactggggc cagggcatcc tggtgaccgt gtccagc        357

<210> 722
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v17 VH (nt -
      CO)

<400> 722
caaatcactc taaaggaaag tggtccaact ctcgtgaaac caacccagac cctgacactg      60
acctgtacct ttagcggctt ctccgtgacc acctctggcg tgggagtggg ctggatccgg     120
cagcctcctg gcaaggccct ggaatacctg gctctgatct actgggagaa cgacaagcgg     180
tatagcacat ctctgaagtc cagactgaca atcaccaagg acacttccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtcctct        357

<210> 723
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v18 VH (nt -
      CO)

<400> 723
caaatcactc taaaggaaag tggtccaact ctcgtcaaac caactcagac cctgacactg      60
acctgtacct tttccggctt ctccgtgacc acatctggcg tgggagtggg ctggatccgg     120
cagcctcctg gcaaggccct ggaatacctg gctctgatct actggaacga ggacaagcgg     180
tatagcacct ctctgaagtc cagactgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ctatcttcga ctactggggc cagggcatcc tggtgaccgt gtccagc        357

<210> 724
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v19 VH (nt -
      CO)

<400> 724
caaatcactc taaaggaaag tggtccaact ctggtgaagc ctacccagac cctgacactg      60
acctgtactt tttctggctt ctccgtgacc acctctggag tgggcgtggg ctggatccgg     120
cagcctccag gcaaggccct cgagtacctg gctctgatct actggaacaa cgacaagcgg     180
tatagcacat ctctgaagtc cagactgaca atcaccaaag atacctccaa gaatcaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gacaccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 725
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v20 VH (nt -
      CO)

<400> 725
caaatcactc taaaggaaag tggtccaact ctggtgaaac caacccagac cctgacactg      60
acctgtactt tttctggctt ctccgtgacc acaagcggag tgggcgtggg ctggatcaga     120
cagcctcctg gcaaggccct ggaatacctg gctctgatct acttcgagga ggacaagcgg     180
tattccacct ctctgaagtc tcggctcaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 726
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v21 VH (nt -
      CO)

<400> 726
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacccagac cctgacactg      60
acctgtacct ttagcggctt ctccgtgact acatctggcg tgggagtcgg ctggatccgg     120
cagcctccag gcaaggccct ggaatacctg gctctgatct acttcgagaa cgacaagcgg     180
tatagcacct ctctgaagtc cagactgaca atcaccaaag atacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gacaccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtgaccgt gtcctct        357

<210> 727
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v22 VH (nt -
      CO)

<400> 727
caaatcactc taaaggaaag tggtccaact ctcgtgaaac caacccagac cctgacactg      60
acctgtacct tctccggctt ttctgtgacc acatctggcg tgggagtggg ctggatccgg     120
cagcctcctg gcaaggccct ggaatacctg gctctgatct acttcaacga ggacaagcgg     180
tatagcacct ctctgaagtc cagactgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gatactgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 728
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v23 VH (nt -
      CO)

<400> 728
caaatcactc taaaggaaag tggtccaact ctcgtgaaac caacccagac cctgacactg      60
acctgtacct tttctggctt ctccgtgact acctctggag tcggcgtggg ctggatccgg     120
cagcctcctg gcaaggccct ggagtacctg gctctgatct acttcaacaa cgacaagcgg     180
tatagcacat ctctgaagtc cagactgaca atcaccaagg acacctccaa gaatcaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtgaccgt gtccagc        357

<210> 729
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v24 VH (nt -
      CO)

<400> 729
caaatcactc taaaggaaag tggtccaact ctggtgaaac caacccagac cctgacactc      60
acatgtactt tttctggctt ctccgtgacc acaagcggcg tgggagtggg ctggatccgg     120
cagcctcctg gcaaggccct ggaatacctg gctctgatct actacgagga ggacaagcgg     180
tattctacct ctctgaagtc cagactgacc atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 730
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v25 VH (nt -
      CO)

<400> 730
caaatcactc taaaggaaag tggtccaact ctcgtcaaac caacccagac cctgacactg      60
acctgtacct tctccggctt ttctgtgact acatctggcg tgggagtggg ctggatccgg     120
cagcctcctg gcaaggccct ggaatacctg gctctgatct actacgagaa cgacaagcgg     180
tattccacct ctctgaagtc cagactgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccca gcatcttcga ctactggggc cagggcatcc tggtgaccgt gtccagc        357

<210> 731
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v26 VH (nt -
      CO)

<400> 731
caaatcactc taaaggaaag tggtccaact ctcgtgaagc ctacccagac cctgacactg      60
acctgtacct tttctggctt ctccgtgact acaagcggcg tgggagtggg ctggatccgg     120
cagcctccag gcaaagctct ggaatacctg gccctgatct actacaacga ggacaagcgg     180
tattctacct ctctgaagtc cagactgaca atcaccaagg acacctccaa gaaccaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gataccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 732
<211> 357
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_2_v27 VH (nt -
      CO)

<400> 732
caaatcactc taaaggaaag tggtccaact ctggtgaagc ctacccagac cctgacactg      60
acctgtacct tttctggctt ctccgtgacc acctctggcg tgggagtggg ctggatccgg     120
cagcctccag gcaaggccct cgagtacctg gctctgatct actacaacaa cgacaagcgg     180
tattctacta gcctgaagtc cagactgaca atcaccaagg atacatccaa aaatcaagtg     240
gtgctgacca tgaccaacat ggaccctgtg gacaccgcta cctactactg cgccagacac     300
accatcccct ccatcttcga ctactggggc cagggcatcc tggtcaccgt gtccagc        357

<210> 733
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody S2D106-v1.1 VH

<400> 733
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtt      60
tcctgcaagg cttctggagg ccccttcagc agctctgcta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaggg atcatcccta tggtaggtac agcaaactat     180
gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac     240
atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
cgctattgta gtggtggtag ctgctactcc gtctggttcg acccctgggg ccagggaacc     360
ctggtcaccg tctcctca                                                   378

<210> 734
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v2  VH

<400> 734
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtt      60
tcctgcaagg cttctggagg ccccttcagc agctctgcta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaggg atcatcccta tagtaggtac agcaaactat     180
gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac     240
atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
cgctattgta gtggtggtag ctgctactcc gtctggttcg acccctgggg ccagggaacc     360
ctggtcaccg tctcctca                                                   378

<210> 735
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v3 VH

<400> 735
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtt      60
tcctgcaagg cttctggagg ccccttcagc agctctgcta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaggg atcatcccta tggtaggtac agcaaactat     180
gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac     240
atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
cgctattgta gtggtggtag ctgctactcc gtcttcttcg acccctgggg ccagggaacc     360
ctggtcaccg tctcctca                                                   378

<210> 736
<211> 378
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v4 VH

<400> 736
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtt      60
tcctgcaagg cttctggagg ccccttcagc agctctgcta tcagctgggt gcgacaggcc     120
cctggacaag ggcttgagtg gatgggaggg atcatcccta tagtaggtac agcaaactat     180
gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac     240
atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagattcg     300
cgctattgta gtggtggtag ctgctactcc gtcttcttcg acccctgggg ccagggaacc     360
ctggtcaccg tctcctca                                                   378

<210> 737
<211> 327
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody S2E12-v1.1 VL(VK)

<400> 737
gatattgtgt tgacgcagac tccaggcacc ctgtctttgt ctccagggga aagagccacc      60
ctctcctgca gggccagtca gagtgttagc agcagttact tagcctggta ccagcagaaa     120
cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca     180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag     240
cctgaagatt ttgcagtgta ttactgtcag cagtatgttg gcttaacagg gtggacgttc     300
ggccaaggga ccaaggtgga aatcaaa                                         327

<210> 738
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v2 VL(VK)

<400> 738
Asp Ile Val Leu Thr Gln Thr Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
            20                  25                  30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Ala Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Gly Leu Thr
                85                  90                  95
Gly Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 739
<211> 327
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v2 VL(VK)

<400> 739
gatattgtgt tgacgcagac tccaggcacc ctgtctttgt ctccagggga aagagccacc      60
ctctcctgca gggccagtca gagtgttagc agcagttact tagcctggta ccagcagaaa     120
cctggccagg ctcccagggc cctcatctat ggtgcatcca gcagggccac tggcatccca     180
gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag     240
cctgaagatt ttgcagtgta ttactgtcag cagtatgttg gcttaacagg gtggacgttc     300
ggccaaggga ccaaggtgga aatcaaa                                         327

<210> 740
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_3_1_v2 VH

<400> 740
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Ser Gly Tyr Leu Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp
            100                 105                 110
Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 741
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_3_1_v3 VH

<400> 741
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Ser Gly Tyr Leu Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp
            100                 105                 110
Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 742
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_3_1_v4 VH

<400> 742
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Ala Thr Ser Ile Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Ser Gly Tyr Leu Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp
            100                 105                 110
Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 743
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_3_1_v5 VH

<400> 743
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
            20                  25                  30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Phe Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Phe Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Ser Gly Tyr Leu Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp
            100                 105                 110
Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120

<210> 744
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v3 VL(VK)

<400> 744
Asp Ile Val Leu Thr Gln Thr Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
            20                  25                  30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Gly Leu Thr
                85                  90                  95
Gly Phe Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 745
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v3 CDRL3

<400> 745
Gln Gln Tyr Val Gly Leu Thr Gly Phe Thr
 1               5                  10

<210> 746
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v4 VL(VK)

<400> 746
Asp Ile Val Leu Thr Gln Thr Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
            20                  25                  30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Gly Leu Thr
                85                  90                  95
Gly Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
            100                 105

<210> 747
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v4 CDRL3

<400> 747
Gln Gln Tyr Val Gly Leu Thr Gly Tyr Thr
 1               5                  10

<210> 748
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v5 VH

<400> 748
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Phe Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 749
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v6 VH

<400> 749
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Tyr Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 750
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v7 VH

<400> 750
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Ala Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 751
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v7 CDRH3

<400> 751
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Ala Phe Asp Ile
 1               5                  10                  15

<210> 752
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v8 VH

<400> 752
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Ser Ser Gly Gly Ser Ser Ser Asp Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 753
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v8 CDRH3

<400> 753
Ala Ser Pro Tyr Ser Ser Gly Gly Ser Ser Ser Asp Gly Phe Asp Ile
 1               5                  10                  15

<210> 754
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v9 VH

<400> 754
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Pro Ser Gly Gly Ser Pro Ser Asp Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 755
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v9 CDRH3

<400> 755
Ala Ser Pro Tyr Pro Ser Gly Gly Ser Pro Ser Asp Gly Phe Asp Ile
 1               5                  10                  15

<210> 756
<211> 122
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v10 VH

<400> 756
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Met
65                  70                  75                  80
Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala
                85                  90                  95
Ser Pro Tyr Ala Ser Gly Gly Ser Ala Ser Asp Gly Phe Asp Ile Trp
            100                 105                 110
Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 757
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v10 CDRH3

<400> 757
Ala Ser Pro Tyr Ala Ser Gly Gly Ser Ala Ser Asp Gly Phe Asp Ile
 1               5                  10                  15

<210> 758
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v11 VH

<400> 758
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Phe Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Glu Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 759
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v12 VH

<400> 759
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Glu Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 760
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v12 CDRH3

<400> 760
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Glu Gly Phe Asp Ile
 1               5                  10                  15

<210> 761
<211> 123
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_4_v13 VH

<400> 761
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Ala Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120

<210> 762
<211> 126
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v5 VH

<400> 762
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Ser Ser Ser
            20                  25                  30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Gly Ile Ile Pro Met Val Gly Thr Ala Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Arg Tyr Ala Ser Gly Gly Ser Ala Tyr Ser Val Trp
            100                 105                 110
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 763
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v5 CDRH3

<400> 763
Ala Arg Asp Ser Arg Tyr Ala Ser Gly Gly Ser Ala Tyr Ser Val Trp
 1               5                  10                  15
Phe Asp Pro


<210> 764
<211> 126
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v6 VH

<400> 764
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
 1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Ser Ser Ser
            20                  25                  30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45
Gly Gly Ile Ile Pro Met Val Gly Thr Ala Asn Tyr Ala Gln Lys Phe
    50                  55                  60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Ser Arg Tyr Ser Ser Gly Gly Ser Ser Tyr Ser Val Trp
            100                 105                 110
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
        115                 120                 125

<210> 765
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence Antibody 409_11_1_v6 CDRH3

<400> 765
Ala Arg Asp Ser Arg Tyr Ser Ser Gly Gly Ser Ser Tyr Ser Val Trp
 1               5                  10                  15
Phe Asp Pro


<210> 766
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb CDRH3
      (IMGT)

<400> 766
Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Gly Phe Asp Ile
 1               5                  10

<210> 767
<211> 453
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 S2E12-v1 mAb CDRH3
      (IMGT)

<400> 767
Gln Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr
 1               5                  10                  15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Ser Ser
            20                  25                  30
Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Val
        35                  40                  45
Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe
    50                  55                  60
His Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Gly Phe Asp Ile
            100                 105                 110
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly
        115                 120                 125
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly
    130                 135                 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145                 150                 155                 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
                165                 170                 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
            180                 185                 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val
        195                 200                 205
Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys
    210                 215                 220
Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu
225                 230                 235                 240
Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
                245                 250                 255
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
            260                 265                 270
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
        275                 280                 285
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
    290                 295                 300
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu
305                 310                 315                 320
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
                325                 330                 335
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
            340                 345                 350
Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln
        355                 360                 365
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
    370                 375                 380
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
385                 390                 395                 400
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
                405                 410                 415
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
            420                 425                 430
Val Leu His Glu Ala Leu His Ser His Tyr Thr Gln Lys Ser Leu Ser
        435                 440                 445
Leu Ser Pro Gly Lys
    450

<210> 768
<211> 216
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 409_11_4_v2 VL light
      chain

<400> 768
Asp Ile Val Leu Thr Gln Thr Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
            20                  25                  30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Ala Leu
        35                  40                  45
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Gly Leu Thr
                85                  90                  95
Gly Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val
            100                 105                 110
Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys
        115                 120                 125
Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg
    130                 135                 140
Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn
145                 150                 155                 160
Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser
                165                 170                 175
Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys
            180                 185                 190
Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr
        195                 200                 205
Lys Ser Phe Asn Arg Gly Glu Cys
    210                 215

<210> 769
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 409_11_4_v7 CDRH3
      (IMGT)

<400> 769
Pro Tyr Cys Ser Gly Gly Ser Cys Ser Asp Ala Phe Asp Ile
 1               5                  10

<210> 770
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 409_11_4_v8 CDRH3
      (IMGT)

<400> 770
Pro Tyr Ser Ser Gly Gly Ser Ser Ser Asp Gly Phe Asp Ile
 1               5                  10

<210> 771
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 409_11_4_v9 CDRH3
      (IMGT)

<400> 771
Pro Tyr Pro Ser Gly Gly Ser Pro Ser Asp Gly Phe Asp Ile
 1               5                  10

<210> 772
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 409_11_4_v10 CDRH3
      (IMGT)

<400> 772
Pro Tyr Ala Ser Gly Gly Ser Ala Ser Asp Gly Phe Asp Ile
 1               5                  10

<210> 773
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic sequence SARS-CoV-2 409_11_4_v11 and
      409_11_4_v12 CDRH3 (IMGT)

<400> 773
Pro Tyr Cys Ser Gly Gly Ser Cys Ser Glu Gly Phe Asp Ile
 1               5                  10
